Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,A1BG,Alpha-1B-glycoprotein,24225,32,1.52 [0.21-11.17],0.6795386975703344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AAMDC,Mth938 domain-containing protein,23514,31,1.21 [0.64-2.30],0.5504184239116445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AARSD1,Alanyl-tRNA editing protein Aarsd1,27720,38,0.95 [0.57-1.58],0.833414637518318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABCA2,ATP-binding cassette sub-family A member 2,23415,31,1.38 [0.57-3.32],0.469697800620934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABHD14B,Protein ABHD14B,27559,38,0.94 [0.57-1.55],0.8217638869580837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABL1,Tyrosine-protein kinase ABL1,27720,38,0.88 [0.57-1.35],0.5609508388237179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABO,Histo-blood group ABO system transferase,24214,32,0.73 [0.57-0.93],0.0103959628219497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABRAXAS2,BRISC complex subunit Abraxas 2,23415,31,0.98 [0.58-1.65],0.945988020575919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27162,39,1.02 [0.73-1.44],0.8912894591884822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23748,32,0.68 [0.35-1.35],0.2722253561912615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24190,32,0.69 [0.46-1.04],0.078610548149695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAN,Aggrecan core protein,27593,37,1.32 [0.46-3.77],0.6005313119848212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE,Angiotensin-converting enzyme,24214,32,1.11 [0.31-4.03],0.8735052627115619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE2,Angiotensin-converting enzyme 2,27343,37,1.47 [0.89-2.42],0.1301605315585484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACHE,Acetylcholinesterase,23650,32,1.30 [0.49-3.47],0.6040123068199094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOT13,Acyl-coenzyme A thioesterase 13,24098,32,0.90 [0.67-1.20],0.4628047395534383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27845,37,0.61 [0.32-1.15],0.1236542549612261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23505,32,0.73 [0.33-1.65],0.4538826815845127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP5,Tartrate-resistant acid phosphatase type 5,27946,37,1.74 [0.75-4.01],0.194832601665594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP6,Lysophosphatidic acid phosphatase type 6,28060,39,0.75 [0.53-1.07],0.110305273237094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRBP,Acrosin-binding protein,24076,32,1.10 [0.47-2.55],0.8266585032428545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRV1,Acrosomal protein SP-10,23505,32,1.19 [0.84-1.69],0.3289728422000133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23415,31,0.75 [0.25-2.27],0.612615118397276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTA2,"Actin, aortic smooth muscle",27343,37,1.29 [0.72-2.29],0.3914194448840735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN2,Alpha-actinin-2,23415,31,0.58 [0.29-1.15],0.1169047792241505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN4,Alpha-actinin-4,27328,39,1.32 [0.62-2.79],0.470227155408717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACVRL1,Serine/threonine-protein kinase receptor R3,27608,38,1.19 [0.35-4.05],0.7762809667044385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY1,Aminoacylase-1,27845,37,1.20 [0.77-1.90],0.4200694260928563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23415,31,0.95 [0.52-1.73],0.8575157348693947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACYP1,Acylphosphatase-1,23559,32,1.03 [0.61-1.72],0.9216072426495832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA,Adenosine deaminase,28182,39,1.13 [0.52-2.44],0.7611674067110501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA2,Adenosine deaminase 2,27665,39,1.41 [0.73-2.74],0.3057743650507868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23505,32,1.77 [0.95-3.30],0.0715216022020881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27343,37,1.24 [0.48-3.19],0.6535214258735648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27656,38,1.10 [0.49-2.47],0.8212317406139527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28182,39,1.13 [0.49-2.59],0.769494460297987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28067,39,1.23 [0.46-3.24],0.6817558998663824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24098,32,1.99 [0.75-5.23],0.1654311816138479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23505,32,1.07 [0.37-3.08],0.9056191922439364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28187,37,0.67 [0.38-1.17],0.1592817411827492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27720,38,1.22 [0.61-2.47],0.5746626611021561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27343,37,0.55 [0.18-1.68],0.2899557210950286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23505,32,0.99 [0.39-2.49],0.9804776193818158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,27911,38,1.15 [0.61-2.15],0.6699070830533027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL2,ADAMTS-like protein 2,24183,32,1.82 [0.70-4.73],0.2204366375021358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL4,ADAMTS-like protein 4,23514,31,1.29 [0.32-5.22],0.7232047358638377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL5,ADAMTS-like protein 5,24190,32,1.01 [0.43-2.33],0.9889696257709716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27162,39,1.10 [0.51-2.38],0.8100206342560196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADD1,Alpha-adducin,23650,32,0.79 [0.48-1.30],0.359168644624764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRB3,Adhesion G protein-coupled receptor B3,27608,38,0.30 [0.12-0.76],0.0106699732931571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRD1,Adhesion G-protein coupled receptor D1,23650,32,1.72 [0.80-3.68],0.1631099819227081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE1,Adhesion G protein-coupled receptor E1,24098,32,1.00 [0.54-1.86],0.9989071897419144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE2,Adhesion G protein-coupled receptor E2,27968,39,0.63 [0.23-1.75],0.3780264525450381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE5,Adhesion G protein-coupled receptor E5,28036,37,0.56 [0.20-1.54],0.2627358901894651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRF5,Adhesion G protein-coupled receptor F5,24190,32,0.79 [0.24-2.62],0.7056752463441369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG1,Adhesion G-protein coupled receptor G1,27720,38,1.33 [0.89-1.96],0.1599571724345665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG2,Adhesion G-protein coupled receptor G2,27845,37,0.56 [0.28-1.11],0.0962101441251198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRV1,Adhesion G-protein coupled receptor V1,23416,30,1.25 [0.84-1.85],0.2692079176960069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH1B,All-trans-retinol dehydrogenase,23650,32,1.24 [0.82-1.87],0.3125245779048022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27343,37,1.20 [0.86-1.68],0.2849083251024059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADIPOQ,Adiponectin,24225,32,0.76 [0.47-1.25],0.2845395623285747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADM,Pro-adrenomedullin,28097,39,1.22 [0.43-3.49],0.7103371834667564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADRA2A,Alpha-2A adrenergic receptor,23415,31,0.76 [0.41-1.42],0.3889903452839568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFAP1,Actin filament-associated protein 1,23650,32,1.26 [0.87-1.82],0.2267122732408143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFM,Afamin,24225,32,2.33 [0.42-12.78],0.3305728729231605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFP,Alpha-fetoprotein,27568,38,0.95 [0.62-1.47],0.8261030227751822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGBL2,Cytosolic carboxypeptidase 2,23416,30,0.91 [0.63-1.31],0.6093864733088951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGER,Advanced glycosylation end product-specific receptor,27777,39,0.48 [0.24-0.97],0.0394515774044985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR2,Anterior gradient protein 2 homolog,26973,38,0.87 [0.65-1.16],0.3330809453656267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR3,Anterior gradient protein 3,27125,39,0.89 [0.54-1.47],0.6606716231523909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRN,Agrin,27968,39,0.98 [0.41-2.35],0.9692634598411004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRP,Agouti-related protein,28182,39,1.08 [0.64-1.83],0.7808190561901603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGT,Angiotensinogen,24214,32,1.58 [0.39-6.44],0.5220322276954106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGXT,Serine--pyruvate aminotransferase,27845,37,1.26 [0.89-1.77],0.1988499264943908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHCY,Adenosylhomocysteinase,27845,37,0.97 [0.63-1.48],0.876966480053645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK,Neuroblast differentiation-associated protein AHNAK,23514,31,0.55 [0.18-1.67],0.2931734428715323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK2,Protein AHNAK2,23514,31,0.90 [0.28-2.93],0.8661115403850475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24076,32,0.93 [0.54-1.59],0.7940483248520298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSG,Alpha-2-HS-glycoprotein,24214,32,0.72 [0.41-1.26],0.2540735263226476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSP,Alpha-hemoglobin-stabilizing protein,27795,38,0.98 [0.70-1.35],0.8804603956210604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIDA,"Axin interactor, dorsalization-associated protein",23520,31,0.83 [0.51-1.35],0.4460217501072312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1,Allograft inflammatory factor 1,27162,39,0.72 [0.42-1.24],0.2361293593236814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1L,Allograft inflammatory factor 1-like,23514,31,0.98 [0.53-1.82],0.95225102018117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",27669,38,1.06 [0.81-1.38],0.6821958885903385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK1,Adenylate kinase isoenzyme 1,27845,37,1.04 [0.66-1.64],0.8624770287637972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK2,"Adenylate kinase 2, mitochondrial",24123,32,0.94 [0.69-1.28],0.6939445951224281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKAP12,A-kinase anchor protein 12,23650,32,1.36 [0.34-5.47],0.6662336892704628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B1,Aldo-keto reductase family 1 member B1,27162,39,0.99 [0.68-1.43],0.9495865065649024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B10,Aldo-keto reductase family 1 member B10,23520,31,0.75 [0.39-1.41],0.3698376860099349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1C4,Aldo-keto reductase family 1 member C4,27343,37,1.31 [0.86-2.01],0.2109672677394509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23505,32,1.04 [0.65-1.69],0.8624746373730687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT1S1,Proline-rich AKT1 substrate 1,27189,38,0.95 [0.62-1.46],0.8149107346704945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT2,RAC-beta serine/threonine-protein kinase,24155,32,0.93 [0.71-1.20],0.5711824702263103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT3,RAC-gamma serine/threonine-protein kinase,27022,39,0.91 [0.56-1.48],0.6892954276598797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALCAM,CD166 antigen,28187,37,0.60 [0.13-2.73],0.5054800340415968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH1A1,Retinal dehydrogenase 1,27836,38,1.00 [0.59-1.71],0.9877902358834214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24076,32,1.39 [0.88-2.21],0.1615958619329875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27795,38,1.18 [0.80-1.74],0.4095430077388922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24155,32,0.76 [0.35-1.63],0.4779850836025847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALMS1,Alstrom syndrome protein 1,23748,32,0.45 [0.17-1.20],0.1110705781155284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPI,Intestinal-type alkaline phosphatase,23505,32,1.09 [0.83-1.43],0.5233404770364064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPP,"Alkaline phosphatase, placental type",27720,38,1.04 [0.81-1.35],0.7405067135346812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBN,Ameloblastin,27328,39,0.66 [0.20-2.16],0.4904353638488572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBP,Protein AMBP,28061,39,0.63 [0.15-2.70],0.5379867385595061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24183,32,0.51 [0.15-1.77],0.290233509334565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMFR,E3 ubiquitin-protein ligase AMFR,27189,38,0.91 [0.57-1.45],0.6871969994829854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO1,Amphoterin-induced protein 1,23520,31,0.89 [0.43-1.85],0.7594558945709894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO2,Amphoterin-induced protein 2,27720,38,0.87 [0.25-3.04],0.8278579254340296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMN,Protein amnionless,27328,39,1.13 [0.63-2.04],0.6815190784142222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOT,Angiomotin,23650,32,0.75 [0.31-1.82],0.518478364176554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOTL2,Angiomotin-like protein 2,23997,32,0.57 [0.23-1.42],0.2295770333392368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMPD3,AMP deaminase 3,24123,32,1.06 [0.66-1.69],0.8055007858302924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22700,31,0.93 [0.46-1.88],0.8421100504503165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2A,Pancreatic alpha-amylase,26798,35,0.79 [0.41-1.52],0.4809525254050518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2B,Alpha-amylase 2B,25958,34,0.72 [0.37-1.39],0.3229829231109343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANG,Angiogenin,27746,39,0.94 [0.40-2.21],0.8916800080342001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT1,Angiopoietin-1,27762,38,0.75 [0.55-1.04],0.0857149767417454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT2,Angiopoietin-2,28097,39,1.16 [0.55-2.44],0.6999445546053018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL1,Angiopoietin-related protein 1,27428,37,0.65 [0.23-1.81],0.4107836020565033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL2,Angiopoietin-related protein 2,27877,39,0.97 [0.47-1.99],0.9283936444175622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL3,Angiopoietin-related protein 3,27845,39,0.75 [0.34-1.65],0.4704140687902871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL4,Angiopoietin-related protein 4,27925,39,1.31 [0.72-2.41],0.3781176655602506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL7,Angiopoietin-related protein 7,28097,39,1.26 [0.59-2.67],0.5484345787041021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANK2,Ankyrin-2,23415,31,0.75 [0.40-1.39],0.3577742627108737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23505,32,0.84 [0.55-1.30],0.4402939556907265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRA2,Ankyrin repeat family A protein 2,23333,31,0.82 [0.42-1.60],0.5588962359236269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRD54,Ankyrin repeat domain-containing protein 54,27162,39,1.35 [0.90-2.01],0.1474632696468771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23514,31,1.52 [0.86-2.69],0.1505935610991396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANPEP,Aminopeptidase N,27877,39,1.09 [0.39-3.05],0.8648138331145998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA1,Annexin A1,23514,32,1.19 [0.62-2.28],0.5950300146266051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA10,Annexin A10,27189,38,1.43 [1.06-1.91],0.0183774098125084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA11,Annexin A11,27784,36,1.11 [0.70-1.75],0.6605380553933993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA2,Annexin A2,23174,31,1.07 [0.66-1.74],0.7852594861522503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA3,Annexin A3,28067,39,1.00 [0.67-1.49],0.9950386880414716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA4,Annexin A4,27701,37,0.87 [0.58-1.30],0.5041258696808171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA5,Annexin A5,27094,38,1.17 [0.45-3.02],0.7487175190375397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27328,39,0.51 [0.25-1.06],0.0732048266528821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC3,Membrane primary amine oxidase,27924,39,0.62 [0.25-1.52],0.291804092079478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP1G2,AP-1 complex subunit gamma-like 2,24076,32,0.76 [0.49-1.17],0.2132864570971469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP2B1,AP-2 complex subunit beta,23520,31,0.65 [0.30-1.44],0.2927694272165628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3B1,AP-3 complex subunit beta-1,24098,32,0.78 [0.50-1.23],0.2922801101468791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3S2,AP-3 complex subunit sigma-2,24123,32,0.72 [0.34-1.53],0.3886295911527133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27720,38,0.87 [0.45-1.66],0.6652552984664799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APCS,Serum amyloid P-component,24022,32,0.73 [0.28-1.93],0.5251921759697951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28020,39,1.06 [0.67-1.70],0.7981195779340057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APLP1,Amyloid-like protein 1,27845,37,0.62 [0.35-1.10],0.1026415686164826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA1,Apolipoprotein A-I,24225,32,0.79 [0.21-2.98],0.7308643316679133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA2,Apolipoprotein A-II,24214,32,1.80 [0.93-3.50],0.081095617631588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA4,Apolipoprotein A-IV,24225,32,0.61 [0.21-1.73],0.3510165569951984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOB,Apolipoprotein B-100,24214,32,0.98 [0.22-4.37],0.982066502658494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOBR,Apolipoprotein B receptor,23514,31,1.00 [0.44-2.26],0.996435051994758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOC1,Apolipoprotein C-I,24175,32,1.39 [0.62-3.11],0.4192670251480479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOD,Apolipoprotein D,23094,31,1.11 [0.53-2.31],0.7830062011252785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOE,Apolipoprotein E,24225,32,1.35 [1.03-1.77],0.0322613715268566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOF,Apolipoprotein F,24214,32,0.37 [0.17-0.80],0.0116050737151796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOH,Beta-2-glycoprotein 1,27836,38,0.81 [0.36-1.83],0.612808688580267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOL1,Apolipoprotein L1,24214,32,0.77 [0.42-1.40],0.3862816690603765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOM,Apolipoprotein M,27890,39,0.74 [0.46-1.20],0.223301746892004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APP,Amyloid-beta precursor protein,27786,38,0.67 [0.43-1.05],0.0792747464276079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APPL2,DCC-interacting protein 13-beta,23650,32,0.88 [0.65-1.18],0.3858070233036362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APRT,Adenine phosphoribosyltransferase,27623,38,1.13 [0.62-2.06],0.6982898025738231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARAF,Serine/threonine-protein kinase A-Raf,23748,32,0.90 [0.53-1.53],0.7005668725636955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AREG,Amphiregulin,27720,38,1.20 [0.63-2.29],0.5720970086878208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARF6,ADP-ribosylation factor 6,24098,32,0.87 [0.64-1.18],0.3710596977884404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARFIP1,Arfaptin-1,24155,32,1.04 [0.65-1.68],0.8662949742104705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG1,Arginase-1,27705,38,0.92 [0.53-1.60],0.7756608085278185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG2,"Arginase-2, mitochondrial",24076,32,0.48 [0.17-1.35],0.1634424258687489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP1,Rho GTPase-activating protein 1,27162,39,0.93 [0.51-1.68],0.8034679950060937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP25,Rho GTPase-activating protein 25,27162,39,1.15 [0.74-1.78],0.5433031247867461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP30,Rho GTPase-activating protein 30,23748,32,0.46 [0.13-1.69],0.243884724230553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP45,Rho GTPase-activating protein 45,23650,32,0.84 [0.55-1.27],0.4054447896753375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP5,Rho GTPase-activating protein 5,23333,31,0.77 [0.45-1.33],0.3493996190747186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF1,Rho guanine nucleotide exchange factor 1,24123,32,0.93 [0.64-1.36],0.7210415412590594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF10,Rho guanine nucleotide exchange factor 10,24155,32,0.87 [0.61-1.26],0.4600275377822558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF12,Rho guanine nucleotide exchange factor 12,27833,38,1.01 [0.76-1.33],0.948719377524622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF5,Rho guanine nucleotide exchange factor 5,23416,30,1.18 [0.77-1.80],0.4511083088227962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID3A,AT-rich interactive domain-containing protein 3A,23416,30,0.62 [0.24-1.63],0.3341524753893896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID4B,AT-rich interactive domain-containing protein 4B,27189,38,0.51 [0.20-1.28],0.1525730791183398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL13B,ADP-ribosylation factor-like protein 13B,23415,31,0.88 [0.53-1.48],0.632922013816759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23415,31,0.39 [0.16-0.95],0.0387583171518625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARMCX2,Armadillo repeat-containing X-linked protein 2,23416,30,0.54 [0.22-1.28],0.1606599586901356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNT,Aryl hydrocarbon receptor nuclear translocator,27328,39,0.31 [0.12-0.79],0.0142501770377771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23415,31,0.86 [0.40-1.87],0.7119010981259574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSA,Arylsulfatase A,27836,38,0.97 [0.52-1.81],0.9340943654957184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSB,Arylsulfatase B,27720,38,0.77 [0.45-1.30],0.3312632296897426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART3,Ecto-ADP-ribosyltransferase 3,27924,39,0.75 [0.33-1.74],0.5082481405595215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART5,Ecto-ADP-ribosyltransferase 5,23416,30,1.26 [0.82-1.93],0.2850159493172627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARTN,Artemin,27328,39,0.73 [0.34-1.58],0.4300546107284136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH1,Acid ceramidase,23981,32,0.76 [0.36-1.63],0.4843179319540227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH2,Neutral ceramidase,27656,38,1.03 [0.60-1.77],0.9026150027719604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR1,Asialoglycoprotein receptor 1,27656,38,1.40 [0.55-3.56],0.4860015860569294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR2,Asialoglycoprotein receptor 2,24214,32,0.93 [0.25-3.41],0.9103714945361808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPN,Asporin,24190,32,0.51 [0.13-1.95],0.3268229972788354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPSCR1,Tether containing UBX domain for GLUT4,24155,32,0.74 [0.45-1.23],0.2499793601214989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23514,31,0.88 [0.62-1.23],0.4459835977649101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASS1,Argininosuccinate synthase,23415,31,1.02 [0.66-1.57],0.9439907237856996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27189,38,1.08 [0.74-1.58],0.6845537514123842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF4,Cyclic AMP-dependent transcription factor ATF-4,23333,31,0.97 [0.34-2.77],0.9514431352814898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG16L1,Autophagy-related protein 16-1,24098,32,0.90 [0.61-1.34],0.6118450327147662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG4A,Cysteine protease ATG4A,27162,39,0.84 [0.52-1.37],0.490974440141229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATOX1,Copper transport protein ATOX1,27911,38,1.22 [0.82-1.81],0.330636111289548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23415,31,0.82 [0.35-1.91],0.6446534376633475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23415,31,1.26 [0.44-3.64],0.6634161379826398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23415,31,0.46 [0.15-1.43],0.177260108237526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B4,Protein ATP1B4,23333,31,0.49 [0.18-1.34],0.1643928662163054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23415,31,0.70 [0.33-1.46],0.3387498952216336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23415,31,0.69 [0.29-1.62],0.3901088295510682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5IF1,"ATPase inhibitor, mitochondrial",27968,39,0.83 [0.65-1.07],0.1479586996881694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5PO,"ATP synthase subunit O, mitochondrial",27189,38,0.77 [0.37-1.61],0.4918440551015661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6AP2,Renin receptor,27162,39,0.45 [0.19-1.08],0.0734006489293787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1D,V-type proton ATPase subunit D,27720,38,1.28 [0.49-3.39],0.6129163213523954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1F,V-type proton ATPase subunit F,27141,38,0.76 [0.48-1.20],0.2448654712098229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G1,V-type proton ATPase subunit G 1,23514,31,0.79 [0.49-1.29],0.3494054197459985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G2,V-type proton ATPase subunit G 2,23415,31,0.96 [0.66-1.39],0.8241125142943128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRAID,All-trans retinoic acid-induced differentiation factor,24098,32,0.50 [0.14-1.82],0.2921304831287031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRN,"Attractin, Isoform 2",24225,32,0.93 [0.12-7.25],0.943481845027736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN10,Ataxin-10,27189,38,0.83 [0.56-1.22],0.3350189787662839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2,Ataxin-2,23416,30,0.87 [0.59-1.28],0.4854909088950964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2L,Ataxin-2-like protein,24155,32,0.67 [0.30-1.53],0.3432689462741685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN3,Ataxin-3,24123,32,1.03 [0.60-1.76],0.9167583077443282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXIN1,Axin-1,27833,38,1.01 [0.75-1.37],0.9258988565771212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXL,Tyrosine-protein kinase receptor UFO,27924,39,0.87 [0.31-2.48],0.800588741623131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZI2,5-azacytidine-induced protein 2,24155,32,0.94 [0.51-1.73],0.8388890266813268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZU1,Azurocidin,27011,37,0.86 [0.57-1.29],0.4667010773092517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B2M,Beta-2-microglobulin,24225,32,1.48 [0.90-2.45],0.1219100975603349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23415,31,0.56 [0.09-3.29],0.5175566214590333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23514,31,1.11 [0.44-2.80],0.825496752916905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GALT1,"Beta-1,4-galactosyltransferase 1",27968,39,0.84 [0.29-2.41],0.7432314072107655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GAT1,"Beta-1,4-glucuronyltransferase 1",27836,38,0.80 [0.48-1.34],0.4001642345155903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BABAM1,BRISC and BRCA1-A complex member 1,23505,32,0.78 [0.22-2.77],0.7055698469569243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BACH1,Transcription regulator protein BACH1,27833,38,1.14 [0.78-1.66],0.4944889944630294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG3,BAG family molecular chaperone regulator 3,27608,38,0.69 [0.36-1.30],0.249113127668115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG4,BAG family molecular chaperone regulator 4,23505,32,0.51 [0.23-1.13],0.0954079354297722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG6,Large proline-rich protein BAG6,27343,37,0.97 [0.44-2.14],0.9313520612223862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27162,39,1.17 [0.76-1.79],0.4787348286870083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAMBI,BMP and activin membrane-bound inhibitor homolog,27162,39,1.24 [0.48-3.17],0.654109140168561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BANK1,B-cell scaffold protein with ankyrin repeats,27833,38,1.07 [0.81-1.41],0.6519405537272811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAP18,Chromatin complexes subunit BAP18,24123,32,0.84 [0.49-1.44],0.5205392545711891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BATF,Basic leucine zipper transcriptional factor ATF-like,23520,31,0.78 [0.45-1.35],0.3685926386986685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAX,Apoptosis regulator BAX,27139,38,1.01 [0.73-1.38],0.9728971095820408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAM,Basal cell adhesion molecule,27836,38,0.48 [0.14-1.66],0.2493963636370781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAN,Brevican core protein,27656,38,0.73 [0.51-1.06],0.0943010679385852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24190,32,0.82 [0.26-2.57],0.7342826363404067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23416,30,0.43 [0.16-1.14],0.0899734258976289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCHE,Cholinesterase,23756,30,1.10 [0.31-3.93],0.8885235232262401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2,Apoptosis regulator Bcl-2,24098,32,0.87 [0.44-1.74],0.6972821797600885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L1,Bcl-2-like protein 1,24123,32,0.90 [0.64-1.25],0.5213273307159432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",27833,38,1.26 [0.63-2.53],0.5144968140896107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L15,Bcl-2-like protein 15,23505,32,0.75 [0.39-1.45],0.3916621801400521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7A,B-cell CLL/lymphoma 7 protein family member A,23333,31,1.36 [0.94-1.97],0.0991693757777863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24076,32,0.58 [0.23-1.50],0.2601589205073465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCR,Breakpoint cluster region protein,27833,38,1.06 [0.78-1.45],0.7069481363745367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BDNF,Brain-derived neurotrophic factor,24183,32,0.98 [0.66-1.46],0.924020540495816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BECN1,Beclin-1,23514,31,0.79 [0.43-1.45],0.4519781049046631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BEX3,Protein BEX3,23333,31,0.77 [0.32-1.82],0.5515538592882435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGLAP,Osteocalcin,24183,32,1.42 [0.98-2.05],0.0622959236506341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGN,Biglycan,27124,39,0.97 [0.76-1.23],0.7887187552486437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHLHE40,Class E basic helix-loop-helix protein 40,23416,30,0.80 [0.45-1.42],0.4456521439504273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23415,31,0.54 [0.15-1.97],0.3496160227025765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BID,BH3-interacting domain death agonist,27833,38,0.72 [0.46-1.13],0.1549413345859984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIN2,Bridging integrator 2,27836,38,0.75 [0.54-1.05],0.0908291087748547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIRC2,Baculoviral IAP repeat-containing protein 2,27162,39,0.90 [0.57-1.41],0.638961644715717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLMH,Bleomycin hydrolase,28187,37,0.72 [0.30-1.74],0.4637282057475844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLNK,B-cell linker protein,23505,32,0.37 [0.13-1.04],0.0584551514521453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23416,30,1.15 [0.76-1.74],0.5019297645496804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24123,32,0.60 [0.24-1.46],0.2573839204095939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLVRB,Flavin reductase,27836,38,0.88 [0.57-1.38],0.5862865418671812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP10,Bone morphogenetic protein 10,23650,32,0.92 [0.28-3.08],0.8972164827697471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP4,Bone morphogenetic protein 4,27608,38,0.74 [0.39-1.43],0.3718755526396109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP6,Bone morphogenetic protein 6,27293,37,0.99 [0.48-2.03],0.9756100251550952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMPER,BMP-binding endothelial regulator protein,23650,32,1.89 [0.57-6.30],0.3020734668997973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24190,32,0.79 [0.29-2.18],0.6448238387562965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23505,32,0.66 [0.29-1.52],0.331707533913659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOC,Brother of CDO,27343,37,0.40 [0.12-1.39],0.1489636550467194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA1,BolA-like protein 1,23416,30,1.39 [0.85-2.27],0.1936791732873407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA2_BOLA2B,BolA-like protein 2,23514,31,0.98 [0.52-1.86],0.9627177861000836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFA2,BPI fold-containing family A member 2,22672,29,0.98 [0.71-1.35],0.8899993532298669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB1,BPI fold-containing family B member 1,27791,37,1.11 [0.70-1.75],0.658289885281266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB2,BPI fold-containing family B member 2,24150,32,1.11 [0.65-1.89],0.6978342154095251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRAP,BRCA1-associated protein,23869,32,0.86 [0.64-1.16],0.3166202685618404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD1,Bromodomain-containing protein 1,23748,32,0.61 [0.17-2.20],0.4520802195610641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD2,Bromodomain-containing protein 2,23416,30,0.60 [0.18-2.00],0.4022939674726659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD3,Bromodomain-containing protein 3,23415,31,0.54 [0.21-1.40],0.2061782186455384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRDT,Bromodomain testis-specific protein,23415,31,0.74 [0.28-1.92],0.5340722474247094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRK1,Protein BRICK1,27189,38,0.84 [0.44-1.61],0.6090307696868726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRME1,Break repair meiotic recombinase recruitment factor 1,23416,30,1.27 [0.64-2.54],0.4961462047857631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRSK2,Serine/threonine-protein kinase BRSK2,24155,32,0.66 [0.25-1.76],0.4035794003557283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSG,Basigin,28133,38,5.45 [1.52-19.56],0.0093038681231872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSND,Barttin,23333,31,1.13 [0.43-2.94],0.8060898959193944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28109,39,0.98 [0.54-1.79],0.9507135699592268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST2,Bone marrow stromal antigen 2,28109,39,1.94 [1.38-2.72],0.0001494316025918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTC,Probetacellulin,27162,39,0.92 [0.62-1.36],0.6714951315668216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTD,Biotinidase,24225,32,2.27 [0.42-12.12],0.337967744733838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTLA,B- and T-lymphocyte attenuator,23333,31,0.83 [0.50-1.37],0.4590532599468091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN1A1,Butyrophilin subfamily 1 member A1,24033,32,0.83 [0.31-2.17],0.6971812107316628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN2A1,Butyrophilin subfamily 2 member A1,27968,39,1.00 [0.32-3.08],0.998230799473043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN3A2,Butyrophilin subfamily 3 member A2,27833,38,1.16 [0.53-2.54],0.7037557507363494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTNL10,Butyrophilin-like protein 10,23333,31,0.57 [0.18-1.82],0.3400673260467398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C19orf12,Protein C19orf12,27189,38,0.94 [0.59-1.50],0.7851953633361166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1GALT1C1,C1GALT1-specific chaperone 1,23415,31,0.68 [0.21-2.19],0.5232582490845846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QA,Complement C1q subcomponent subunit A,28039,38,1.14 [0.32-4.03],0.8382702644019943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24155,32,0.51 [0.22-1.19],0.1197061018099303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QL2,Complement C1q-like protein 2,23505,32,0.77 [0.34-1.75],0.5294619127984058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,27924,39,0.92 [0.47-1.80],0.7981905519740231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23650,32,1.53 [0.60-3.87],0.3692122028967083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24155,32,0.77 [0.24-2.48],0.6606980260925504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23610,32,0.48 [0.28-0.83],0.008645573540063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1R,Complement C1r subcomponent,24225,32,1.62 [0.46-5.65],0.4493405599633456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1RL,Complement C1r subcomponent-like protein,24186,32,1.23 [0.21-7.03],0.8169247671558537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1S,Complement C1s subcomponent,24225,32,0.96 [0.20-4.70],0.9599845191614852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2,Complement C2,27890,39,0.60 [0.35-1.02],0.0579524976174865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2CD2L,Phospholipid transfer protein C2CD2L,27141,38,1.08 [0.56-2.09],0.8245348525165247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2orf69,UPF0565 protein C2orf69,23520,31,0.85 [0.43-1.69],0.6476042149450842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C3,Complement C3,22995,30,0.92 [0.40-2.09],0.8395185518558628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C4BPB,C4b-binding protein beta chain,27911,38,1.18 [0.58-2.42],0.6501966881927651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C5,Complement C5,24225,32,1.09 [0.12-9.47],0.9398117490210892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7,Complement component C7,23657,29,1.48 [0.48-4.59],0.5002546588141602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7orf50,Uncharacterized protein C7orf50,24123,32,0.84 [0.18-4.05],0.8317552785340894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C8B,Complement component C8 beta chain,24225,32,0.42 [0.15-1.21],0.10973914584765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9,Complement component C9,24214,32,1.70 [0.89-3.24],0.1055266117963922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9orf40,Uncharacterized protein C9orf40,24098,32,1.09 [0.73-1.65],0.6663209586606749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA1,Carbonic anhydrase 1,27200,38,0.84 [0.51-1.37],0.4818143239369534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA11,Carbonic anhydrase-related protein 11,27162,39,0.83 [0.53-1.28],0.3873382922038699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA12,Carbonic anhydrase 12,27720,38,0.88 [0.35-2.20],0.789067606367702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA13,Carbonic anhydrase 13,27518,37,0.95 [0.72-1.24],0.6930480379070056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA14,Carbonic anhydrase 14,28097,39,0.70 [0.32-1.53],0.3687360328140958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA2,Carbonic anhydrase 2,27756,38,0.98 [0.65-1.49],0.9397522094402592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA3,Carbonic anhydrase 3,28140,37,0.84 [0.52-1.37],0.4894200160823775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA4,Carbonic anhydrase 4,28187,37,0.55 [0.16-1.86],0.3365353515506931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA5A,"Carbonic anhydrase 5A, mitochondrial",27343,37,0.99 [0.72-1.37],0.96786130840082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA6,Carbonic anhydrase 6,27744,38,0.58 [0.38-0.89],0.0116908285566758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA7,Carbonic anhydrase 7,23748,32,1.49 [0.69-3.22],0.3092263692872555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA8,Carbonic anhydrase-related protein,23505,32,0.43 [0.07-2.54],0.3537288451248178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA9,Carbonic anhydrase 9,28097,39,1.39 [0.78-2.50],0.2667746851719162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CABP2,Calcium-binding protein 2,23520,31,1.10 [0.66-1.82],0.7251827604401617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23416,30,0.63 [0.18-2.22],0.4683994008667898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23415,31,0.79 [0.37-1.69],0.542414508511817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23416,30,0.88 [0.47-1.66],0.6930030025266191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24155,32,0.97 [0.66-1.45],0.896552906497008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACYBP,Calcyclin-binding protein,23598,32,0.91 [0.66-1.27],0.5913957362488693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CADPS,Calcium-dependent secretion activator 1,23520,31,0.54 [0.18-1.60],0.2624666636070049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB1,Calbindin,27720,38,0.59 [0.34-1.02],0.0570085014045861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB2,Calretinin,27189,38,1.17 [0.47-2.92],0.7398026295828616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCA,Calcitonin,27608,38,1.32 [0.88-1.98],0.1785048579574635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCB,Calcitonin gene-related peptide 2,24123,32,1.12 [0.49-2.57],0.7877114866288163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28016,39,0.93 [0.71-1.23],0.6173671369312953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23514,31,0.98 [0.62-1.54],0.9255331562841802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALY,Neuron-specific vesicular protein calcyon,23415,31,0.43 [0.14-1.34],0.1446430665743032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27162,39,0.78 [0.41-1.51],0.4697698563956191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23520,31,0.65 [0.31-1.38],0.2647166907407227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24155,32,0.83 [0.60-1.15],0.2643098823865266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CANT1,Soluble calcium-activated nucleotidase 1,27772,37,0.47 [0.11-1.99],0.3025105869963712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPG,Macrophage-capping protein,27673,38,0.94 [0.58-1.53],0.8106100358345045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPN3,Calpain-3,24076,32,0.53 [0.18-1.58],0.2550595879792625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPS,Calcyphosin,24123,32,0.71 [0.38-1.35],0.2948394068032759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CARHSP1,Calcium-regulated heat-stable protein 1,27189,38,0.84 [0.47-1.51],0.5633979600171795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASC3,Protein CASC3,23520,31,0.59 [0.24-1.43],0.2426585925127145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP1,Caspase-1,27189,38,0.95 [0.62-1.46],0.818189030142795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP10,Caspase-10,27189,38,0.94 [0.63-1.41],0.7714204042103449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP2,Caspase-2,27833,38,0.89 [0.58-1.36],0.5818546763691497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP3,Caspase-3,28187,37,0.91 [0.66-1.26],0.5726442301343281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP4,Caspase-4,23748,32,0.84 [0.65-1.08],0.1653541360774864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP7,Caspase-7,24123,32,1.03 [0.69-1.53],0.8972916806532493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP8,Caspase-8,28024,39,0.85 [0.53-1.35],0.483043550786653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP9,Caspase-9,23505,32,0.84 [0.48-1.48],0.5489010270467514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASQ2,Calsequestrin-2,23415,31,1.20 [0.66-2.19],0.5579933966106668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAT,Catalase,23849,32,1.08 [0.59-1.99],0.7920513809076626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLIF,Cobalamin binding intrinsic factor,27813,37,1.25 [0.82-1.91],0.2904545234391139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN1,Cerebellin-1,23416,30,0.98 [0.67-1.44],0.9158271650711942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN4,Cerebellin-4,28097,39,0.39 [0.16-0.93],0.0347849171331284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBS,Cystathionine beta-synthase,23514,31,1.13 [0.59-2.15],0.7201893629520515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBX2,Chromobox protein homolog 2,23415,31,0.41 [0.10-1.57],0.1920920272215271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27656,38,0.87 [0.58-1.29],0.4832370992446896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCAR2,Cell cycle and apoptosis regulator protein 2,24123,32,1.04 [0.58-1.87],0.8908746048726095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC134,Coiled-coil domain-containing protein 134,24076,32,0.45 [0.21-0.95],0.0359910188450677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC28A,Coiled-coil domain-containing protein 28A,23520,31,2.78 [0.93-8.26],0.0664168001976185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC50,Coiled-coil domain-containing protein 50,24155,32,0.99 [0.64-1.53],0.9485642957509764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC80,Coiled-coil domain-containing protein 80,27845,37,0.73 [0.30-1.79],0.4928901473147296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23514,31,1.00 [0.58-1.73],0.9988625324682796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL11,Eotaxin,28182,39,1.08 [0.52-2.25],0.8359139335503495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL13,C-C motif chemokine 13,28133,39,0.83 [0.55-1.25],0.3637586051628801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL14,C-C motif chemokine 14,27746,39,0.82 [0.40-1.69],0.5897351628971396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL15,C-C motif chemokine 15,28187,37,0.97 [0.50-1.86],0.9167688497319504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL16,C-C motif chemokine 16,28187,37,0.75 [0.46-1.20],0.2309845075924121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL17,C-C motif chemokine 17,27775,39,0.96 [0.70-1.31],0.7918121381839069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL18,C-C motif chemokine 18,27450,39,0.85 [0.55-1.31],0.4580890192442457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL19,C-C motif chemokine 19,28109,39,0.67 [0.46-0.98],0.0377453496861829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL2,C-C motif chemokine 2,27608,38,0.69 [0.39-1.21],0.1979725165301091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL20,C-C motif chemokine 20,28182,39,0.90 [0.62-1.29],0.5554974977532441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL21,C-C motif chemokine 21,27968,39,0.51 [0.23-1.13],0.0983807379824981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL22,C-C motif chemokine 22,27528,39,1.03 [0.59-1.79],0.9186561229394334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL23,C-C motif chemokine 23,27968,39,1.14 [0.59-2.19],0.6994191427722015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL24,C-C motif chemokine 24,27925,39,0.84 [0.59-1.19],0.3220959760209753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL25,C-C motif chemokine 25,28182,39,1.35 [0.77-2.35],0.2892227444592487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL26,C-C motif chemokine 26,27833,38,0.71 [0.49-1.01],0.0593134049944026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL27,C-C motif chemokine 27,27845,37,0.68 [0.45-1.02],0.0649415727492929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL28,C-C motif chemokine 28,27750,38,1.31 [0.86-2.02],0.212837952191407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL3,C-C motif chemokine 3,27833,38,0.91 [0.58-1.43],0.6895108703740209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL4,C-C motif chemokine 4,27870,39,0.72 [0.42-1.22],0.2185721147182953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL5,C-C motif chemokine 5,27924,39,0.83 [0.63-1.10],0.1939931183156987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL7,C-C motif chemokine 7,27833,38,0.88 [0.52-1.48],0.6220495950241361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL8,C-C motif chemokine 8,28061,39,0.99 [0.63-1.56],0.9706953156336716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN1,CCN family member 1,27681,38,0.96 [0.66-1.39],0.8238938163507026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN2,CCN family member 2,27847,39,0.78 [0.48-1.26],0.3035426549198478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN3,CCN family member 3,28141,37,1.19 [0.49-2.86],0.703639396680626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN4,CCN family member 4,28097,39,1.15 [0.59-2.25],0.6889707193894974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN5,CCN family member 5,27836,38,0.97 [0.46-2.06],0.9338766113504248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCND2,G1/S-specific cyclin-D2,23748,32,0.46 [0.29-0.73],0.00094493988382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCNE1,G1/S-specific cyclin-E1,23505,32,0.66 [0.33-1.31],0.2335917385679236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCS,Copper chaperone for superoxide dismutase,27656,38,0.89 [0.48-1.65],0.718355975749734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCT5,T-complex protein 1 subunit epsilon,27162,39,0.85 [0.44-1.67],0.6441843749850868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD101,Immunoglobulin superfamily member 2,24098,32,0.83 [0.39-1.80],0.6440803904649453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD109,CD109 antigen,27836,38,0.59 [0.29-1.22],0.155860567057078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD14,Monocyte differentiation antigen CD14,27228,39,1.21 [0.61-2.39],0.5771813606394596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD160,CD160 antigen,28182,39,1.00 [0.54-1.85],0.9912961683287522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD163,Scavenger receptor cysteine-rich type 1 protein M130,27924,39,0.83 [0.43-1.62],0.5821592892677799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164,Sialomucin core protein 24,27836,38,0.69 [0.20-2.36],0.5575601889975981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164L2,CD164 sialomucin-like 2 protein,23520,31,1.20 [0.48-3.01],0.7012245848465026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD177,CD177 antigen,27789,38,1.14 [0.89-1.48],0.3028962071089537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD1C,T-cell surface glycoprotein CD1c,27911,38,0.97 [0.30-3.13],0.9551947519925384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2,T-cell surface antigen CD2,23415,31,1.31 [0.62-2.75],0.4753881412008943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200,OX-2 membrane glycoprotein,27833,38,0.50 [0.16-1.55],0.2309403133688434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200R1,Cell surface glycoprotein CD200 receptor 1,27732,38,1.15 [0.52-2.54],0.7321771765207123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD207,C-type lectin domain family 4 member K,27250,37,0.97 [0.45-2.09],0.9413084395192222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD209,CD209 antigen,27903,37,0.43 [0.21-0.89],0.0230420965917686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD22,B-cell receptor CD22,28182,39,0.96 [0.48-1.92],0.8992365088546868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD226,CD226 antigen,23505,32,0.69 [0.31-1.56],0.3757278981993635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD244,Natural killer cell receptor 2B4,28182,39,0.84 [0.29-2.40],0.7416454139261783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD248,Endosialin,24183,32,1.03 [0.45-2.38],0.9402029159512124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD27,CD27 antigen,27911,38,1.73 [0.90-3.31],0.1005821764649726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD274,Programmed cell death 1 ligand 1,27656,38,1.31 [0.58-2.98],0.5161115207416834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD276,CD276 antigen,27823,39,1.03 [0.46-2.26],0.9509337299223288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD28,T-cell-specific surface glycoprotein CD28,27162,39,1.20 [0.55-2.63],0.641116629549978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2AP,CD2-associated protein,27845,37,1.00 [0.63-1.58],0.9942863292318866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300A,CMRF35-like molecule 8,23650,32,2.19 [0.76-6.29],0.1464313003724948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300C,CMRF35-like molecule 6,28109,39,1.12 [0.51-2.49],0.7776196220658094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300E,CMRF35-like molecule 2,28008,39,1.67 [0.85-3.30],0.1371228423222977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LF,CMRF35-like molecule 1,28097,39,1.03 [0.66-1.59],0.9014238884721614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LG,CMRF35-like molecule 9,27836,38,0.87 [0.39-1.92],0.7329923110962366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD302,CD302 antigen,27720,38,2.40 [1.08-5.34],0.0320281776638812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD33,Myeloid cell surface antigen CD33,27911,38,0.99 [0.69-1.43],0.96438215099486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD34,Hematopoietic progenitor cell antigen CD34,28012,39,0.80 [0.47-1.36],0.4048045126357431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD36,Platelet glycoprotein 4,23505,32,0.85 [0.42-1.75],0.6681303638867315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27720,38,2.02 [0.82-4.97],0.1245165891112068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3D,T-cell surface glycoprotein CD3 delta chain,23416,30,0.52 [0.14-1.92],0.3257161887819016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23748,32,1.28 [0.61-2.66],0.510812319969774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3G,T-cell surface glycoprotein CD3 gamma chain,23505,32,0.88 [0.56-1.39],0.5770452516869897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD4,T-cell surface glycoprotein CD4,27788,38,1.42 [0.59-3.43],0.4309167181587685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40,Tumor necrosis factor receptor superfamily member 5,27827,39,0.60 [0.32-1.10],0.0962383026983195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40LG,CD40 ligand,28182,39,0.97 [0.68-1.38],0.8724130893487487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD46,Membrane cofactor protein,27655,39,0.55 [0.19-1.58],0.2678598928818125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD48,CD48 antigen,27925,39,1.30 [0.50-3.37],0.593321135314981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5,T-cell surface glycoprotein CD5,28061,39,0.58 [0.25-1.38],0.2197612115505616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD55,Complement decay-accelerating factor,26842,38,0.43 [0.13-1.42],0.1635869056518046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD58,Lymphocyte function-associated antigen 3,27768,39,0.36 [0.08-1.67],0.1921262048184509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD59,CD59 glycoprotein,26806,36,1.03 [0.25-4.29],0.9647590750088708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5L,CD5 antigen-like,24094,32,1.33 [0.66-2.68],0.4242163011836958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD6,T-cell differentiation antigen CD6,28133,38,1.10 [0.64-1.89],0.7207883974880924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD63,CD63 antigen,27608,38,0.88 [0.51-1.54],0.6577419366077135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD69,Early activation antigen CD69,27693,37,0.86 [0.63-1.19],0.3705831746021689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD7,T-cell antigen CD7,23471,32,0.97 [0.43-2.16],0.9378003342543592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD70,CD70 antigen,27833,38,1.32 [0.69-2.53],0.4078209743062678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD72,B-cell differentiation antigen CD72,23650,32,1.31 [0.59-2.89],0.5052184045540222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD74,HLA class II histocompatibility antigen gamma chain,28109,39,1.86 [0.87-3.95],0.107753663703036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD79B,B-cell antigen receptor complex-associated protein beta chain,28182,39,1.67 [0.94-2.97],0.0784240299138416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD80,T-lymphocyte activation antigen CD80,24190,32,2.20 [0.94-5.11],0.067693360267319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD82,CD82 antigen,23748,32,0.65 [0.23-1.85],0.4219996378206433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD83,CD83 antigen,27833,38,1.59 [0.70-3.61],0.2696112222814582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD84,SLAM family member 5,27833,38,1.21 [0.50-2.94],0.6706230295791271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD86,T-lymphocyte activation antigen CD86,24098,32,0.69 [0.29-1.66],0.4044881245574722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD8A,T-cell surface glycoprotein CD8 alpha chain,28109,39,1.01 [0.56-1.81],0.9712164385404845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD93,Complement component C1q receptor,26757,39,0.44 [0.17-1.16],0.0969315932145537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99,CD99 antigen,27836,38,0.33 [0.07-1.52],0.1559254040491511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99L2,CD99 antigen-like protein 2,27836,38,0.54 [0.18-1.58],0.2566576912274932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDA,Cytidine deaminase,24150,32,1.06 [0.55-2.08],0.8556690779954759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDAN1,Codanin-1,24123,32,0.47 [0.09-2.52],0.3805454615149817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC123,Cell division cycle protein 123 homolog,23333,31,1.27 [0.84-1.92],0.2490284500683027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC25A,M-phase inducer phosphatase 1,23333,31,0.40 [0.14-1.10],0.076668812987077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC26,Anaphase-promoting complex subunit CDC26,24059,32,0.92 [0.57-1.50],0.7481912788079599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC27,Cell division cycle protein 27 homolog,27162,39,0.82 [0.49-1.35],0.4261593270269579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC37,Hsp90 co-chaperone Cdc37,27911,38,0.92 [0.65-1.29],0.6216870095979399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24098,32,0.87 [0.62-1.21],0.4081948613547197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDCP1,CUB domain-containing protein 1,27656,38,1.37 [0.83-2.26],0.2190532826982264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH1,Cadherin-1,26884,38,0.69 [0.30-1.56],0.3712415551362962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH15,Cadherin-15,28061,39,1.13 [0.72-1.78],0.5993403720432715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH17,Cadherin-17,27845,37,0.85 [0.55-1.32],0.4730123267315255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH2,Cadherin-2,27845,37,1.29 [0.57-2.92],0.5343486356054794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH22,Cadherin-22,23748,32,0.93 [0.27-3.24],0.9087401302271002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH23,Cadherin-23,24123,32,0.45 [0.11-1.80],0.2611524448239187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH3,Cadherin-3,28109,39,0.66 [0.29-1.52],0.3298333980192428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH4,Cadherin-4,23416,30,0.59 [0.24-1.46],0.2541495644989791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH5,Cadherin-5,28187,37,0.68 [0.26-1.80],0.4401786771094963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH6,Cadherin-6,27845,37,0.75 [0.35-1.63],0.4667282233092167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR1,Cadherin-related family member 1,27189,38,0.51 [0.23-1.13],0.0954340520182185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR2,Cadherin-related family member 2,27720,38,1.37 [0.91-2.04],0.1272649792531604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR5,Cadherin-related family member 5,27845,37,0.67 [0.34-1.33],0.2537982200891873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK1,Cyclin-dependent kinase 1,23333,31,0.45 [0.18-1.15],0.0954981911915081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24155,32,0.77 [0.41-1.45],0.425042249856568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKL5,Cyclin-dependent kinase-like 5,23416,30,0.53 [0.22-1.28],0.1557096481374685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN1A,Cyclin-dependent kinase inhibitor 1,27720,38,0.94 [0.72-1.22],0.630632393697882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27720,38,1.00 [0.74-1.35],0.9912227706951472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDNF,Cerebral dopamine neurotrophic factor,27720,38,1.43 [0.66-3.10],0.371231510085648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27873,39,0.31 [0.11-0.83],0.0201390906075741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDSN,Corneodesmosin,28091,39,0.95 [0.49-1.84],0.8854734764969738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27870,38,2.17 [0.66-7.17],0.2019460198001678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24098,32,0.83 [0.56-1.23],0.3573540317926653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23748,32,0.92 [0.53-1.58],0.753773430951098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24098,32,0.54 [0.24-1.22],0.1409504177290709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23748,32,1.70 [1.06-2.74],0.0278650467477247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,27833,38,1.40 [1.02-1.91],0.0354610522943038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27162,39,1.10 [0.63-1.91],0.7464346166721352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26788,39,0.92 [0.58-1.47],0.7341735063770637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24183,32,1.55 [0.83-2.86],0.1669407428740473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27343,37,1.01 [0.58-1.78],0.968541643383946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPA,CCAAT/enhancer-binding protein alpha,23505,32,0.86 [0.31-2.36],0.7657737201743977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPB,CCAAT/enhancer-binding protein beta,27343,37,1.19 [0.58-2.45],0.6349159525637034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA2A,Chymotrypsin-like elastase family member 2A,24183,32,1.15 [0.67-1.98],0.6078797358901884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA3A,Chymotrypsin-like elastase family member 3A,28138,37,0.94 [0.57-1.55],0.795269628653105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23650,32,0.93 [0.27-3.16],0.90559065818776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEMIP2,Cell surface hyaluronidase,23505,32,0.73 [0.21-2.51],0.614068884558223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEND1,Cell cycle exit and neuronal differentiation protein 1,23416,30,1.03 [0.58-1.85],0.9186722538923408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPF,Centromere protein F,23748,32,1.08 [0.59-1.98],0.7931893684227177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPJ,Centromere protein J,23748,32,0.98 [0.60-1.61],0.9433780990161234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP112,Centrosomal protein of 112 kDa,23415,31,1.35 [0.82-2.20],0.2332553417432549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP152,Centrosomal protein of 152 kDa,23333,31,0.94 [0.41-2.15],0.8746115316756501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP164,Centrosomal protein of 164 kDa,27328,39,1.21 [0.86-1.72],0.2707974995949919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP170,Centrosomal protein of 170 kDa,23514,31,0.70 [0.43-1.15],0.1580178235907053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP20,Centrosomal protein 20,27162,39,0.98 [0.67-1.43],0.9009238526234902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP290,Centrosomal protein of 290 kDa,23748,32,0.47 [0.20-1.11],0.0863125072244546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP350,Centrosome-associated protein 350,23333,31,0.91 [0.35-2.39],0.8520366519557556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP43,Centrosomal protein 43,27127,37,1.12 [0.75-1.69],0.5789363006018775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP85,Centrosomal protein of 85 kDa,27162,39,0.80 [0.50-1.26],0.331251665197553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CERT,Ceramide transfer protein,27189,38,1.02 [0.64-1.62],0.9449149038400084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES1,Liver carboxylesterase 1,27892,37,0.94 [0.65-1.34],0.7258348518960775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES2,Cocaine esterase,27720,38,0.57 [0.32-1.03],0.0608544903530549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES3,Carboxylesterase 3,27720,38,0.77 [0.48-1.23],0.2809227482395555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN2,Centrin-2,27189,38,0.90 [0.58-1.39],0.6365461627467288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN3,Centrin-3,24098,32,0.82 [0.53-1.27],0.3784511082584498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFB,Complement factor B,23775,31,0.94 [0.33-2.62],0.899185336028076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFC1,Cryptic protein,27162,39,0.79 [0.41-1.53],0.481869889056018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFD,Complement factor D,24225,32,0.91 [0.16-5.08],0.917032963632043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFH,Complement factor H,22817,30,0.71 [0.16-3.11],0.6504341000435274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR2,Complement factor H-related protein 2,24053,32,1.16 [0.62-2.15],0.6468023377719112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR4,Complement factor H-related protein 4,24177,32,0.92 [0.58-1.46],0.7296322284022769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR5,Complement factor H-related protein 5,23903,31,0.44 [0.24-0.80],0.0076235011799064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFI,Complement factor I,24225,32,1.44 [0.27-7.57],0.6663832887769978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFP,Properdin,24225,32,1.16 [0.30-4.45],0.8257140186482016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGA,Glycoprotein hormones alpha chain,27836,38,1.05 [0.71-1.55],0.8053962846590821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24214,32,0.68 [0.28-1.61],0.3758334884124051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGN,Cingulin,23520,31,1.24 [0.57-2.72],0.5891969192558297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGREF1,Cell growth regulator with EF hand domain protein 1,27845,37,0.70 [0.35-1.40],0.317585294387905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27162,39,0.87 [0.53-1.43],0.5741284998315637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAD,Chondroadherin,23650,32,1.33 [0.67-2.66],0.4180719620082067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24123,32,1.23 [0.56-2.70],0.6030956278324904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD6,MICOS complex subunit MIC25,24076,32,1.14 [0.37-3.49],0.822507651729492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHEK2,Serine/threonine-protein kinase Chk2,27343,37,0.42 [0.17-1.04],0.0602328504742071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGA,Chromogranin-A,24183,32,0.89 [0.56-1.42],0.6345462324113024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGB,Secretogranin-1,28012,39,0.97 [0.48-1.97],0.9337407544924466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHI3L1,Chitinase-3-like protein 1,27183,39,0.92 [0.63-1.34],0.65905396947246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHIT1,Chitotriosidase-1,27953,37,1.03 [0.85-1.24],0.7920518024307031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHL1,Neural cell adhesion molecule L1-like protein,27881,39,0.78 [0.52-1.19],0.2579157237378405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHM,Rab proteins geranylgeranyltransferase component A 1,23520,31,0.70 [0.39-1.28],0.2464224694345824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP1A,Charged multivesicular body protein 1a,27656,38,0.93 [0.65-1.33],0.674211761978075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP6,Charged multivesicular body protein 6,24190,32,0.73 [0.41-1.31],0.2950952083569652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHP1,Calcineurin B homologous protein 1,23416,30,1.10 [0.73-1.68],0.644156199172413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL1,Chordin-like protein 1,27925,39,0.80 [0.32-1.99],0.6261015688562499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL2,Chordin-like protein 2,27845,37,0.75 [0.43-1.33],0.3267627836567995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRM1,Muscarinic acetylcholine receptor M1,23520,31,0.82 [0.29-2.31],0.7108000214356458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIAPIN1,Anamorsin,27911,38,0.96 [0.61-1.51],0.858984972056372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CILP,Cartilage intermediate layer protein 1,24183,32,1.14 [0.61-2.13],0.6894903081105093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CINP,Cyclin-dependent kinase 2-interacting protein,23748,32,0.67 [0.26-1.71],0.4012001520853095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIRBP,Cold-inducible RNA-binding protein,24098,32,0.90 [0.64-1.27],0.5533066206924684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIT,Citron Rho-interacting kinase,23520,31,1.11 [0.55-2.26],0.7741310590841204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKAP4,Cytoskeleton-associated protein 4,28036,38,2.37 [1.01-5.57],0.0471871241281481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKB,Creatine kinase B-type,24183,32,0.99 [0.55-1.78],0.984790377514513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27722,39,1.34 [0.86-2.10],0.192644667632671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLASP1,CLIP-associating protein 1,23333,31,0.73 [0.41-1.30],0.2846051609835399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLC,Galectin-10,27807,37,0.69 [0.43-1.11],0.1261429186532308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC10A,C-type lectin domain family 10 member A,27656,38,0.64 [0.29-1.38],0.2506348088569943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC11A,C-type lectin domain family 11 member A,27788,38,0.75 [0.41-1.36],0.3478259490443848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC12A,C-type lectin domain family 12 member A,23505,32,0.53 [0.09-3.21],0.4913025933480002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC14A,C-type lectin domain family 14 member A,27836,38,1.07 [0.42-2.76],0.8845684179518867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1A,C-type lectin domain family 1 member A,27343,37,0.78 [0.31-1.95],0.5948341924345193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1B,C-type lectin domain family 1 member B,28109,39,0.89 [0.67-1.19],0.4279578063374978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC2L,C-type lectin domain family 2 member L,23520,31,0.64 [0.25-1.61],0.3430445199477866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC3B,Tetranectin,23662,31,0.86 [0.17-4.22],0.8500691994525519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4A,C-type lectin domain family 4 member A,27833,38,0.49 [0.25-0.97],0.0410549613116508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4C,C-type lectin domain family 4 member C,27833,38,1.15 [0.63-2.11],0.6430705061732029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4D,C-type lectin domain family 4 member D,27833,38,1.18 [0.76-1.84],0.4638147615751938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4G,C-type lectin domain family 4 member G,27833,38,0.53 [0.23-1.24],0.145407994816527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4M,C-type lectin domain family 4 member M,24143,32,0.70 [0.36-1.37],0.3013174846067915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC5A,C-type lectin domain family 5 member A,27746,37,1.19 [0.45-3.13],0.7201546621131211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC6A,C-type lectin domain family 6 member A,27162,39,1.51 [0.87-2.61],0.1450799532430496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC7A,C-type lectin domain family 7 member A,28182,39,2.00 [1.05-3.79],0.0344094761184083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLGN,Calmegin,23520,31,1.77 [0.94-3.33],0.0752759443603018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIC5,Chloride intracellular channel protein 5,23520,31,0.43 [0.12-1.61],0.2119184966158356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLINT1,Clathrin interactor 1,23333,31,0.94 [0.44-2.01],0.8679698763014978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIP2,CAP-Gly domain-containing linker protein 2,27833,38,0.93 [0.73-1.19],0.5778368931290797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLMP,CXADR-like membrane protein,28097,39,1.06 [0.28-3.98],0.9296886725913104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLNS1A,Methylosome subunit pICln,23520,31,1.34 [0.54-3.31],0.5309729425338325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27608,38,1.10 [0.82-1.47],0.5328874179236147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPS,Colipase,27795,38,0.91 [0.61-1.37],0.6562078978303306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSPN,Claspin,27141,38,0.51 [0.17-1.50],0.2213842103629671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN1,Calsyntenin-1,27189,38,0.66 [0.35-1.26],0.2092332266782548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN2,Calsyntenin-2,28182,39,1.18 [0.59-2.37],0.6309941873185363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN3,Calsyntenin-3,24123,32,1.70 [0.62-4.63],0.301525684243024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLTA,Clathrin light chain A,27343,37,0.62 [0.31-1.26],0.1886072481021991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLU,Clusterin,24225,32,1.28 [0.58-2.83],0.5350344954485753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLUL1,Clusterin-like protein 1,27798,37,1.29 [0.70-2.39],0.4089554221837956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMC1,COX assembly mitochondrial protein homolog,24190,32,0.79 [0.55-1.16],0.2294584471895691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMIP,C-Maf-inducing protein,24076,32,0.85 [0.57-1.28],0.4422562664357699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNDP1,Beta-Ala-His dipeptidase,27924,39,0.74 [0.42-1.30],0.2940969071824469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23416,30,0.75 [0.33-1.71],0.4891915588382468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23470,31,0.96 [0.62-1.48],0.8432138056701243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY2,Protein canopy homolog 2,27343,37,0.95 [0.57-1.61],0.8613902526767998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY4,Protein canopy homolog 4,27720,38,1.02 [0.70-1.48],0.9112517641891484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNST,Consortin,27845,37,0.84 [0.64-1.10],0.2015191020046051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTF,Ciliary neurotrophic factor,23416,30,1.30 [0.47-3.65],0.6124160330434721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN1,Contactin-1,28187,37,0.70 [0.44-1.10],0.1203550837848368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN2,Contactin-2,28097,39,0.73 [0.38-1.40],0.34759224272011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN3,Contactin-3,27836,38,0.83 [0.35-1.99],0.6783589385255062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN4,Contactin-4,27836,38,0.89 [0.26-3.01],0.8471837693884211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN5,Contactin-5,27926,39,0.47 [0.21-1.05],0.0652411349579582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP2,Contactin-associated protein-like 2,27833,38,0.41 [0.20-0.83],0.0136357242455423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP4,Contactin-associated protein-like 4,23520,31,1.05 [0.76-1.43],0.7841530148092755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COCH,Cochlin,24190,32,1.13 [0.56-2.28],0.7375921247684242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL15A1,Collagen alpha-1(XV) chain,24183,32,0.86 [0.24-3.10],0.8158728996058254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL18A1,Collagen alpha-1(XVIII) chain,27940,37,1.15 [0.32-4.12],0.8277465322434744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL1A1,Collagen alpha-1(I) chain,28187,37,1.66 [0.53-5.22],0.383175194747378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL24A1,Collagen alpha-1(XXIV) chain,24098,32,0.66 [0.47-0.92],0.0147658723892076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL28A1,Collagen alpha-1(XXVIII) chain,23520,31,1.02 [0.67-1.55],0.9155549770644128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL2A1,Collagen alpha-1(II) chain,23514,31,1.04 [0.67-1.60],0.858349500635435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL3A1,Collagen alpha-1(III) chain,24183,32,0.36 [0.08-1.53],0.1659253729414628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A1,Collagen alpha-1(IV) chain,27845,37,1.24 [0.60-2.60],0.5609670005542585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A4,Collagen alpha-4(IV) chain,23707,32,0.89 [0.47-1.65],0.7020398150004501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL5A1,Collagen alpha-1(V) chain,23650,32,0.99 [0.41-2.36],0.973035174692672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL6A3,Collagen alpha-3(VI) chain,28187,37,1.34 [0.57-3.17],0.5023657921008504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A1,Collagen alpha-1(IX) chain,27833,38,1.48 [0.83-2.65],0.1819323146031194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A2,Collagen alpha-2(IX) chain,23748,32,0.68 [0.28-1.68],0.4046559483001386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COLEC12,Collectin-12,27823,39,0.83 [0.26-2.59],0.7427152872774304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD1,COMM domain-containing protein 1,23514,31,0.72 [0.40-1.29],0.2677552681367653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD9,COMM domain-containing protein 9,24076,32,0.42 [0.15-1.17],0.0979590961842644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMP,Cartilage oligomeric matrix protein,27534,39,0.66 [0.28-1.56],0.3430162677748594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMT,Catechol O-methyltransferase,27039,37,1.03 [0.73-1.45],0.8807534577242756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPB2,Coatomer subunit beta',23415,31,0.62 [0.26-1.48],0.2858943616643949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPE,Coatomer subunit epsilon,27189,38,0.80 [0.39-1.63],0.540414306365785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23514,31,1.43 [0.77-2.66],0.2564157275545754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO1A,Coronin-1A,27292,37,0.84 [0.59-1.19],0.3285914437548555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO6,Coronin-6,23416,30,0.57 [0.20-1.67],0.3060937036890865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27720,38,0.85 [0.56-1.30],0.4615652120783342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX6B1,Cytochrome c oxidase subunit 6B1,24190,32,0.33 [0.10-1.01],0.0528562438202257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA1,Carboxypeptidase A1,28187,37,1.10 [0.70-1.75],0.6776397004957957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA2,Carboxypeptidase A2,28009,38,0.87 [0.56-1.36],0.5436759236443094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA4,Carboxypeptidase A4,23178,31,0.90 [0.41-1.96],0.7822435433289388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB1,Carboxypeptidase B,28187,37,1.18 [0.74-1.86],0.4874310343034087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB2,Carboxypeptidase B2,24175,32,0.76 [0.17-3.33],0.7151967397301582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPE,Carboxypeptidase E,27897,38,0.80 [0.40-1.58],0.5211543544486318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPLX2,Complexin-2,23333,31,0.43 [0.12-1.51],0.1887554616238908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPM,Carboxypeptidase M,27983,39,0.95 [0.43-2.06],0.8894915092318584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23505,32,2.46 [1.00-6.03],0.0498505794436062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPPED1,Serine/threonine-protein phosphatase CPPED1,28109,39,0.77 [0.50-1.19],0.2410287178608471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPQ,Carboxypeptidase Q,24143,32,0.84 [0.39-1.84],0.6691499969911113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPTP,Ceramide-1-phosphate transfer protein,23415,31,0.70 [0.26-1.88],0.4792367055812451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPVL,Probable serine carboxypeptidase CPVL,28045,39,1.83 [0.89-3.78],0.1026321380965628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM1,Probable carboxypeptidase X1,27911,38,0.80 [0.53-1.22],0.303077425966248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM2,Inactive carboxypeptidase-like protein X2,24190,32,1.23 [0.33-4.49],0.7584932601158805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR1,Complement receptor type 1,24121,32,0.72 [0.28-1.88],0.5072412160404323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR2,Complement receptor type 2,27924,39,0.44 [0.24-0.80],0.0074777004846848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27162,39,0.84 [0.59-1.19],0.3191185520887639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRADD,Death domain-containing protein CRADD,27608,38,0.85 [0.58-1.24],0.4032594405162505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREB3,Cyclic AMP-responsive element-binding protein 3,23333,31,0.60 [0.28-1.32],0.2061503298284999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREBZF,CREB/ATF bZIP transcription factor,23333,31,2.08 [0.76-5.73],0.1550177895790105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREG1,Protein CREG1,27453,38,0.72 [0.34-1.53],0.3887161763218884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD1,Protein disulfide isomerase CRELD1,23650,32,0.68 [0.27-1.71],0.4065375278023336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD2,Protein disulfide isomerase CRELD2,27925,39,1.14 [0.67-1.93],0.6209823242104631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRH,Corticoliberin,27117,39,0.73 [0.52-1.03],0.0739998952403461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHBP,Corticotropin-releasing factor-binding protein,27823,39,1.13 [0.42-3.09],0.8073758979675055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHR1,Corticotropin-releasing factor receptor 1,27343,37,0.37 [0.21-0.68],0.0011656631486351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIM1,Cysteine-rich motor neuron 1 protein,27968,39,1.55 [0.38-6.36],0.5420945980089775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIP2,Cysteine-rich protein 2,27656,38,1.47 [0.72-3.01],0.2903758177372616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP2,Cysteine-rich secretory protein 2,28097,39,0.77 [0.48-1.24],0.2767905886825654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP3,Cysteine-rich secretory protein 3,23978,31,0.91 [0.26-3.20],0.8772867340260606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRKL,Crk-like protein,27870,39,0.93 [0.72-1.21],0.5790541189549012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRLF1,Cytokine receptor-like factor 1,27968,39,1.06 [0.35-3.19],0.9228607905221956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRNN,Cornulin,27021,38,0.89 [0.58-1.38],0.6107287357886098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAC1,Cartilage acidic protein 1,28187,37,0.88 [0.34-2.27],0.7856896230572451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAM,Cytotoxic and regulatory T-cell molecule,27656,38,1.08 [0.61-1.92],0.7858313413265833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAP,Cartilage-associated protein,23520,31,0.55 [0.22-1.41],0.2154820092152318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRX,Cone-rod homeobox protein,27343,37,1.17 [0.95-1.45],0.1413017844221252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB1,Beta-crystallin B1,24190,32,0.84 [0.51-1.39],0.5000639506500857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB2,Beta-crystallin B2,24123,32,1.00 [0.57-1.74],0.990918853501362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYGD,Gamma-crystallin D,24123,32,0.86 [0.61-1.22],0.3997257982004831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYM,Ketimine reductase mu-crystallin,23416,30,0.83 [0.49-1.40],0.4776765769910186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYZL1,Quinone oxidoreductase-like protein 1,23514,31,0.89 [0.61-1.30],0.5535909207659976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSDE1,Cold shock domain-containing protein E1,23415,31,0.79 [0.55-1.13],0.1961131896536129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1,Macrophage colony-stimulating factor 1,27968,39,1.02 [0.35-3.02],0.9666338583475468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1R,Macrophage colony-stimulating factor 1 receptor,24214,32,1.11 [0.48-2.56],0.8105911536066324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2,Granulocyte-macrophage colony-stimulating factor,23415,31,0.77 [0.50-1.19],0.2347899586543741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27656,38,0.96 [0.59-1.54],0.8572693629399323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RB,Cytokine receptor common subunit beta,23505,32,0.92 [0.42-2.03],0.8423427574364253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3,Granulocyte colony-stimulating factor,27328,39,0.67 [0.36-1.23],0.1962199969970009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3R,Granulocyte colony-stimulating factor receptor,23505,32,1.02 [0.37-2.84],0.9680727423466812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSH1,Chorionic somatomammotropin hormone 1,24214,32,1.20 [0.44-3.22],0.722469409430003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK1D,Casein kinase I isoform delta,23505,32,0.74 [0.41-1.34],0.3176921610610597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK2A1,Casein kinase II subunit alpha,24155,32,0.60 [0.28-1.30],0.1939742603487778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG4,Chondroitin sulfate proteoglycan 4,24183,32,1.12 [0.40-3.08],0.8319215008473326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG5,Chondroitin sulfate proteoglycan 5,23416,30,0.43 [0.18-1.05],0.0646972258242533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSRP3,Cysteine and glycine-rich protein 3,23415,31,0.70 [0.45-1.09],0.1174631633154499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST1,Cystatin-SN,20962,27,0.71 [0.48-1.04],0.079980440409328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST3,Cystatin-C,27876,39,1.49 [0.54-4.10],0.4399450803628489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST5,Cystatin-D,27334,37,1.05 [0.63-1.77],0.8407519694592395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST6,Cystatin-M,27130,35,0.86 [0.46-1.63],0.6476811547733203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST7,Cystatin-F,27870,39,1.04 [0.79-1.38],0.7751791808471955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSTB,Cystatin-B,27463,37,1.21 [0.63-2.30],0.5657403065802387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTAG1A_CTAG1B,Cancer/testis antigen 1,23698,32,1.05 [0.53-2.06],0.8931929910199042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTBS,Di-N-acetylchitobiase,23880,32,1.90 [0.61-5.87],0.2665384928996225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTF1,Cardiotrophin-1,27343,37,1.00 [0.71-1.41],0.9833386083352093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTHRC1,Collagen triple helix repeat-containing protein 1,24183,32,0.89 [0.26-3.08],0.8587032357197282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTLA4,Cytotoxic T-lymphocyte protein 4,24183,32,0.75 [0.23-2.38],0.620997054423807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTNNA1,Catenin alpha-1,23416,30,0.45 [0.11-1.87],0.2707432004241391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRB1,Chymotrypsinogen B,27836,38,0.98 [0.58-1.66],0.9471185326647464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRC,Chymotrypsin-C,27824,39,0.89 [0.57-1.39],0.6133629283246381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRL,Chymotrypsin-like protease CTRL-1,24123,32,1.07 [0.66-1.74],0.7911856505080817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSB,Cathepsin B,27849,37,0.75 [0.42-1.36],0.3487629398375071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSC,Dipeptidyl peptidase 1,27778,39,0.87 [0.45-1.68],0.6721021419986275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSD,Cathepsin D,25965,37,1.66 [0.93-2.97],0.0849150092972462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSE,Cathepsin E,23650,32,0.65 [0.35-1.21],0.1724310726109662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSF,Cathepsin F,27911,38,0.56 [0.28-1.10],0.0923837076739637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSH,Pro-cathepsin H,27260,37,1.32 [0.89-1.94],0.1640669437744868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSL,Cathepsin L1,27845,37,2.58 [0.88-7.59],0.0845234325510119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSO,Cathepsin O,28182,39,1.72 [0.71-4.16],0.2298983927806498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSS,Cathepsin S,21972,29,2.92 [0.72-11.86],0.1330638060620561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSV,Cathepsin L2,28005,39,0.34 [0.17-0.68],0.0021908531096849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSZ,Cathepsin Z,27823,39,0.74 [0.30-1.83],0.5092929502463045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23520,31,1.18 [0.55-2.52],0.6715292136896693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CWC15,Spliceosome-associated protein CWC15 homolog,23971,32,0.80 [0.41-1.53],0.4964776503259237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CX3CL1,Fractalkine,27656,38,1.34 [0.57-3.16],0.4981672392181495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXADR,Coxsackievirus and adenovirus receptor,27833,38,1.82 [1.14-2.90],0.012123138878499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL1,Growth-regulated alpha protein,27781,39,1.20 [0.92-1.57],0.1778406275504045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL10,C-X-C motif chemokine 10,27968,39,0.86 [0.54-1.37],0.5356622386303463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL11,C-X-C motif chemokine 11,28109,39,0.98 [0.69-1.40],0.9249321033977268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL12,Stromal cell-derived factor 1,27328,39,0.76 [0.37-1.57],0.4577037685654168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL13,C-X-C motif chemokine 13,28109,39,1.11 [0.70-1.74],0.6640545325862577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL14,C-X-C motif chemokine 14,27328,39,0.91 [0.54-1.52],0.7165204505650922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL16,C-X-C motif chemokine 16,28134,37,0.73 [0.21-2.60],0.6274724008093053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL17,C-X-C motif chemokine 17,28182,39,1.60 [0.93-2.76],0.0876742764910768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL3,C-X-C motif chemokine 3,27827,39,0.93 [0.69-1.24],0.6124135712046184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL5,C-X-C motif chemokine 5,27750,37,0.97 [0.76-1.24],0.8275659239393117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL6,C-X-C motif chemokine 6,28182,39,1.12 [0.78-1.61],0.5318215180137548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL8,Interleukin-8,27624,38,1.10 [0.74-1.62],0.6453037188613971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL9,C-X-C motif chemokine 9,27968,39,1.15 [0.77-1.71],0.4977818000193635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5A,Cytochrome b5,23333,31,0.86 [0.50-1.47],0.5718171907537262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5R2,NADH-cytochrome b5 reductase 2,23813,32,0.78 [0.43-1.41],0.417522687330881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23415,31,1.02 [0.69-1.52],0.906369947945626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTH3,Cytohesin-3,23333,31,0.83 [0.49-1.43],0.5103711007612002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTL1,Cytokine-like protein 1,24183,32,0.33 [0.08-1.32],0.1171706421207495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAAM1,Disheveled-associated activator of morphogenesis 1,23650,32,0.73 [0.47-1.11],0.1379853851814662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAB2,Disabled homolog 2,28097,39,0.99 [0.77-1.27],0.9322259878211474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAG1,Dystroglycan,27968,39,0.80 [0.45-1.43],0.4513458309347392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAND5,DAN domain family member 5,23505,32,0.59 [0.39-0.90],0.0151906703562713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPK2,Death-associated protein kinase 2,23505,32,0.95 [0.51-1.75],0.8658062301078091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,27833,38,1.05 [0.82-1.34],0.6956182463597002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27608,38,0.95 [0.64-1.41],0.7956456947357239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBH,Dopamine beta-hydroxylase,24174,32,1.11 [0.80-1.55],0.538132328655532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBI,Acyl-CoA-binding protein,27695,38,0.94 [0.66-1.34],0.7307682253105565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBN1,Drebrin,23505,32,0.52 [0.25-1.09],0.0830962216823203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBNL,Drebrin-like protein,27968,39,0.95 [0.70-1.28],0.7410515458259315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",27911,38,1.18 [0.53-2.66],0.6816995314938545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCC,Netrin receptor DCC,23520,31,0.75 [0.37-1.52],0.4227082521825942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCDC2C,Doublecortin domain-containing protein 2C,23333,31,0.65 [0.34-1.25],0.1974225535525038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCLRE1C,Protein artemis,23333,31,0.50 [0.15-1.67],0.2593408314371445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCN,Decorin,27343,37,0.68 [0.17-2.64],0.5736371457099063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTD,Deoxycytidylate deaminase,23650,32,0.92 [0.65-1.31],0.6631437464294319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN1,Dynactin subunit 1,28097,39,1.07 [0.70-1.65],0.742574744367775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN2,Dynactin subunit 2,27720,38,0.88 [0.65-1.20],0.4267509625604923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN6,Dynactin subunit 6,27189,38,0.84 [0.53-1.31],0.4332774736069781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTPP1,dCTP pyrophosphatase 1,27845,37,1.24 [0.50-3.06],0.6382212442555624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D1,DCN1-like protein 1,23416,30,0.73 [0.39-1.34],0.3048726155779843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D2,DCN1-like protein 2,23333,31,1.05 [0.69-1.60],0.8365713640351534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCXR,L-xylulose reductase,27911,38,1.18 [0.70-1.98],0.533853081133868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDA1,DET1- and DDB1-associated protein 1,23415,31,0.38 [0.12-1.18],0.0935482191362997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27720,38,1.13 [0.61-2.11],0.6889416074351405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDC,Aromatic-L-amino-acid decarboxylase,27813,37,0.71 [0.39-1.29],0.2595551677616116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDHD2,Phospholipase DDHD2,24155,32,0.75 [0.45-1.25],0.2647554269279526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDI2,Protein DDI1 homolog 2,23650,32,0.99 [0.64-1.55],0.9726451090618392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDR1,Epithelial discoidin domain-containing receptor 1,28109,39,0.41 [0.11-1.48],0.1749039521814984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDT,D-dopachrome decarboxylase,24183,32,1.00 [0.45-2.23],0.9940947624696904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX1,ATP-dependent RNA helicase DDX1,24098,32,1.01 [0.51-2.00],0.9679070568299112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX25,ATP-dependent RNA helicase DDX25,23520,31,1.02 [0.40-2.61],0.9591370765800518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX39A,ATP-dependent RNA helicase DDX39A,23505,32,0.52 [0.10-2.69],0.4344863758316335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX4,Probable ATP-dependent RNA helicase DDX4,23505,32,0.69 [0.32-1.50],0.3483805881959746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX53,Probable ATP-dependent RNA helicase DDX53,23520,31,0.78 [0.29-2.11],0.6233280671333058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX58,Antiviral innate immune response receptor RIG-I,27162,39,0.95 [0.58-1.55],0.8287994201189884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",27833,38,0.87 [0.65-1.18],0.3766556857200599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFA1_DEFA1B,Neutrophil defensin 1,27253,39,1.21 [0.73-1.99],0.4617026190728107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB103A_DEFB103B,Beta-defensin 103,23339,32,1.14 [0.54-2.43],0.7261537215098866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB104A_DEFB104B,Beta-defensin 104,23416,30,0.52 [0.23-1.17],0.1139914127485735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB116,Beta-defensin 116,23416,30,1.36 [0.99-1.87],0.0564881849224634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB118,Beta-defensin 118,23416,30,1.09 [0.63-1.88],0.767027297410273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB4A_DEFB4B,Beta-defensin 4A,27425,38,1.06 [0.87-1.29],0.5673373283035322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENND2B,DENN domain-containing protein 2B,23415,31,0.57 [0.20-1.58],0.2770532031926189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENR,Density-regulated protein,23505,32,0.98 [0.53-1.79],0.9374460746983854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DFFA,DNA fragmentation factor subunit alpha,28182,39,1.00 [0.66-1.52],0.9888882864377114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGCR6,Protein DGCR6,23416,30,0.70 [0.26-1.84],0.4660832869859701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKA,Diacylglycerol kinase alpha,23505,32,0.84 [0.44-1.59],0.5840627179283875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKZ,Diacylglycerol kinase zeta,27328,39,1.24 [0.59-2.59],0.5733809513371603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHODH,Dihydroorotate dehydrogenase,23415,31,0.65 [0.27-1.61],0.3550870653177101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHPS,Deoxyhypusine synthase,24076,32,1.13 [0.51-2.51],0.7609916784274315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24123,32,0.86 [0.40-1.86],0.7090375338039001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIABLO,"Diablo homolog, mitochondrial",27746,37,0.81 [0.63-1.06],0.1248098705224291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK1C,Divergent protein kinase domain 1C,23520,31,1.76 [1.01-3.04],0.0441284215797713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK2B,Divergent protein kinase domain 2B,23650,32,1.13 [0.36-3.61],0.8308006642451429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK1,Dickkopf-related protein 1,28109,39,0.69 [0.43-1.09],0.1077526751085754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK3,Dickkopf-related protein 3,28187,37,0.83 [0.31-2.24],0.7163566405969364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK4,Dickkopf-related protein 4,27605,38,2.01 [1.27-3.18],0.0030155418233771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKKL1,Dickkopf-like protein 1,27720,38,1.10 [0.78-1.56],0.5930703645139919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLG4,Disks large homolog 4,24123,32,0.79 [0.49-1.30],0.3616444699136573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLGAP5,Disks large-associated protein 5,24155,32,0.98 [0.49-1.93],0.9494264203308522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLK1,Protein delta homolog 1,28187,37,0.81 [0.49-1.35],0.4247688386779438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL1,Delta-like protein 1,27911,38,1.06 [0.39-2.86],0.915257687696862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL4,Delta-like protein 4,23514,31,1.02 [0.71-1.47],0.9172426028028124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMD,Dystrophin,23514,31,0.83 [0.40-1.73],0.6207732067832888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMP1,Dentin matrix acidic phosphoprotein 1,23514,31,1.20 [0.65-2.21],0.5586896276548196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA1,DnaJ homolog subfamily A member 1,23333,31,0.73 [0.30-1.76],0.478245724325215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA2,DnaJ homolog subfamily A member 2,28085,39,0.92 [0.66-1.30],0.6461715428797259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA4,DnaJ homolog subfamily A member 4,24123,32,0.86 [0.54-1.39],0.5465322041280435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB1,DnaJ homolog subfamily B member 1,27720,38,0.97 [0.69-1.34],0.8334138048746729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB14,DnaJ homolog subfamily B member 14,24098,32,1.07 [0.64-1.77],0.8049633624199638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB2,DnaJ homolog subfamily B member 2,23650,32,0.97 [0.51-1.82],0.9132934665765542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB6,DnaJ homolog subfamily B member 6,23429,32,0.82 [0.55-1.23],0.3338006543491124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB8,DnaJ homolog subfamily B member 8,27343,37,0.99 [0.59-1.67],0.9716310649727492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC21,DnaJ homolog subfamily C member 21,24123,32,0.67 [0.26-1.70],0.397207557882042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23514,31,0.93 [0.62-1.40],0.7304239538413873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC9,DnaJ homolog subfamily C member 9,24098,32,1.08 [0.70-1.66],0.7420951108758478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNER,Delta and Notch-like epidermal growth factor-related receptor,27782,39,0.54 [0.18-1.60],0.2635919141090307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNLZ,DNL-type zinc finger protein,23416,30,0.99 [0.64-1.52],0.9555302016154854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM1,Dynamin-1,24098,32,1.00 [0.75-1.34],0.9939273266827464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM3,Dynamin-3,24155,32,0.84 [0.44-1.61],0.6089309460167562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNMBP,Dynamin-binding protein,27656,38,0.76 [0.46-1.25],0.2764703466173848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPEP,Aspartyl aminopeptidase,24123,32,1.26 [0.71-2.25],0.4335458772324659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,27913,39,0.93 [0.53-1.61],0.7915893513932929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOC2B,Double C2-like domain-containing protein beta,23520,31,1.13 [0.47-2.70],0.779275564173278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOCK9,Dedicator of cytokinesis protein 9,23416,30,1.08 [0.81-1.43],0.6113956211502498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK1,Docking protein 1,24123,32,0.97 [0.76-1.24],0.8248126831123783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK2,Docking protein 2,27845,37,0.90 [0.71-1.14],0.3869770417604055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP1,Dipeptidase 1,27608,38,0.62 [0.35-1.10],0.1016799702006284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP2,Dipeptidase 2,27720,38,0.90 [0.34-2.38],0.8393822275065248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP10,Inactive dipeptidyl peptidase 10,27833,38,0.36 [0.15-0.90],0.028086722389887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP4,Dipeptidyl peptidase 4,27288,39,0.87 [0.32-2.33],0.7806037262083669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP6,Dipeptidyl aminopeptidase-like protein 6,27720,38,0.76 [0.52-1.10],0.1436896355201673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP7,Dipeptidyl peptidase 2,27606,37,0.93 [0.58-1.48],0.7566902568319798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPT,Dermatopontin,28187,37,2.45 [0.77-7.82],0.1306506403095641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPY30,Protein dpy-30 homolog,28020,39,1.06 [0.68-1.66],0.7969017698450263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRAXIN,Draxin,27656,38,0.97 [0.49-1.93],0.935185999653282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRG2,Developmentally-regulated GTP-binding protein 2,27720,38,0.91 [0.55-1.52],0.729574143502836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSC2,Desmocollin-2,27502,37,0.92 [0.38-2.20],0.8472130531608703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSCAM,Down syndrome cell adhesion molecule,24155,32,1.54 [0.62-3.84],0.3510111745556729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG2,Desmoglein-2,27836,38,0.38 [0.13-1.10],0.0738137797695072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG3,Desmoglein-3,28013,39,0.65 [0.28-1.48],0.3017404757910648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG4,Desmoglein-4,27626,38,0.78 [0.44-1.37],0.3813908474343325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTD1,D-aminoacyl-tRNA deacylase 1,23650,32,0.79 [0.54-1.17],0.2450061062941341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTNB,Dystrobrevin beta,24037,32,0.70 [0.34-1.45],0.3366839032790086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23520,31,1.15 [0.70-1.89],0.5799152501934721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX3,Probable E3 ubiquitin-protein ligase DTX3,27720,38,1.18 [0.36-3.88],0.7902718809165592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTYMK,Thymidylate kinase,24190,32,0.90 [0.55-1.47],0.673633739941756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUOX2,Dual oxidase 2,27343,37,1.07 [0.73-1.57],0.7349450534182882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP13,Dual specificity protein phosphatase 13 isoform A,24076,32,0.73 [0.32-1.68],0.4563625112557686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP29,Dual specificity phosphatase 29,23520,31,1.14 [0.72-1.79],0.5789072265458037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP3,Dual specificity protein phosphatase 3,27189,38,0.90 [0.62-1.31],0.5825034644823345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24098,32,0.99 [0.71-1.37],0.947494326139952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DXO,Decapping and exoribonuclease protein,24123,32,1.08 [0.52-2.26],0.8299070797657238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24076,32,0.86 [0.39-1.93],0.7181702231052738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT1,Dynein light chain Tctex-type 1,23520,31,0.78 [0.48-1.27],0.3160719425714478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT3,Dynein light chain Tctex-type 3,24076,32,0.90 [0.42-1.94],0.7837988579718784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27656,38,0.88 [0.65-1.19],0.3992516139721308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBI3_IL27,Interleukin-27,28060,39,0.80 [0.31-2.06],0.6429173005020989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECE1,Endothelin-converting enzyme 1,27189,38,0.49 [0.22-1.09],0.0821173597620342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24190,32,1.40 [0.97-2.01],0.074404127261572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23514,31,0.97 [0.68-1.38],0.8588828993333772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECI2,Enoyl-CoA delta isomerase 2,23415,31,0.96 [0.55-1.69],0.8967962787420853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECM1,Extracellular matrix protein 1,23539,31,0.96 [0.38-2.43],0.9320484492241338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECSCR,Endothelial cell-specific chemotaxis regulator,23416,30,0.94 [0.45-1.95],0.8595459673990846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDA2R,Tumor necrosis factor receptor superfamily member 27,28097,39,1.25 [0.57-2.74],0.5779695487246335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDAR,Tumor necrosis factor receptor superfamily member EDAR,27833,38,0.93 [0.68-1.27],0.6662348858070672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDDM3B,Epididymal secretory protein E3-beta,24076,32,0.91 [0.49-1.69],0.767154935654517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23415,31,0.60 [0.19-1.94],0.3968537178796477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDF1,Endothelial differentiation-related factor 1,24155,32,0.98 [0.60-1.60],0.9457060707646826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27343,37,1.00 [0.46-2.18],0.9978202628719188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDN1,Endothelin-1,23514,31,3.75 [1.57-8.96],0.0028734560632147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDNRB,Endothelin receptor type B,23505,32,0.83 [0.59-1.18],0.3118815735930089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EEF1D,Elongation factor 1-delta,24190,32,0.83 [0.56-1.21],0.3223694028209125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24098,32,0.70 [0.18-2.63],0.5936003506083909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB2,Dynein regulatory complex protein 8,23748,32,0.94 [0.35-2.48],0.8968843706265212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27871,39,0.78 [0.31-1.98],0.5962161596727875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFHD1,EF-hand domain-containing protein D1,24155,32,1.21 [0.50-2.92],0.6784120698950851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA1,Ephrin-A1,27786,38,1.43 [0.50-4.08],0.5057297583112733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA4,Ephrin-A4,27608,38,2.24 [0.96-5.20],0.0614464014193198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNB2,Ephrin-B2,23520,31,1.24 [0.80-1.93],0.3346290582052102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGF,Pro-epidermal growth factor,27777,39,0.91 [0.70-1.19],0.4878065121972672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFL7,Epidermal growth factor-like protein 7,27162,39,0.81 [0.39-1.67],0.5605665483605138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFLAM,Pikachurin,24098,32,1.15 [0.39-3.35],0.8023793281004011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFR,Epidermal growth factor receptor,28187,37,0.52 [0.23-1.18],0.1173533823608896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGLN1,Egl nine homolog 1,27833,38,0.86 [0.48-1.53],0.6052874596516645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHBP1,EH domain-binding protein 1,24190,32,0.85 [0.54-1.34],0.4766822648614099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHD3,EH domain-containing protein 3,23514,31,0.92 [0.69-1.23],0.5858414137017145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24123,32,0.72 [0.34-1.49],0.372402181273974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24022,31,1.14 [0.85-1.54],0.3875204268573351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23415,31,0.71 [0.39-1.28],0.2575501511878856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23514,31,1.03 [0.47-2.28],0.9351473462087352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4B,Eukaryotic translation initiation factor 4B,27656,38,0.95 [0.58-1.58],0.8550926446952136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4E,Eukaryotic translation initiation factor 4E,23505,32,0.91 [0.63-1.34],0.6444144616817198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,27845,37,0.90 [0.57-1.41],0.6445635373648351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28182,39,0.96 [0.72-1.27],0.7598033314533192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24155,32,0.76 [0.44-1.32],0.3326539905676282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5,Eukaryotic translation initiation factor 5,23415,31,0.76 [0.31-1.84],0.5429579006938072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5A,Eukaryotic translation initiation factor 5A-1,27328,39,1.56 [0.82-2.98],0.1780600082999293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAC1,Zinc phosphodiesterase ELAC protein 1,24155,32,0.86 [0.58-1.27],0.4583595698763956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAVL4,ELAV-like protein 4,23416,30,1.19 [0.83-1.70],0.3501730563072023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELN,Elastin,24190,32,1.56 [0.61-3.98],0.3550176418000101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOA,Elongin-A,27720,38,0.95 [0.56-1.63],0.8594123809859913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOB,Elongin-B,23415,31,0.64 [0.23-1.77],0.3905994968010666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENAH,Protein enabled homolog,27328,39,1.15 [0.64-2.05],0.6392062454373453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENDOU,Poly(U)-specific endoribonuclease,22344,27,0.96 [0.48-1.92],0.9026009850533824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENG,Endoglin,28187,37,0.43 [0.08-2.41],0.3383002073745362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO1,Alpha-enolase,27813,38,1.00 [0.70-1.44],0.9862603626083086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO2,Gamma-enolase,28109,39,0.78 [0.51-1.20],0.2617017145606822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO3,Beta-enolase,23514,31,1.19 [0.72-1.97],0.4971735967569289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOPH1,Enolase-phosphatase E1,24076,32,0.59 [0.34-1.03],0.0620825778221545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23415,31,0.55 [0.14-2.14],0.3878339307288516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPEP,Glutamyl aminopeptidase,23415,31,1.28 [0.69-2.40],0.4357045117652897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28187,37,0.61 [0.19-2.00],0.417434966221536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,27968,39,0.82 [0.47-1.44],0.4977373231350243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23514,31,0.56 [0.22-1.41],0.2174049277334645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27041,35,1.30 [0.91-1.84],0.1482109326121067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENSA,Alpha-endosulfine,24076,32,0.74 [0.38-1.48],0.3990056882385656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27162,39,1.02 [0.52-1.98],0.9622576561706212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27343,37,0.80 [0.21-2.98],0.737356660512269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27343,37,0.87 [0.30-2.49],0.7881126512673948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTR1,Endosome-associated-trafficking regulator 1,23514,31,1.05 [0.60-1.83],0.8664657561514162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EP300,Histone acetyltransferase p300,23505,32,0.54 [0.16-1.79],0.3143452136626616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPB41L5,Band 4.1-like protein 5,23520,31,0.81 [0.43-1.52],0.512910274217581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPCAM,Epithelial cell adhesion molecule,27834,39,0.84 [0.62-1.14],0.2542691116150951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPGN,Epigen,24076,32,1.07 [0.56-2.06],0.8360988580371664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA1,Ephrin type-A receptor 1,27913,39,0.85 [0.37-1.97],0.7043321192551599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA10,Ephrin type-A receptor 10,27189,38,0.84 [0.50-1.42],0.5233841034500224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA2,Ephrin type-A receptor 2,26835,38,1.63 [0.65-4.11],0.2972773985641692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA4,Ephrin type-A receptor 4,23650,32,0.55 [0.17-1.80],0.3235866959137541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB4,Ephrin type-B receptor 4,28187,37,2.04 [0.69-6.09],0.1999437052189794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB6,Ephrin type-B receptor 6,27608,38,0.84 [0.32-2.16],0.7145924955320407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHX2,Bifunctional epoxide hydrolase 2,27343,37,0.74 [0.42-1.31],0.3016255561126683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPN1,Epsin-1,23748,32,0.48 [0.16-1.42],0.1826078514052666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPO,Erythropoietin,27833,38,1.47 [1.14-1.91],0.0032800613745283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPPK1,Epiplakin,23514,31,0.94 [0.60-1.47],0.7844935390263086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28057,39,1.11 [0.44-2.79],0.8287038197055476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB2,Receptor tyrosine-protein kinase erbB-2,27911,38,1.28 [0.40-4.09],0.6769496048735277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB3,Receptor tyrosine-protein kinase erbB-3,27720,39,0.33 [0.09-1.28],0.1100741619945672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB4,Receptor tyrosine-protein kinase erbB-4,27911,38,0.40 [0.18-0.92],0.0310372231766154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBIN,Erbin,27720,38,0.92 [0.70-1.22],0.5757025019550032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERC2,ERC protein 2,23520,31,1.26 [0.90-1.77],0.1795025664397958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERCC1,DNA excision repair protein ERCC-1,23333,31,0.62 [0.19-2.03],0.4277830489159511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EREG,Proepiregulin,27608,38,0.94 [0.66-1.36],0.7592609021862994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERI1,3'-5' exoribonuclease 1,23748,32,0.39 [0.13-1.20],0.1000570171278302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERMAP,Erythroid membrane-associated protein,23505,32,1.07 [0.51-2.25],0.850517514638858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24076,32,0.47 [0.19-1.16],0.101007273671486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP29,Endoplasmic reticulum resident protein 29,23650,32,0.90 [0.68-1.20],0.4710774563733548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP44,Endoplasmic reticulum resident protein 44,27681,38,0.67 [0.22-2.02],0.4778413673094731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23415,31,0.89 [0.40-2.00],0.777328230924474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESAM,Endothelial cell-selective adhesion molecule,28187,37,0.74 [0.29-1.88],0.5298381330113662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESM1,Endothelial cell-specific molecule 1,27823,39,1.58 [0.71-3.52],0.2630577003645407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESPL1,Separin,23333,31,0.52 [0.21-1.30],0.1609538059350857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESR1,Estrogen receptor,23505,32,0.62 [0.27-1.40],0.2476545872351759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESYT2,Extended synaptotagmin-2,24123,32,0.85 [0.56-1.28],0.4335228771449672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI2B,Protein EVI2B,23333,31,1.06 [0.48-2.38],0.8828756790246651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI5,Ecotropic viral integration site 5 protein homolog,23505,32,0.94 [0.65-1.37],0.754453367581008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVPL,Envoplakin,23748,32,1.99 [1.07-3.70],0.0291005659873705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXOSC10,Exosome component 10,23415,31,0.63 [0.27-1.44],0.269658879175048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXTL1,Exostosin-like 1,23415,31,1.30 [0.73-2.32],0.3746072846770927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EZR,Ezrin,28109,39,1.22 [0.40-3.75],0.7245317381271827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F10,Coagulation factor X,24214,32,0.40 [0.11-1.44],0.1598079676366092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11,Coagulation factor XI,23864,31,0.55 [0.16-1.84],0.3316753533404302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11R,Junctional adhesion molecule A,27836,38,0.86 [0.52-1.43],0.5598680922432773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F12,Coagulation factor XII,24225,32,1.30 [0.57-2.93],0.5314932485702605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F13B,Coagulation factor XIII B chain,24094,32,0.77 [0.21-2.78],0.6844813564166294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2,Prothrombin,24225,32,0.72 [0.26-2.00],0.5244927287909374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2R,Proteinase-activated receptor 1,27925,39,1.05 [0.65-1.68],0.84990061936168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F3,Tissue factor,27923,39,0.68 [0.24-1.94],0.467420117710659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F7,Coagulation factor VII,27878,39,0.58 [0.23-1.45],0.2446787215533908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F9,Coagulation factor IX,27890,39,0.72 [0.38-1.38],0.329737997405899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP1,"Fatty acid-binding protein, liver",27823,39,0.96 [0.71-1.30],0.8103011408831303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP2,"Fatty acid-binding protein, intestinal",27845,37,0.77 [0.52-1.14],0.18567743673072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP3,"Fatty acid-binding protein, heart",24190,32,0.88 [0.45-1.73],0.7128831200035408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP4,"Fatty acid-binding protein, adipocyte",28187,37,1.46 [0.84-2.54],0.1838355515976505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP5,Fatty acid-binding protein 5,28029,39,0.92 [0.61-1.39],0.684483483191524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP6,Gastrotropin,27307,37,1.02 [0.60-1.74],0.9364006468428172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP9,Fatty acid-binding protein 9,27833,38,1.01 [0.61-1.68],0.9602231903514326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FADD,FAS-associated death domain protein,27845,37,0.87 [0.59-1.27],0.4673543015684079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM13A,Protein FAM13A,24098,32,1.00 [0.62-1.64],0.9850611015298636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171A2,Protein FAM171A2,24155,32,0.72 [0.54-0.97],0.0302207305996506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171B,Protein FAM171B,24076,32,0.74 [0.42-1.31],0.305339220755895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM172A,Cotranscriptional regulator FAM172A,23514,31,0.91 [0.52-1.59],0.7382888824551861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM20A,Pseudokinase FAM20A,24190,32,0.98 [0.30-3.22],0.9790914690622876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3B,Protein FAM3B,27720,38,1.09 [0.51-2.36],0.8173090222042909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3C,Protein FAM3C,27813,37,0.64 [0.23-1.77],0.3934589792615304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3D,Protein FAM3D,24098,32,0.73 [0.48-1.09],0.1255194359754924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAP,Prolyl endopeptidase FAP,28187,37,0.92 [0.32-2.66],0.8811077937838974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FARSA,Phenylalanine--tRNA ligase alpha subunit,23520,31,0.93 [0.55-1.56],0.7768477614287781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAS,Tumor necrosis factor receptor superfamily member 6,28088,37,1.30 [0.65-2.59],0.4537522543613977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FASLG,Tumor necrosis factor ligand superfamily member 6,28182,39,0.88 [0.42-1.86],0.7397951904134097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBLN2,Fibulin-2,24183,32,1.97 [0.72-5.41],0.1854724798328318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBN2,Fibrillin-2,23520,31,1.03 [0.57-1.85],0.9202270599898033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBP1,"Fructose-1,6-bisphosphatase 1",27845,37,0.87 [0.58-1.30],0.4903901083127053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24190,32,1.11 [0.70-1.77],0.664015848696824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAR,Immunoglobulin alpha Fc receptor,27833,38,0.93 [0.51-1.70],0.8187572800774074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24155,32,2.41 [0.91-6.36],0.0764176172801722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER2,Low affinity immunoglobulin epsilon Fc receptor,27836,38,0.60 [0.33-1.08],0.0874440564771238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27705,39,0.95 [0.60-1.52],0.8392448756165678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27162,39,1.04 [0.65-1.68],0.8591629664049591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,27835,39,0.67 [0.40-1.13],0.1313579718608309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN1,Ficolin-1,24174,32,1.10 [0.59-2.04],0.7617565737709244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN2,Ficolin-2,27709,39,0.81 [0.43-1.54],0.5252939182847146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL1,Fc receptor-like protein 1,27845,37,0.91 [0.47-1.76],0.771122326583197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL2,Fc receptor-like protein 2,28057,38,1.49 [0.88-2.51],0.1382592649935458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL3,Fc receptor-like protein 3,27328,39,1.30 [0.78-2.19],0.313849446941196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL5,Fc receptor-like protein 5,27836,38,1.01 [0.61-1.66],0.9826432102362485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL6,Fc receptor-like protein 6,27833,38,0.89 [0.59-1.37],0.6056259206792505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRLB,Fc receptor-like B,27162,39,1.06 [0.66-1.71],0.8009551758578503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX1,"Adrenodoxin, mitochondrial",23415,31,1.25 [0.81-1.94],0.3176297285934762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX2,"Ferredoxin-2, mitochondrial",23415,31,0.81 [0.41-1.59],0.5325047178650975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FEN1,Flap endonuclease 1,27162,39,0.71 [0.41-1.25],0.2406483562813456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FES,Tyrosine-protein kinase Fes/Fps,27162,39,1.08 [0.60-1.92],0.8013720315634558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FETUB,Fetuin-B,27890,39,0.93 [0.41-2.15],0.8730107631944422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGA,Fibrinogen alpha chain,23643,31,1.24 [0.42-3.72],0.6947161911494507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24155,32,0.88 [0.58-1.34],0.547508337860255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF12,Fibroblast growth factor 12,23505,32,0.63 [0.20-1.96],0.4249183667792751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF16,Fibroblast growth factor 16,23505,32,0.92 [0.43-1.97],0.8204367652270335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF19,Fibroblast growth factor 19,27968,39,1.19 [0.83-1.71],0.3485769202016563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF2,Fibroblast growth factor 2,27833,38,0.73 [0.47-1.15],0.1722845581440855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF20,Fibroblast growth factor 20,23505,32,0.52 [0.17-1.57],0.2452284198339604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF21,Fibroblast growth factor 21,28060,39,1.17 [0.94-1.45],0.1546655172617232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF23,Fibroblast growth factor 23,28047,39,1.65 [1.22-2.22],0.0010764979477798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF3,Fibroblast growth factor 3,23505,32,0.47 [0.11-2.01],0.3114029744507551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF5,Fibroblast growth factor 5,27328,39,0.68 [0.29-1.61],0.3804074641495497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF6,Fibroblast growth factor 6,23505,32,0.38 [0.11-1.28],0.1180743018561812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF7,Fibroblast growth factor 7,23333,31,1.06 [0.70-1.59],0.7869805250476194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF9,Fibroblast growth factor 9,23287,31,0.75 [0.32-1.74],0.4998904462283859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP1,Fibroblast growth factor-binding protein 1,27911,38,0.49 [0.23-1.03],0.0602968609317364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP2,Fibroblast growth factor-binding protein 2,24183,32,0.94 [0.48-1.82],0.8529059275162533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP3,Fibroblast growth factor-binding protein 3,24123,32,1.64 [0.67-4.02],0.2756615273247921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR2,Fibroblast growth factor receptor 2,27911,38,1.29 [0.35-4.84],0.70237401764839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR4,Fibroblast growth factor receptor 4,23650,32,0.81 [0.43-1.52],0.5086331954586867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGL1,Fibrinogen-like protein 1,24214,32,1.38 [0.82-2.33],0.2264586709150318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGR,Tyrosine-protein kinase Fgr,27189,38,0.99 [0.61-1.60],0.9655991557568994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FH,"Fumarate hydratase, mitochondrial",23416,30,0.92 [0.57-1.49],0.7425351991174902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23415,31,0.40 [0.17-0.93],0.0344544390873903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIT,Bis(5'-adenosyl)-triphosphatase,27189,38,0.85 [0.57-1.25],0.3991968988537551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FIS1,Mitochondrial fission 1 protein,27815,39,0.87 [0.60-1.26],0.470152253235055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24155,32,0.91 [0.65-1.27],0.5853443662212148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,27960,38,0.89 [0.69-1.15],0.3862977792048642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27656,38,0.99 [0.52-1.90],0.978578176154202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27656,38,0.92 [0.68-1.24],0.5958327666752343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27141,38,0.81 [0.41-1.61],0.5545224039124935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBPL,FK506-binding protein-like,24098,32,0.83 [0.46-1.48],0.5276055803794527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLI1,Friend leukemia integration 1 transcription factor,27162,39,0.90 [0.69-1.17],0.4266670058275691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27656,38,1.75 [0.68-4.50],0.2429958348350417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT1,Vascular endothelial growth factor receptor 1,27675,38,1.27 [0.37-4.42],0.7036338887300558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3,Receptor-type tyrosine-protein kinase FLT3,27162,39,0.58 [0.21-1.59],0.2905017826273391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3LG,Fms-related tyrosine kinase 3 ligand,28182,39,1.31 [0.57-3.00],0.5299520580590666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT4,Vascular endothelial growth factor receptor 3,27911,38,0.65 [0.29-1.43],0.28221722900336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMNL1,Formin-like protein 1,27189,38,0.94 [0.59-1.50],0.7890122790026095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMR1,Synaptic functional regulator FMR1,27162,39,0.60 [0.27-1.37],0.2283036008250694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FN1,Fibronectin,24225,32,0.67 [0.19-2.41],0.5394944490289892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNDC1,Fibronectin type III domain-containing protein 1,24123,32,1.10 [0.54-2.25],0.790261874504105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24076,32,0.48 [0.16-1.41],0.1819405544631693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLH1,Glutamate carboxypeptidase 2,23505,32,0.89 [0.60-1.31],0.551627524382033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR1,Folate receptor alpha,27779,38,0.73 [0.26-2.03],0.5409761969474514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR2,Folate receptor beta,28109,39,1.22 [0.47-3.18],0.6872267680754851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR3,Folate receptor gamma,27820,38,0.90 [0.75-1.08],0.261839816719577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOS,Proto-oncogene c-Fos,23287,31,0.45 [0.18-1.16],0.0997040612514355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOSB,Protein fosB,27189,38,0.47 [0.18-1.22],0.1217753440718811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXJ3,Forkhead box protein J3,23505,32,0.58 [0.24-1.37],0.2143613284820438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO1,Forkhead box protein O1,27833,38,1.04 [0.75-1.45],0.8135550825397464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO3,Forkhead box protein O3,27162,39,0.88 [0.65-1.20],0.4274848583559978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD4B,FERM domain-containing protein 4B,23415,31,0.72 [0.42-1.23],0.2249207252842474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD7,FERM domain-containing protein 7,23520,31,1.09 [0.39-3.04],0.8631761713167304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRZB,Secreted frizzled-related protein 3,27560,38,1.62 [0.54-4.88],0.3913403104856597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSHB,Follitropin subunit beta,23514,31,1.64 [1.07-2.51],0.021769162658882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FST,Follistatin,27925,39,1.33 [0.78-2.28],0.2989605940975987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL1,Follistatin-related protein 1,23514,31,2.22 [0.61-8.04],0.2239295206528134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL3,Follistatin-related protein 3,27786,38,0.79 [0.29-2.12],0.6366582824028388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FTCD,Formimidoyltransferase-cyclodeaminase,24084,32,1.13 [0.77-1.66],0.5285420771744753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUCA1,Tissue alpha-L-fucosidase,27995,37,0.87 [0.62-1.21],0.4074666854667749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUOM,Fucose mutarotase,23650,32,1.25 [0.74-2.10],0.4053451426635454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FURIN,Furin,27911,38,0.95 [0.41-2.20],0.9084593787285956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUS,RNA-binding protein FUS,27112,39,0.88 [0.43-1.82],0.7334929999652909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23709,32,0.77 [0.40-1.46],0.4170677781751303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28109,39,1.02 [0.56-1.88],0.9380866281384068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT8,"Alpha-(1,6)-fucosyltransferase",27656,38,0.97 [0.59-1.58],0.9027305221567246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXN,"Frataxin, mitochondrial",28097,39,0.90 [0.62-1.33],0.608731465242967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXYD5,FXYD domain-containing ion transport regulator 5,27328,39,0.88 [0.56-1.37],0.559562641857412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FYB1,FYN-binding protein 1,27795,38,0.83 [0.61-1.13],0.2300991502296919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD10,Frizzled-10,23520,31,0.72 [0.33-1.55],0.3973580617679775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD8,Frizzled-8,23416,30,1.13 [0.52-2.47],0.7588252748098772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24076,32,1.00 [0.49-2.02],0.9993453067172376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23748,32,1.00 [0.60-1.67],0.9999941591041048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23416,30,0.61 [0.29-1.30],0.198664646616214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD1,Glutamate decarboxylase 1,23333,31,0.40 [0.11-1.50],0.1762034063380427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD2,Glutamate decarboxylase 2,23505,32,0.67 [0.27-1.70],0.4038572417757115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23748,32,1.02 [0.52-2.00],0.9603355713617422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23514,31,0.78 [0.39-1.53],0.468757063901954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAGE2A,G antigen 2A,23333,31,1.18 [0.72-1.92],0.511106204681498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAL,Galanin peptides,27968,39,0.92 [0.60-1.41],0.7005306299026288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27720,38,1.08 [0.39-2.95],0.8873667444059128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28097,39,1.27 [0.43-3.77],0.665580761505711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27328,39,1.09 [0.56-2.13],0.8011737392943442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24190,32,0.40 [0.12-1.31],0.1305583698565856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT7,N-acetylgalactosaminyltransferase 7,27720,38,1.90 [0.47-7.59],0.366267118697959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAMT,Guanidinoacetate N-methyltransferase,23415,31,0.89 [0.31-2.51],0.8232304782458648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23148,31,2.24 [0.64-7.86],0.2071397341378997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GART,Trifunctional purine biosynthetic protein adenosine-3,24155,32,0.86 [0.22-3.36],0.8289189273795761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS2,Growth arrest-specific protein 2,23748,32,0.89 [0.43-1.82],0.7421638042750296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS6,Growth arrest-specific protein 6,27989,37,0.79 [0.25-2.49],0.6917492610561882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GASK1A,Golgi-associated kinase 1A,23415,31,0.58 [0.26-1.30],0.1846212491342087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAST,Gastrin,24123,32,1.23 [0.97-1.55],0.0860814992316592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23333,31,0.65 [0.18-2.40],0.5172674063134195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23514,31,0.91 [0.58-1.43],0.6879961139257055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBA,Lysosomal acid glucosylceramidase,23520,31,0.93 [0.49-1.77],0.8346379040715068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP1,Guanylate-binding protein 1,24078,32,1.58 [1.00-2.48],0.0484414493196988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP2,Guanylate-binding protein 2,27328,39,0.93 [0.57-1.50],0.7579016182710706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP4,Guanylate-binding protein 4,27189,38,1.16 [0.66-2.03],0.6035692354645762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP6,Guanylate-binding protein 6,23415,31,0.68 [0.26-1.80],0.4422057513947448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GC,Vitamin D-binding protein,24225,32,0.76 [0.20-2.88],0.6894909106971487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCC1,GRIP and coiled-coil domain-containing protein 1,24123,32,0.91 [0.67-1.24],0.5428166235494157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCG,Pro-glucagon,27162,39,1.11 [0.88-1.39],0.382620674277104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23068,31,0.90 [0.45-1.81],0.7716417430377784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCLM,Glutamate--cysteine ligase regulatory subunit,23415,31,0.73 [0.30-1.76],0.4847114472194874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27720,38,0.90 [0.39-2.10],0.8124246048772198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF15,Growth/differentiation factor 15,28187,37,2.16 [1.51-3.08],2.3627623411996104e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF2,Growth/differentiation factor 2,27845,37,0.38 [0.16-0.87],0.0216973567715818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDNF,Glial cell line-derived neurotrophic factor,27189,38,1.04 [0.49-2.20],0.9204419522488144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GET3,ATPase GET3,24190,32,0.61 [0.28-1.30],0.1996820860522779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFAP,Glial fibrillary acidic protein,27120,39,1.01 [0.53-1.92],0.9877549933405286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFER,FAD-linked sulfhydryl oxidase ALR,27162,39,0.96 [0.62-1.49],0.854497544454602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27162,39,0.94 [0.73-1.21],0.6371616987745712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA1,GDNF family receptor alpha-1,28060,39,2.03 [0.75-5.47],0.1622519984293747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA2,GDNF family receptor alpha-2,27720,38,1.25 [0.31-5.07],0.7502052349275716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA3,GDNF family receptor alpha-3,27563,37,1.01 [0.35-2.90],0.992184525530697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRAL,GDNF family receptor alpha-like,23422,30,0.74 [0.41-1.32],0.3081161643403823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGA1,ADP-ribosylation factor-binding protein GGA1,27189,38,1.10 [0.75-1.61],0.6265372174913788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGACT,Gamma-glutamylaminecyclotransferase,24190,32,1.00 [0.62-1.60],0.9939690675799112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGCT,Gamma-glutamylcyclotransferase,24149,32,0.69 [0.33-1.41],0.308122957601955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGH,Gamma-glutamyl hydrolase,27330,39,1.35 [0.62-2.94],0.4454063936384659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT1,Glutathione hydrolase 1 proenzyme,27786,38,1.80 [1.14-2.83],0.0113582984722209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT5,Glutathione hydrolase 5 proenzyme,27656,38,0.50 [0.15-1.75],0.2822097211032713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH1,Somatotropin,27813,37,1.06 [0.91-1.24],0.423810476893023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH2,Growth hormone variant,27162,39,0.95 [0.79-1.14],0.5808761808874665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHR,Growth hormone receptor,23650,32,0.59 [0.19-1.90],0.3817990525194326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRHR,Growth hormone-releasing hormone receptor,27189,38,0.63 [0.31-1.27],0.1960962531008344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRL,Appetite-regulating hormone,27845,37,0.79 [0.56-1.13],0.2058566430452194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GID8,Glucose-induced degradation protein 8 homolog,24155,32,0.88 [0.29-2.68],0.8271911587363423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIGYF2,GRB10-interacting GYF protein 2,24155,32,0.68 [0.43-1.07],0.0975614784120158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP7,GTPase IMAP family member 7,23650,32,0.75 [0.24-2.36],0.6194552398048614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP8,GTPase IMAP family member 8,23333,31,1.74 [1.08-2.80],0.0223602269472819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIP,Gastric inhibitory polypeptide,23514,31,1.29 [0.62-2.67],0.4939274080134698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC2,PDZ domain-containing protein GIPC2,24123,32,1.20 [0.40-3.60],0.7508543280897526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC3,PDZ domain-containing protein GIPC3,24098,32,0.90 [0.65-1.25],0.5334066221056328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPR,Gastric inhibitory polypeptide receptor,23505,32,0.53 [0.21-1.35],0.184535871238247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIT1,ARF GTPase-activating protein GIT1,23505,32,0.88 [0.62-1.26],0.4944228697472406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GJA8,Gap junction alpha-8 protein,23333,31,0.64 [0.31-1.30],0.2136450001525552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GKN1,Gastrokine-1,26666,35,0.71 [0.25-2.01],0.5194482308176982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLA,Alpha-galactosidase A,23598,32,0.72 [0.29-1.74],0.4619750503627846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLB1,Beta-galactosidase,27656,38,0.69 [0.34-1.37],0.2873702397741429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLI2,Zinc finger protein GLI2,23505,32,0.61 [0.18-2.03],0.4191483535360399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLO1,Lactoylglutathione lyase,27343,37,1.26 [0.77-2.06],0.3663039589523423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLOD4,Glyoxalase domain-containing protein 4,27772,39,0.84 [0.38-1.86],0.6629381102269309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLP1R,Glucagon-like peptide 1 receptor,23416,30,0.36 [0.11-1.25],0.1075275295428473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX,Glutaredoxin-1,27673,37,1.05 [0.64-1.72],0.8614393794604251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23650,32,0.82 [0.56-1.22],0.3264967331955513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27189,38,0.98 [0.52-1.86],0.959126786599266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLYR1,Putative oxidoreductase GLYR1,24076,32,1.17 [0.71-1.94],0.5388809678398447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GM2A,Ganglioside GM2 activator,23615,31,1.30 [0.61-2.76],0.4983719812308735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMFG,Glia maturation factor gamma,24190,32,0.86 [0.54-1.37],0.5352504016480824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR,GMP reductase 1,28182,39,0.91 [0.52-1.60],0.749715743935695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR2,GMP reductase 2,23650,32,0.91 [0.55-1.53],0.7258927037923358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNAS,Neuroendocrine secretory protein 55,24155,32,1.36 [1.01-1.84],0.0456546818789348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27162,39,0.95 [0.61-1.47],0.8059791875336962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23520,31,0.42 [0.15-1.12],0.0820933187302315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNLY,Granulysin,27836,38,0.99 [0.58-1.69],0.9772215920638748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA1,Glucosamine-6-phosphate isomerase 1,23514,31,0.88 [0.29-2.65],0.8144816799490647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA2,Glucosamine-6-phosphate isomerase 2,23650,32,0.31 [0.12-0.82],0.0181614389712607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLGA3,Golgin subfamily A member 3,24155,32,1.01 [0.65-1.56],0.9670421205533866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLM2,Protein GOLM2,28109,39,1.38 [0.40-4.75],0.610046195574345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,27833,38,0.94 [0.71-1.24],0.661607240534013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GORASP2,Golgi reassembly-stacking protein 2,24098,32,0.66 [0.31-1.39],0.2694460115135711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOT1,"Aspartate aminotransferase, cytoplasmic",24183,32,0.98 [0.44-2.18],0.9536044903116834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BA,Platelet glycoprotein Ib alpha chain,27709,39,0.37 [0.15-0.88],0.02380280768566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BB,Platelet glycoprotein Ib beta chain,23415,31,0.83 [0.50-1.37],0.4648212740961795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,26987,37,0.59 [0.38-0.91],0.0164441076932785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP5,Platelet glycoprotein V,23650,32,0.82 [0.34-1.98],0.6547721743895681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP6,Platelet glycoprotein VI,27795,38,0.96 [0.70-1.32],0.8102818047015359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPA33,Cell surface A33 antigen,27720,38,0.92 [0.74-1.14],0.4442178459985102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC1,Glypican-1,28097,39,0.79 [0.30-2.08],0.6291597202266284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC5,Glypican-5,27656,38,0.70 [0.42-1.16],0.1643085821499199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPD1,Glycerol-3-phosphate dehydrogenase,24076,32,1.47 [0.83-2.60],0.1890487406733801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPHA2,Glycoprotein hormone alpha-2,24098,32,0.83 [0.35-1.94],0.6651715785728142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPI,Glucose-6-phosphate isomerase,24214,32,0.68 [0.32-1.42],0.301153533964853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24098,32,0.88 [0.56-1.37],0.5657756395794554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPKOW,G-patch domain and KOW motifs-containing protein,27189,38,0.72 [0.23-2.27],0.5805225534167797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPNMB,Transmembrane glycoprotein NMB,27093,37,1.40 [0.50-3.94],0.5211275267831685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR101,Probable G-protein coupled receptor 101,23416,30,0.86 [0.43-1.71],0.6589391617734521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR158,Probable G-protein coupled receptor 158,24155,32,0.80 [0.52-1.22],0.2976799999136899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR15L,Protein GPR15L,24098,32,1.16 [0.70-1.94],0.566653077901087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR37,Prosaposin receptor GPR37,27343,37,1.15 [0.73-1.83],0.5426087826825825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPRC5C,G-protein coupled receptor family C group 5 member C,24076,32,1.64 [1.21-2.22],0.0013973403854573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRAP2,GRB2-related adapter protein 2,27845,37,0.97 [0.78-1.21],0.788165472442593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24190,32,0.82 [0.48-1.38],0.4494822923316255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIK2,"Glutamate receptor ionotropic, kainate 2",24155,32,0.38 [0.12-1.17],0.0928149483254625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23416,30,0.67 [0.28-1.60],0.3699822106491558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRK5,G protein-coupled receptor kinase 5,27343,37,0.72 [0.37-1.41],0.338380282690667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRN,Progranulin,27697,38,1.55 [0.52-4.65],0.4310430598978161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRP,Gastrin-releasing peptide,23514,31,1.19 [0.62-2.30],0.6032443470848028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRPEL1,"GrpE protein homolog 1, mitochondrial",27720,38,1.32 [0.88-1.99],0.1797553991195522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRSF1,G-rich sequence factor 1,23201,31,0.62 [0.39-1.01],0.0543697176527253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSAP,Gamma-secretase-activating protein,27162,39,0.97 [0.68-1.37],0.8538890806917324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSN,Gelsolin,24114,31,0.65 [0.11-3.96],0.638894784837995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSR,"Glutathione reductase, mitochondrial",24081,32,0.65 [0.14-2.96],0.5776528305414175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA1,Glutathione S-transferase A1,27807,37,1.10 [0.79-1.54],0.5645924500671107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA3,Glutathione S-transferase A3,27162,39,0.81 [0.54-1.21],0.3044239445849772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTM4,Glutathione S-transferase Mu 4,23415,31,0.47 [0.22-0.99],0.0460844028232873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTP1,Glutathione S-transferase P,27016,37,0.80 [0.51-1.25],0.3265786690011107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTT2B,Glutathione S-transferase theta-2B,24123,32,1.00 [0.87-1.15],0.9491044315587313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23748,32,0.96 [0.58-1.60],0.8819471632084082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTPBP2,GTP-binding protein 2,23520,31,0.89 [0.58-1.36],0.5809255474848231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCA2A,Guanylin,27704,38,1.32 [0.54-3.21],0.5376335204315199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCY2C,Heat-stable enterotoxin receptor,23748,32,0.89 [0.56-1.42],0.631871886408343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUK1,Guanylate kinase,23415,31,0.47 [0.15-1.44],0.1864775583324626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUSB,Beta-glucuronidase,27946,37,1.20 [0.75-1.93],0.4501229768647631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GYS1,"Glycogen [starch] synthase, muscle",27343,37,0.98 [0.72-1.34],0.8942064210302334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMA,Granzyme A,28182,39,1.29 [0.58-2.86],0.5338286593070776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMB,Granzyme B,27833,38,0.85 [0.53-1.35],0.4940801724560655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMH,Granzyme H,27343,37,1.15 [0.83-1.59],0.394044908621083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,H2AP,Huntingtin-interacting protein M,23333,31,0.42 [0.14-1.24],0.1169919332641431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23415,31,0.85 [0.44-1.62],0.611757060327579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28024,39,1.17 [0.79-1.71],0.4339306873096988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAO1,Hydroxyacid oxidase 1,28097,39,1.21 [0.98-1.49],0.0732166442267628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HARS1,"Histidine--tRNA ligase, cytoplasmic",27836,38,0.87 [0.60-1.25],0.4509157007902401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR1,Hepatitis A virus cellular receptor 1,28061,39,1.08 [0.69-1.71],0.7377345550092318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR2,Hepatitis A virus cellular receptor 2,27836,38,1.35 [0.60-3.07],0.4692026296397028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBEGF,Proheparin-binding EGF-like growth factor,28024,39,0.76 [0.52-1.10],0.1461465599242083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBQ1,Hemoglobin subunit theta-1,28097,39,1.05 [0.68-1.63],0.8129862876184658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBZ,Hemoglobin subunit zeta,24190,32,1.22 [0.92-1.62],0.1752836822256093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCG22,Protein PBMUCL2,23415,31,0.42 [0.14-1.21],0.1084960065434036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCLS1,Hematopoietic lineage cell-specific protein,28182,39,1.09 [0.66-1.80],0.7437545744271516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC8,Histone deacetylase 8,23505,32,0.54 [0.22-1.30],0.1689730310101988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC9,Histone deacetylase 9,23416,30,0.80 [0.40-1.59],0.5253793459577869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDDC2,5'-deoxynucleotidase HDDC2,24098,32,1.00 [0.47-2.12],0.992157178766178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGF,Hepatoma-derived growth factor,28065,39,0.97 [0.72-1.32],0.8540075999956043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGFL2,Hepatoma-derived growth factor-related protein 2,24123,32,0.85 [0.49-1.46],0.5483602473713152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEBP1,Heme-binding protein 1,27343,37,0.94 [0.54-1.66],0.8348529447794181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEG1,Protein HEG homolog 1,23650,32,4.56 [1.43-14.50],0.0102384496159752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPACAM2,HEPACAM family member 2,24123,32,0.55 [0.25-1.22],0.1441758039138273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPH,Hephaestin,24190,32,1.24 [0.34-4.47],0.7451506044013602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEXIM1,Protein HEXIM1,27833,38,0.96 [0.67-1.37],0.8189415824417605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGF,Hepatocyte growth factor,28182,39,1.10 [0.49-2.46],0.8199453437869386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGFAC,Hepatocyte growth factor activator,23987,32,0.71 [0.22-2.32],0.5715346798372042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27162,39,0.89 [0.61-1.29],0.5375580686559273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HHEX,Hematopoietically-expressed homeobox protein HHEX,24123,32,0.85 [0.55-1.31],0.4503040109763869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIF1A,Hypoxia-inducible factor 1-alpha,23505,32,0.88 [0.69-1.11],0.2719584148765923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1,Huntingtin-interacting protein 1,23415,31,0.82 [0.51-1.30],0.3947910462872146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1R,Huntingtin-interacting protein 1-related protein,24086,32,1.16 [0.61-2.21],0.6510420341871244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HJV,Hemojuvelin,24155,32,0.78 [0.33-1.82],0.5616715251849739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HK2,Hexokinase-2,27343,37,0.53 [0.18-1.54],0.2408953890259604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24155,32,1.69 [0.59-4.88],0.3305066652885552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27743,36,1.74 [0.81-3.71],0.1532554176413062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27833,38,2.69 [1.13-6.43],0.0258102149682032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMBS,Porphobilinogen deaminase,28097,39,0.87 [0.45-1.68],0.685602853096523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMCN2,Hemicentin-2,23603,32,0.92 [0.51-1.64],0.7691694673027387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23514,31,0.85 [0.42-1.75],0.6653508051081012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23415,31,0.66 [0.27-1.61],0.3609221335907425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMMR,Hyaluronan mediated motility receptor,23294,31,0.96 [0.45-2.04],0.9153202009096236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX1,Heme oxygenase 1,27530,36,1.07 [0.58-1.96],0.824213427641568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX2,Heme oxygenase 2,27189,38,1.10 [0.62-1.94],0.7542351080338715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNF1A,Hepatocyte nuclear factor 1-alpha,23520,31,0.52 [0.24-1.16],0.1087168402298917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNMT,Histamine N-methyltransferase,27523,38,0.94 [0.50-1.74],0.8381413227594108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27245,37,0.93 [0.64-1.35],0.7054302817912912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24155,32,0.71 [0.33-1.53],0.3841791405092916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPCAL1,Hippocalcin-like protein 1,28182,39,1.08 [0.74-1.59],0.6818320395661237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPGDS,Hematopoietic prostaglandin D synthase,27162,39,0.47 [0.22-1.01],0.0534060637195487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPSE,Heparanase,23871,32,0.96 [0.68-1.37],0.8402821546909335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRAS,GTPase Hras,23714,31,1.02 [0.73-1.43],0.9073165364246896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23514,31,1.78 [0.87-3.61],0.1132684546633711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRG,Histidine-rich glycoprotein,24094,32,0.86 [0.31-2.44],0.7823407875344414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS1BP3,HCLS1-binding protein 3,23514,31,1.06 [0.73-1.54],0.7470787260997684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27720,38,1.13 [0.53-2.40],0.7548937145121519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28097,39,1.22 [0.54-2.75],0.6393345453811172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23505,32,0.95 [0.35-2.54],0.9140752266240652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSBP1,Heat shock factor-binding protein 1,23514,31,1.14 [0.80-1.61],0.4698655849622819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,27833,38,0.83 [0.41-1.70],0.6090832253159345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24123,32,0.81 [0.47-1.40],0.4495682456846129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23415,31,1.06 [0.52-2.17],0.8768821380932349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23514,31,0.79 [0.38-1.64],0.5204489112020009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSP90B1,Endoplasmin,27059,38,1.13 [0.77-1.64],0.5339398456676946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA1A,Heat shock 70 kDa protein 1A,27913,39,0.88 [0.59-1.31],0.527928051868402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA2,Heat shock-related 70 kDa protein 2,24076,32,0.65 [0.22-1.92],0.4316865793512557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB1,Heat shock protein beta-1,27378,36,0.84 [0.57-1.25],0.3987266347526851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB6,Heat shock protein beta-6,28097,39,0.93 [0.44-1.96],0.8538908902791786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27616,39,1.47 [0.51-4.25],0.4801044667189305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1A,5-hydroxytryptamine receptor 1A,23416,30,0.99 [0.62-1.59],0.97943838321927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1B,5-hydroxytryptamine receptor 1B,23416,30,0.58 [0.21-1.59],0.2926698431506268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTRA2,"Serine protease HTRA2, mitochondrial",27911,38,0.98 [0.62-1.55],0.9341919212562888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYAL1,Hyaluronidase-1,27658,39,0.35 [0.10-1.22],0.1000846550908244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYOU1,Hypoxia up-regulated protein 1,28187,37,0.54 [0.14-2.03],0.3599666706004977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICA1,Islet cell autoantigen 1,27328,39,0.91 [0.63-1.30],0.5997075677075256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM1,Intercellular adhesion molecule 1,27712,39,1.28 [0.48-3.41],0.61565431740553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM2,Intercellular adhesion molecule 2,28187,37,0.95 [0.38-2.35],0.9048785950606548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM3,Intercellular adhesion molecule 3,28187,37,0.74 [0.24-2.26],0.5934324469532559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM4,Intercellular adhesion molecule 4,27833,38,0.94 [0.54-1.61],0.812573151299017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM5,Intercellular adhesion molecule 5,27845,37,0.90 [0.48-1.69],0.7397376590811178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICOSLG,ICOS ligand,27720,38,0.56 [0.12-2.55],0.4556866640655296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ID4,DNA-binding protein inhibitor ID-4,23748,32,0.43 [0.13-1.37],0.1536740653838514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27189,38,0.48 [0.24-0.96],0.0384904408992769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDO1,"Indoleamine 2,3-dioxygenase 1",23514,31,0.74 [0.42-1.29],0.2829308745668125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDS,Iduronate 2-sulfatase,28182,39,0.89 [0.04-20.66],0.9438270515655064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDUA,Alpha-L-iduronidase,28097,39,1.26 [0.69-2.32],0.4521887335994432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23529,31,1.77 [0.82-3.84],0.145338497843136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23748,32,0.85 [0.42-1.72],0.6528101112721807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23748,32,1.16 [0.51-2.64],0.7275933672841508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNAR1,Interferon alpha/beta receptor 1,24098,32,1.05 [0.29-3.84],0.9362714015988004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNG,Interferon gamma,27328,39,1.00 [0.79-1.28],0.9873519337091204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR1,Interferon gamma receptor 1,27968,39,1.22 [0.31-4.89],0.7765834349374703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR2,Interferon gamma receptor 2,27656,38,1.19 [0.70-2.00],0.524958344751675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL1,Interferon lambda-1,27189,38,1.63 [0.95-2.80],0.0772905539982429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL2,Interferon lambda-2,23416,30,0.82 [0.41-1.64],0.5741406788358606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNLR1,Interferon lambda receptor 1,27833,38,1.53 [0.86-2.71],0.1487404193198426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNW1,Interferon omega-1,23415,31,1.22 [0.51-2.93],0.66106801024573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFT20,Intraflagellar transport protein 20 homolog,23520,31,0.82 [0.36-1.87],0.6322337731649397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGBP1,Immunoglobulin-binding protein 1,24155,32,0.88 [0.51-1.53],0.6553642781835786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23416,30,1.09 [0.56-2.14],0.7985482475404624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24183,32,0.60 [0.18-1.95],0.3936384947152738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF1R,Insulin-like growth factor 1 receptor,27720,38,0.74 [0.18-3.01],0.6792723816950261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23415,31,0.74 [0.30-1.79],0.5014469224733795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2R,Cation-independent mannose-6-phosphate receptor,27836,38,0.47 [0.14-1.56],0.2181101436045288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP1,Insulin-like growth factor-binding protein 1,28140,37,1.09 [0.86-1.37],0.4722481765758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP2,Insulin-like growth factor-binding protein 2,28135,37,0.86 [0.53-1.37],0.5148317728081555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP3,Insulin-like growth factor-binding protein 3,27924,39,0.67 [0.42-1.05],0.0809927184812245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP4,Insulin-like growth factor-binding protein 4,27483,37,0.89 [0.41-1.93],0.7719660084646663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP6,Insulin-like growth factor-binding protein 6,27715,39,0.38 [0.13-1.11],0.0781939957853058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP7,Insulin-like growth factor-binding protein 7,28187,37,0.78 [0.27-2.23],0.6367738952930385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBPL1,Insulin-like growth factor-binding protein-like 1,27845,37,2.23 [1.02-4.86],0.0443264755885118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFL4,Insulin growth factor-like family member 4,23505,32,0.96 [0.59-1.58],0.8753219337148228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGHMBP2,DNA-binding protein SMUBP-2,23415,31,0.85 [0.44-1.64],0.630261167287681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLC2,Immunoglobulin lambda constant 2,24187,32,1.17 [0.37-3.65],0.7928234208396655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLON5,IgLON family member 5,23333,31,0.89 [0.57-1.40],0.6156279122368133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF21,Immunoglobulin superfamily member 21,23514,31,0.36 [0.14-0.95],0.0400591853684765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF3,Immunoglobulin superfamily member 3,27720,38,1.60 [0.87-2.94],0.1337003924916532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF8,Immunoglobulin superfamily member 8,27845,37,0.46 [0.17-1.24],0.1228342690556541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF9,Protein turtle homolog A,24190,32,1.00 [0.67-1.49],0.9996107316602492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKBKG,NF-kappa-B essential modulator,27833,38,1.04 [0.75-1.42],0.8302985702422117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKZF2,Zinc finger protein Helios,27162,39,0.66 [0.40-1.07],0.0935290954518162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10,Interleukin-10,27328,39,1.14 [0.83-1.57],0.4159487496060364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RA,Interleukin-10 receptor subunit alpha,27328,39,0.62 [0.31-1.28],0.1965817402314223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RB,Interleukin-10 receptor subunit beta,27968,39,1.63 [0.66-4.03],0.286174580701759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL11,Interleukin-11,27328,39,0.84 [0.51-1.40],0.5015642025991998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12A_IL12B,Interleukin-12,27720,38,1.25 [0.86-1.82],0.2396425273508475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12B,Interleukin-12 subunit beta,28182,39,1.42 [0.84-2.38],0.186363473019857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB1,Interleukin-12 receptor subunit beta-1,27328,39,0.81 [0.38-1.74],0.5903628451882441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB2,Interleukin-12 receptor subunit beta-2,23505,32,0.61 [0.24-1.53],0.2890823490338652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13,Interleukin-13,27328,39,1.17 [0.73-1.86],0.5177192315453905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA1,Interleukin-13 receptor subunit alpha-1,27471,38,0.66 [0.22-1.95],0.4482667719902731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA2,Interleukin-13 receptor subunit alpha-2,23416,30,0.66 [0.20-2.14],0.4906375681038221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15,Interleukin-15,27833,38,1.95 [0.90-4.23],0.0899131523331542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15RA,Interleukin-15 receptor subunit alpha,27328,39,1.56 [0.68-3.55],0.290000660666441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL16,Pro-interleukin-16,28182,39,0.77 [0.38-1.54],0.4564439645273314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17A,Interleukin-17A,27285,38,0.89 [0.44-1.79],0.7360026341141725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17C,Interleukin-17C,27328,39,1.08 [0.72-1.62],0.7265111042144942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17D,Interleukin-17D,27328,39,1.26 [0.63-2.54],0.5129018455143828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17F,Interleukin-17F,27328,39,0.88 [0.57-1.34],0.5377394177632424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RA,Interleukin-17 receptor A,27836,38,0.94 [0.51-1.76],0.853606817237726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RB,Interleukin-17 receptor B,27468,37,1.73 [1.01-2.95],0.0448318369875974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18,Interleukin-18,27725,39,0.75 [0.40-1.40],0.3692614774752959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18BP,Interleukin-18-binding protein,27924,39,1.22 [0.48-3.07],0.6742587360056238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18R1,Interleukin-18 receptor 1,28182,39,2.40 [1.09-5.30],0.0300022657433689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18RAP,Interleukin-18 receptor accessory protein,27478,38,0.90 [0.75-1.09],0.2760320804376985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL19,Interleukin-19,27158,37,0.98 [0.64-1.49],0.906964056058324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1A,Interleukin-1 alpha,27328,39,1.31 [0.92-1.88],0.1386468470702025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1B,Interleukin-1 beta,27190,39,0.99 [0.60-1.63],0.954435377185764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R1,Interleukin-1 receptor type 1,27786,38,0.94 [0.26-3.45],0.9251958738550884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R2,Interleukin-1 receptor type 2,27777,39,0.79 [0.19-3.24],0.7423617947186124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RAP,Interleukin-1 receptor accessory protein,27836,38,0.55 [0.27-1.12],0.0987620608767805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL1,Interleukin-1 receptor-like 1,28088,37,1.41 [0.76-2.61],0.2720108887533065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL2,Interleukin-1 receptor-like 2,27328,39,0.79 [0.39-1.60],0.5114804615471864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RN,Interleukin-1 receptor antagonist protein,27773,39,1.17 [0.72-1.90],0.5224921252860164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2,Interleukin-2,27328,39,0.96 [0.38-2.38],0.9216267287539917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20,Interleukin-20,27328,39,0.92 [0.50-1.70],0.7998128367305082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RA,Interleukin-20 receptor subunit alpha,27328,39,1.48 [1.00-2.18],0.0500922388711616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RB,Interleukin-20 receptor subunit beta,23505,32,0.99 [0.45-2.18],0.97773146070515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL21R,Interleukin-21 receptor,23505,32,1.30 [0.80-2.12],0.2892887678279965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22,Interleukin-22,24076,32,0.80 [0.46-1.38],0.4160535108228791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22RA1,Interleukin-22 receptor subunit alpha-1,27328,39,0.48 [0.21-1.08],0.0767181052320152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL24,Interleukin-24,27328,39,0.97 [0.52-1.80],0.9171139315481708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL25,Interleukin-25,23250,31,0.91 [0.33-2.52],0.8561797263842998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RA,Interleukin-2 receptor subunit alpha,27664,36,1.52 [0.79-2.93],0.2110200391465478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RB,Interleukin-2 receptor subunit beta,27328,39,0.90 [0.40-2.03],0.7965973939625692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RG,Cytokine receptor common subunit gamma,24076,32,1.22 [0.54-2.72],0.6308331566738141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3,Interleukin-3,23333,31,1.37 [0.73-2.56],0.3273518846054797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31,Interleukin-31,23505,32,0.44 [0.18-1.10],0.0791186076989948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31RA,Interleukin-31 receptor subunit alpha,23424,32,1.46 [0.64-3.33],0.364425493269672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL32,Interleukin-32,27833,38,1.47 [0.81-2.65],0.2046508141367542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL33,Interleukin-33,27328,39,1.18 [0.58-2.41],0.6545199973113898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL34,Interleukin-34,27139,38,1.06 [0.46-2.42],0.8988041236880815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36A,Interleukin-36 alpha,23505,32,0.85 [0.44-1.66],0.6427530093422209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36G,Interleukin-36 gamma,23429,32,0.95 [0.56-1.62],0.85599152342132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3RA,Interleukin-3 receptor subunit alpha,27328,39,2.03 [0.91-4.54],0.0832351781952681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4,Interleukin-4,27328,39,1.06 [0.76-1.48],0.721834163491355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4R,Interleukin-4 receptor subunit alpha,27833,38,2.12 [1.07-4.17],0.0304743345386175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5,Interleukin-5,27328,39,0.99 [0.81-1.22],0.9580712453123404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5RA,Interleukin-5 receptor subunit alpha,27833,38,1.12 [0.67-1.87],0.6675260278331931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6,Interleukin-6,27720,38,0.91 [0.60-1.39],0.6642964555368707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6R,Interleukin-6 receptor subunit alpha,27658,39,0.79 [0.34-1.80],0.5722349858430829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6ST,Interleukin-6 receptor subunit beta,27845,37,0.37 [0.07-1.97],0.2439604583331848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7,Interleukin-7,27833,38,0.98 [0.63-1.51],0.9116640256658466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7R,Interleukin-7 receptor subunit alpha,27836,38,0.86 [0.51-1.48],0.5958674024337403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL9,Interleukin-9,23748,32,0.73 [0.33-1.61],0.4323701283307378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27150,38,0.72 [0.42-1.22],0.2170714971205553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMMT,MICOS complex subunit MIC60,24076,32,1.29 [0.69-2.41],0.4261987887658157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPA1,Inositol monophosphatase 1,27656,38,0.92 [0.58-1.48],0.7449202535223118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPACT,Protein IMPACT,24123,32,1.15 [0.63-2.11],0.6484749845121853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPG1,Interphotoreceptor matrix proteoglycan 1,23416,30,1.18 [0.39-3.63],0.7669210699673635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ING1,Inhibitor of growth protein 1,27141,38,0.75 [0.37-1.51],0.4164563790518398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBB,Inhibin beta B chain,23650,32,1.44 [0.77-2.70],0.2562840197449486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBC,Inhibin beta C chain,27836,38,1.24 [0.61-2.51],0.553509907529841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP1,Inositol polyphosphate 1-phosphatase,27720,38,0.96 [0.57-1.62],0.8868380620110262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23514,31,1.03 [0.57-1.85],0.9308293072554668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24155,32,0.58 [0.22-1.55],0.2787837565717516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27720,38,1.07 [0.80-1.43],0.6602320023110871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL3,Insulin-like 3,24123,32,0.83 [0.56-1.24],0.371805434223627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL4,Early placenta insulin-like peptide,24076,32,0.92 [0.44-1.92],0.8280818152241862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL5,Insulin-like peptide INSL5,24098,32,0.94 [0.67-1.33],0.7407220954811748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSR,Insulin receptor,23505,32,1.20 [0.15-9.28],0.8635878063646228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IPCEF1,Interactor protein for cytohesin exchange factors 1,27608,38,0.99 [0.72-1.36],0.964097209499142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IQGAP2,Ras GTPase-activating-like protein IQGAP2,27720,38,1.18 [0.72-1.94],0.5120136928239305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27343,37,0.85 [0.60-1.22],0.386996957199875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK1,Interleukin-1 receptor-associated kinase 1,27328,39,0.91 [0.61-1.38],0.6702233587936813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK4,Interleukin-1 receptor-associated kinase 4,27833,38,1.04 [0.79-1.37],0.77598173950055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26783,36,0.67 [0.30-1.47],0.3144335785892787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM1,Isthmin-1,27833,38,1.02 [0.49-2.09],0.9660118705730644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM2,Isthmin-2,24183,32,1.08 [0.54-2.16],0.8212830114208316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IST1,IST1 homolog,23923,31,0.93 [0.66-1.32],0.6973198213419232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA11,Integrin alpha-11,27833,38,0.43 [0.18-1.00],0.0490487853935179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA2,Integrin alpha-2,23650,32,0.59 [0.22-1.58],0.2969139575817893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA5,Integrin alpha-5,27836,38,0.63 [0.19-2.03],0.4383216290880254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA6,Integrin alpha-6,27833,38,0.75 [0.42-1.35],0.33994141504034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAL,Integrin alpha-L,23505,32,1.02 [0.47-2.22],0.9610059173807236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAM,Integrin alpha-M,27836,38,0.44 [0.18-1.10],0.0785487155023374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAV,Integrin alpha-V,28097,39,0.75 [0.35-1.58],0.4461793754544485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAX,Integrin alpha-X,23748,32,0.77 [0.37-1.57],0.4700210178722369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1,Integrin beta-1,27786,39,0.66 [0.36-1.20],0.173144136438652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP1,Integrin beta-1-binding protein 1,27162,39,0.60 [0.30-1.21],0.1535727152982039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP2,Integrin beta-1-binding protein 2,27343,37,1.02 [0.79-1.31],0.906919141723651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB2,Integrin beta-2,27678,37,0.31 [0.11-0.89],0.029156261913206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB5,Integrin beta-5,27911,38,0.73 [0.34-1.58],0.4226134006055156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB6,Integrin beta-6,27328,39,0.55 [0.21-1.41],0.2123254135563001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB7,Integrin beta-7,28097,39,1.30 [0.73-2.31],0.3770864289435879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGBL1,Integrin beta-like protein 1,24183,32,2.07 [0.93-4.58],0.0734794833896963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24225,32,0.61 [0.10-3.80],0.5966638722922661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,27924,39,1.20 [0.58-2.48],0.6239251875464374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24225,32,0.58 [0.14-2.37],0.4496049469173279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24076,32,0.67 [0.28-1.60],0.3710749085077586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITM2A,Integral membrane protein 2A,27833,38,1.13 [0.70-1.81],0.6250075727988073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPA,Inosine triphosphate pyrophosphatase,23415,31,0.61 [0.36-1.04],0.0672160117640612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23514,31,1.12 [0.72-1.76],0.605877558136545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23416,30,0.80 [0.34-1.88],0.6077314097325406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27189,38,0.77 [0.41-1.46],0.4310549585540703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IZUMO1,Izumo sperm-egg fusion protein 1,23333,31,1.29 [0.75-2.21],0.364171475794667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM2,Junctional adhesion molecule B,28109,39,1.51 [0.50-4.53],0.4631330156392914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM3,Junctional adhesion molecule C,23650,32,0.55 [0.26-1.16],0.1170401583161589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JCHAIN,Immunoglobulin J chain,27328,39,0.82 [0.52-1.28],0.3774882059560737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23333,31,0.83 [0.42-1.62],0.5777678336664889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JPT2,Jupiter microtubule associated homolog 2,24098,32,0.96 [0.66-1.41],0.8518953416182794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JUN,Transcription factor AP-1,27328,39,0.61 [0.28-1.32],0.2081201115520587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27720,38,1.98 [0.99-3.96],0.0544995321685126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZN,Kazrin,24098,32,0.94 [0.68-1.29],0.7055263886376718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNC4,Potassium voltage-gated channel subfamily C member 4,23416,30,0.93 [0.47-1.84],0.8429286496733663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNH2,Potassium voltage-gated channel subfamily H member 2,23520,31,0.84 [0.48-1.48],0.5524235144104055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNIP4,Kv channel-interacting protein 4,27189,38,0.86 [0.46-1.63],0.6507891965590156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCTD5,BTB/POZ domain-containing protein KCTD5,23657,31,0.83 [0.37-1.85],0.6440573867215933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDM3A,Lysine-specific demethylase 3A,23505,32,0.94 [0.62-1.41],0.7497162578451102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDR,Vascular endothelial growth factor receptor 2,27911,38,0.58 [0.22-1.52],0.2645858919838662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KEL,Kell blood group glycoprotein,27189,38,1.07 [0.48-2.37],0.8657418160797783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHDC3L,KH domain-containing protein 3,23333,31,0.64 [0.30-1.35],0.2419463116613598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHK,Ketohexokinase,23514,31,0.88 [0.52-1.51],0.6509358194605613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA0319,Dyslexia-associated protein KIAA0319,24123,32,1.08 [0.36-3.26],0.8863299424682497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549,UPF0606 protein KIAA1549,23748,32,1.41 [0.96-2.07],0.0815803927118111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549L,UPF0606 protein KIAA1549L,23748,32,0.42 [0.11-1.57],0.195511243727746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA2013,Uncharacterized protein KIAA2013,24076,32,0.52 [0.20-1.34],0.1781724953199016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF1C,Kinesin-like protein KIF1C,23415,31,0.83 [0.54-1.29],0.4067928481280635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF20B,Kinesin-like protein KIF20B,23416,30,0.77 [0.46-1.31],0.3406739246826909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF22,Kinesin-like protein KIF22,23415,31,1.17 [0.88-1.57],0.2747633531918038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIFBP,KIF-binding protein,27720,38,1.00 [0.71-1.40],0.977980637451988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24076,32,0.77 [0.52-1.14],0.1902496629289206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27162,39,0.80 [0.54-1.17],0.2446099968857731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24098,32,0.91 [0.74-1.12],0.3616995772323759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27162,39,0.97 [0.77-1.23],0.8151227771382635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23333,31,0.56 [0.27-1.16],0.1191154682820141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL1,Kin of IRRE-like protein 1,23416,30,0.72 [0.33-1.61],0.4268768778333163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL2,Kin of IRRE-like protein 2,27189,38,1.43 [0.71-2.85],0.3169011841946308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIT,Mast/stem cell growth factor receptor Kit,27890,39,0.72 [0.47-1.11],0.1380690363612324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KITLG,Kit ligand,27845,37,0.50 [0.24-1.03],0.061616546082223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLB,Beta-klotho,27189,38,1.06 [0.72-1.56],0.7584662309501793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLF4,Krueppel-like factor 4,23416,30,0.96 [0.40-2.29],0.933347875216031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLHL41,Kelch-like protein 41,24155,32,0.49 [0.21-1.15],0.1007880340475586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK1,Kallikrein-1,27562,38,1.02 [0.81-1.27],0.8917523279823053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK10,Kallikrein-10,27823,38,1.07 [0.52-2.19],0.8529195293125843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK11,Kallikrein-11,27638,38,0.74 [0.27-2.02],0.560367465170156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK12,Kallikrein-12,27162,39,0.92 [0.75-1.13],0.4225278890375813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK13,Kallikrein-13,27204,38,0.61 [0.31-1.20],0.15230029490528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK14,Kallikrein-14,28097,39,0.97 [0.53-1.77],0.9160763774110988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK15,Kallikrein-15,24038,32,1.21 [0.61-2.41],0.5810454671390353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK3,Prostate-specific antigen,24183,32,0.73 [0.50-1.08],0.1118232917549763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK4,Kallikrein-4,28097,39,1.43 [0.97-2.13],0.0740718601681889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK6,Kallikrein-6,27872,38,0.79 [0.31-2.00],0.6225199565379222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK7,Kallikrein-7,23036,31,1.02 [0.43-2.44],0.960868331188858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK8,Kallikrein-8,26897,37,0.84 [0.36-1.95],0.6910796802502883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLKB1,Plasma kallikrein,23748,30,0.72 [0.40-1.32],0.2881777459590434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28182,39,1.91 [0.93-3.93],0.0775363651180643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23416,30,0.54 [0.24-1.26],0.1551408614201281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRD1,Natural killer cells antigen CD94,28182,39,0.63 [0.34-1.15],0.1309579931003193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23505,32,1.35 [0.80-2.28],0.2683318280133272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRK1,NKG2-D type II integral membrane protein,24123,32,1.10 [0.52-2.34],0.8041280042234473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT14,"Keratin, type I cytoskeletal 14",26323,37,0.83 [0.29-2.39],0.7260845442016359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT17,"Keratin, type I cytoskeletal 17",23415,31,0.92 [0.36-2.33],0.8587393159972557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT18,"Keratin, type I cytoskeletal 18",27720,38,1.18 [0.85-1.65],0.3153201145727842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT19,"Keratin, type I cytoskeletal 19",27795,38,1.30 [0.87-1.95],0.1946221529001595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT5,"Keratin, type II cytoskeletal 5",27189,38,0.87 [0.48-1.57],0.6492373506640168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT6C,"Keratin, type II cytoskeletal 6C",23415,31,0.80 [0.29-2.21],0.6608615563395158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT8,"Keratin, type II cytoskeletal 8",23416,30,1.15 [0.74-1.80],0.5286496407812165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYAT1,Kynurenine--oxoglutarate transaminase 1,27792,37,0.68 [0.40-1.16],0.155742359962234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYNU,Kynureninase,28182,39,1.07 [0.58-1.97],0.8273803370495405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L1CAM,Neural cell adhesion molecule L1,27911,38,0.66 [0.26-1.70],0.3889954309562509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24190,32,0.86 [0.59-1.26],0.43447165688387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACRT,Extracellular glycoprotein lacritin,24032,31,0.89 [0.42-1.91],0.7683534900384704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACTB2,Endoribonuclease LACTB2,27845,37,0.88 [0.57-1.37],0.5728642049673802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAG3,Lymphocyte activation gene 3 protein,27720,38,1.44 [0.79-2.61],0.2344073750057707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27823,39,1.58 [0.97-2.57],0.0675286535405065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27656,38,1.07 [0.80-1.43],0.642261664482344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA1,Laminin subunit alpha-1,23415,31,1.24 [0.74-2.07],0.4173881374660664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA4,Laminin subunit alpha-4,27968,39,0.71 [0.30-1.67],0.4291080708200139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMB1,Laminin subunit beta-1,23514,31,1.05 [0.34-3.21],0.9382685763771976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP1,Lysosome-associated membrane glycoprotein 1,23525,30,0.89 [0.23-3.49],0.8709490921003249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP2,Lysosome-associated membrane glycoprotein 2,26998,35,0.38 [0.09-1.58],0.1813591500548494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP3,Lysosome-associated membrane glycoprotein 3,28133,38,1.52 [0.90-2.57],0.121625064041043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMTOR5,Ragulator complex protein LAMTOR5,24076,32,0.44 [0.16-1.17],0.10099238377456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAP3,Cytosol aminopeptidase,27328,39,0.80 [0.44-1.47],0.4786650991002301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LARP1,La-related protein 1,24076,32,0.75 [0.41-1.39],0.3630071045907402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT,Linker for activation of T-cells family member 1,28182,39,0.94 [0.66-1.35],0.7541421094996129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT2,Linker for activation of T-cells family member 2,27720,38,0.99 [0.79-1.24],0.8981112650810514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LATS1,Serine/threonine-protein kinase LATS1,23505,32,0.75 [0.50-1.12],0.1601458457083285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAYN,Layilin,27608,38,1.24 [0.52-2.97],0.63274427698549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBP,Lipopolysaccharide-binding protein,27924,39,1.31 [0.82-2.09],0.2609020574736193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBR,Delta(14)-sterol reductase LBR,28109,39,0.92 [0.60-1.40],0.6834200423049123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCAT,Phosphatidylcholine-sterol acyltransferase,24214,32,0.36 [0.08-1.54],0.1678083703292535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN15,Lipocalin-15,24155,32,0.99 [0.57-1.72],0.974471760237026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN2,Neutrophil gelatinase-associated lipocalin,26958,39,0.70 [0.32-1.55],0.380405931007734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCP1,Plastin-2,24183,32,1.02 [0.51-2.03],0.9617033158510552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLR,Low-density lipoprotein receptor,27921,36,1.18 [0.68-2.06],0.556754151197512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24155,32,0.93 [0.66-1.30],0.659797016219756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LECT2,Leukocyte cell-derived chemotaxin-2,24190,32,1.27 [0.78-2.08],0.3381172544386728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEFTY2,Left-right determination factor 2,28060,39,1.13 [0.66-1.92],0.6513022547939052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEG1,Protein LEG1 homolog,22809,30,0.84 [0.51-1.39],0.506958526864441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LELP1,Late cornified envelope-like proline-rich protein 1,23416,30,1.01 [0.61-1.65],0.9814824437783204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEO1,RNA polymerase-associated protein LEO1,24155,32,0.95 [0.29-3.16],0.932973280072448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEP,Leptin,27845,37,1.01 [0.67-1.53],0.9524633622747808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEPR,Leptin receptor,27845,37,0.59 [0.22-1.58],0.2943219400669952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LETM1,Mitochondrial proton/calcium exchanger protein,24155,32,0.79 [0.41-1.53],0.4844683737866869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS1,Galectin-1,27845,37,1.12 [0.49-2.56],0.7911520505419083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3,Galectin-3,27914,36,1.07 [0.40-2.89],0.889002425590994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3BP,Galectin-3-binding protein,24225,32,0.98 [0.32-3.02],0.9763250835740432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS4,Galectin-4,27823,39,1.33 [0.80-2.18],0.2690349882863468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS7_LGALS7B,Galectin-7,27795,38,1.03 [0.52-2.04],0.9308090955247698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS8,Galectin-8,28109,39,1.08 [0.69-1.69],0.7385334408586188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS9,Galectin-9,27827,39,1.84 [0.79-4.28],0.1543340884498954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGMN,Legumain,27968,39,1.51 [0.71-3.19],0.2825339379058001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHB,Lutropin subunit beta,27162,39,1.01 [0.73-1.39],0.9710953829690916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,27871,39,0.85 [0.52-1.38],0.5089154406279862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIF,Leukemia inhibitory factor,27189,38,0.78 [0.41-1.46],0.4346308536408354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIFR,Leukemia inhibitory factor receptor,27833,38,0.94 [0.28-3.10],0.9158320598671584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27836,38,0.93 [0.44-1.94],0.8432507798131931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24183,32,0.97 [0.78-1.22],0.7963789760756388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23415,31,0.94 [0.46-1.92],0.855253957926657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27813,37,0.78 [0.32-1.89],0.577476178176907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24190,32,1.01 [0.65-1.58],0.9504647916842582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28187,37,0.90 [0.32-2.56],0.8492749047559234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28036,37,0.79 [0.36-1.78],0.5742377579002838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27328,39,2.01 [1.08-3.74],0.0269637391401688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28187,37,0.92 [0.61-1.38],0.6871365084861787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIPF,Gastric triacylglycerol lipase,23514,31,0.74 [0.42-1.33],0.3181344846101803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB1,Lamin-B1,24049,32,0.88 [0.50-1.54],0.6428383036828327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB2,Lamin-B2,24123,32,1.64 [0.55-4.93],0.3779384141760751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD1,Leiomodin-1,24155,32,1.15 [0.46-2.88],0.757438352340404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD2,Leiomodin-2,23416,30,1.67 [1.16-2.41],0.0060116961723253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LONP1,"Lon protease homolog, mitochondrial",23514,31,1.00 [0.68-1.48],0.9988227183917892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPA,Apolipoprotein(a),23630,31,0.98 [0.80-1.19],0.8269012953761599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPCAT2,Lysophosphatidylcholine acyltransferase 2,27720,38,0.95 [0.46-1.95],0.8911332803604185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPL,Lipoprotein lipase,27845,37,0.71 [0.41-1.22],0.2124753637213337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPO,Lactoperoxidase,26956,36,1.04 [0.65-1.68],0.8581281683296963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPP,Lipoma-preferred partner,23415,31,0.88 [0.52-1.49],0.6385838010427966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23415,31,0.77 [0.46-1.31],0.3364171016909479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23520,31,1.46 [0.92-2.31],0.1052347654673329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRG1,Leucine-rich alpha-2-glycoprotein,24225,32,2.24 [0.67-7.50],0.190855058577781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28024,39,1.04 [0.46-2.32],0.933449511775924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23421,31,0.85 [0.23-3.18],0.811096626687454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP1,Prolow-density lipoprotein receptor-related protein 1,27720,38,0.35 [0.11-1.11],0.0754867284825886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP11,Low-density lipoprotein receptor-related protein 11,27845,37,1.17 [0.52-2.63],0.7085792624108179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2,Low-density lipoprotein receptor-related protein 2,23520,31,1.03 [0.41-2.60],0.9529627519145945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2BP,LRP2-binding protein,23520,31,0.79 [0.45-1.38],0.4117878373743515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28109,39,0.86 [0.49-1.51],0.6089834873365427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC25,Leucine-rich repeat-containing protein 25,27720,38,1.10 [0.53-2.29],0.7968262512528715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24098,32,0.91 [0.42-1.99],0.8138340091710642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC38,Leucine-rich repeat-containing protein 38,23520,31,1.43 [0.78-2.60],0.2467649174436741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC59,Leucine-rich repeat-containing protein 59,24190,32,0.49 [0.21-1.13],0.0958194568172251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24076,32,0.52 [0.23-1.14],0.1027561910710515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRN1,Leucine-rich repeat neuronal protein 1,27328,39,0.81 [0.40-1.66],0.5654151786389426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23520,31,0.61 [0.23-1.66],0.3347115878985817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24155,32,0.73 [0.42-1.27],0.2700844998087119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM1,U6 snRNA-associated Sm-like protein LSm1,27162,39,0.60 [0.32-1.14],0.1165661759250226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM8,U6 snRNA-associated Sm-like protein LSm8,23748,32,1.08 [0.75-1.55],0.6794401409609546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSP1,Lymphocyte-specific protein 1,27833,38,0.93 [0.46-1.88],0.8395383761324064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA,Lymphotoxin-alpha,27833,38,0.99 [0.48-2.07],0.9846578306434476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA4H,Leukotriene A-4 hydrolase,28097,39,1.15 [0.73-1.82],0.5492007297245649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTB,Lymphotoxin-beta,24076,32,0.86 [0.29-2.49],0.7751872622620973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP2,Latent-transforming growth factor beta-binding protein 2,28187,37,1.41 [0.55-3.59],0.4698828173846515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP3,Latent-transforming growth factor beta-binding protein 3,27162,39,0.98 [0.58-1.67],0.945234384354968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBR,Tumor necrosis factor receptor superfamily member 3,27670,39,0.75 [0.26-2.20],0.6039078838125981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTO1,Protein LTO1 homolog,27328,39,1.55 [0.98-2.45],0.0635897660018862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LUZP2,Leucine zipper protein 2,24076,32,1.31 [0.66-2.57],0.4393489434825376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LXN,Latexin,27516,38,1.03 [0.68-1.56],0.893349081907241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY6D,Lymphocyte antigen 6D,27675,39,0.77 [0.34-1.73],0.5228288215275203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY75,Lymphocyte antigen 75,27833,38,1.20 [0.57-2.56],0.6281750014643415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY9,T-lymphocyte surface antigen Ly-9,27559,38,2.12 [0.86-5.25],0.1022028092138356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY96,Lymphocyte antigen 96,27656,38,1.00 [0.46-2.20],0.9972107308129552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYAR,Cell growth-regulating nucleolar protein,27162,39,0.54 [0.27-1.09],0.0861704080651857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYN,Tyrosine-protein kinase Lyn,27720,38,0.94 [0.68-1.31],0.7286423870732387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD1,Ly6/PLAUR domain-containing protein 1,27189,38,0.38 [0.16-0.92],0.0328898750497438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD3,Ly6/PLAUR domain-containing protein 3,27699,37,0.70 [0.30-1.63],0.4095230100097254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD8,Ly6/PLAUR domain-containing protein 8,27162,39,0.91 [0.52-1.58],0.7310291726314682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPLA2,Acyl-protein thioesterase 2,23416,30,0.75 [0.47-1.17],0.2045473339806484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23520,31,0.75 [0.49-1.13],0.1713073594226756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24225,32,0.62 [0.11-3.63],0.5998605502063066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYZL2,Lysozyme-like protein 2,23333,31,0.48 [0.16-1.48],0.2030277502235163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LZTFL1,Leucine zipper transcription factor-like protein 1,23650,32,0.83 [0.51-1.34],0.4463104665670871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,M6PR,Cation-dependent mannose-6-phosphate receptor,23514,31,1.14 [0.50-2.57],0.7612694345124665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27569,38,1.13 [0.68-1.90],0.6342047022314518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAEA,E3 ubiquitin-protein transferase MAEA,27162,39,0.40 [0.17-0.93],0.0333032267809235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAG,Myelin-associated glycoprotein,23520,31,1.08 [0.51-2.26],0.8489796538939345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGEA3,Melanoma-associated antigen 3,23748,32,1.01 [0.67-1.52],0.9615369945164134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGED1,Melanoma-associated antigen D1,27162,39,1.04 [0.58-1.85],0.8910671916500618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC2,MAM domain-containing protein 2,24190,32,2.77 [1.16-6.63],0.022416714330436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC4,Apical endosomal glycoprotein,24076,32,0.99 [0.55-1.79],0.978233007652745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23514,31,1.45 [0.38-5.50],0.581795725810635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN2B2,Epididymis-specific alpha-mannosidase,24190,32,0.67 [0.38-1.19],0.168882459662866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23333,31,0.72 [0.36-1.44],0.3552088181188099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANF,Mesencephalic astrocyte-derived neurotrophic factor,27968,39,0.97 [0.78-1.22],0.820179947830975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC1,MANSC domain-containing protein 1,27911,38,0.61 [0.22-1.70],0.3459089577784239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC4,MANSC domain-containing protein 4,23415,31,0.98 [0.57-1.70],0.9475343853061338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23416,30,0.90 [0.30-2.69],0.843662489975572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23415,31,0.66 [0.29-1.49],0.3213759757190515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2,Microtubule-associated protein 2,24123,32,0.84 [0.40-1.79],0.6578178809556015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24098,32,0.74 [0.44-1.24],0.2501947856248588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,27833,38,0.90 [0.68-1.20],0.4761342965196173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27162,39,0.85 [0.63-1.16],0.312075192023763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27608,38,0.95 [0.74-1.23],0.7229076767212186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK13,Mitogen-activated protein kinase 13,23333,31,1.07 [0.51-2.26],0.8602649514725191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK9,Mitogen-activated protein kinase 9,27833,38,1.02 [0.54-1.95],0.944335676866652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPKAPK2,MAP kinase-activated protein kinase 2,23748,32,0.88 [0.56-1.40],0.5968297786929404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPRE3,Microtubule-associated protein RP/EB family member 3,23333,31,0.94 [0.72-1.23],0.662273814870465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPT,Microtubule-associated protein tau,27189,38,0.96 [0.55-1.67],0.8873716083513193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARCO,Macrophage receptor MARCO,27845,37,0.93 [0.31-2.80],0.8915607616568443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARS1,"Methionine--tRNA ligase, cytoplasmic",23598,32,0.86 [0.58-1.28],0.4562743017644962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MASP1,Mannan-binding lectin serine protease 1,27608,38,1.02 [0.30-3.48],0.9739398825094744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN2,Matrilin-2,27873,39,1.93 [0.76-4.94],0.1687951498799599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN3,Matrilin-3,27608,38,0.57 [0.25-1.34],0.201146202028363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAVS,Mitochondrial antiviral-signaling protein,27162,39,0.88 [0.64-1.21],0.4483975566738858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAX,Protein max,27189,38,1.05 [0.80-1.37],0.748809322665901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MB,Myoglobin,28187,37,0.71 [0.39-1.28],0.2503048980571379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MBL2,Mannose-binding protein C,23873,31,1.03 [0.76-1.41],0.8381911342225268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCAM,Cell surface glycoprotein MUC18,27924,39,0.61 [0.25-1.46],0.2647391118636359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24155,32,1.10 [0.53-2.28],0.7981578527842648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEMP1,Mast cell-expressed membrane protein 1,23505,32,0.72 [0.48-1.09],0.1176444410473187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCFD2,Multiple coagulation factor deficiency protein 2,27725,37,0.94 [0.50-1.78],0.8571463706233324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCTS1,Malignant T-cell-amplified sequence 1,24098,32,0.53 [0.12-2.42],0.4152997230151742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27656,38,0.81 [0.54-1.21],0.3025396989737273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDH1,"Malate dehydrogenase, cytoplasmic",24078,32,0.88 [0.37-2.06],0.7652215171558248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDK,Midkine,27819,38,1.02 [0.59-1.77],0.931151544854351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDM1,Nuclear protein MDM1,23520,31,0.92 [0.30-2.86],0.8884336304099031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23514,31,0.93 [0.64-1.36],0.7177728081136108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED18,Mediator of RNA polymerase II transcription subunit 18,27162,39,0.91 [0.63-1.32],0.6301983606469188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED21,Mediator of RNA polymerase II transcription subunit 21,23415,31,1.12 [0.61-2.06],0.7084365616821465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF10,Multiple epidermal growth factor-like domains protein 10,27823,39,0.88 [0.44-1.78],0.7301680237770269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF11,Multiple epidermal growth factor-like domains protein 11,23415,31,0.78 [0.23-2.62],0.6837085385237884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF9,Multiple epidermal growth factor-like domains protein 9,28088,37,0.35 [0.08-1.53],0.1644108955012669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MELTF,Melanotransferrin,24190,32,0.85 [0.27-2.64],0.7823873593567182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MENT,Protein MENT,23650,32,0.65 [0.15-2.89],0.5762377399839262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1A,Meprin A subunit alpha,24098,32,0.65 [0.40-1.05],0.0767881041276467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1B,Meprin A subunit beta,27845,37,0.90 [0.70-1.14],0.369595253784324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEPE,Matrix extracellular phosphoglycoprotein,27823,39,1.09 [0.34-3.49],0.8865965412267452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MERTK,Tyrosine-protein kinase Mer,28182,39,1.06 [0.34-3.26],0.921665813940564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MESD,LRP chaperone MESD,27836,38,0.93 [0.73-1.17],0.5190102335553526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MET,Hepatocyte growth factor receptor,27926,37,0.81 [0.18-3.61],0.7856128634537574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1,Methionine aminopeptidase 1,27189,38,0.53 [0.19-1.52],0.2393552155774051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",27833,38,0.89 [0.63-1.26],0.5222181732007589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP2,Methionine aminopeptidase 2,28060,39,1.00 [0.61-1.63],0.9962889486150164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3,Microfibril-associated glycoprotein 3,27343,37,0.61 [0.30-1.27],0.1871148829292706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3L,Microfibrillar-associated protein 3-like,23520,31,0.60 [0.26-1.36],0.2214890548706958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP4,Microfibril-associated glycoprotein 4,23650,32,1.70 [0.59-4.87],0.3219970409288926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP5,Microfibrillar-associated protein 5,28187,37,0.48 [0.25-0.95],0.0337250154713431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFGE8,Lactadherin,27836,38,1.17 [0.62-2.21],0.6249498919934559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGLL,Monoglyceride lipase,27925,39,0.93 [0.68-1.27],0.6522900208859541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGMT,Methylated-DNA--protein-cysteine methyltransferase,27833,38,1.08 [0.85-1.38],0.5100809424535366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIA,Melanoma-derived growth regulatory protein,27911,38,1.42 [0.67-3.02],0.3603273901750055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICALL2,MICAL-like protein 2,23520,31,0.62 [0.34-1.14],0.1251558967579407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,27833,38,1.41 [1.02-1.93],0.0350360511921902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIF,Macrophage migration inhibitory factor,27787,38,0.84 [0.55-1.28],0.4126859694892254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MILR1,Allergin-1,27328,39,1.00 [0.57-1.77],0.987611734759122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24076,32,0.87 [0.64-1.19],0.3828979812763686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINK1,Misshapen-like kinase 1,24123,32,0.84 [0.59-1.20],0.3391646305134332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MITD1,MIT domain-containing protein 1,27656,38,0.96 [0.72-1.29],0.7956414816402282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MKI67,Proliferation marker protein Ki-67,23505,32,0.56 [0.19-1.70],0.3089085788873674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLLT1,Protein ENL,23333,31,0.90 [0.52-1.55],0.7077344247319644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLN,Promotilin,27833,38,1.08 [0.79-1.48],0.6254315039675233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MME,Neprilysin,27720,38,1.49 [1.08-2.06],0.0162844509297368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP1,Interstitial collagenase,26860,37,0.71 [0.52-0.96],0.0243816174102284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP10,Stromelysin-2,27795,39,1.18 [0.73-1.89],0.4977521911624039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP12,Macrophage metalloelastase,27890,39,1.33 [0.79-2.26],0.285869295887261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP13,Collagenase 3,27189,38,0.91 [0.37-2.27],0.8442925089446461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP15,Matrix metalloproteinase-15,24190,32,0.53 [0.17-1.63],0.2693409345284533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP3,Stromelysin-1,27836,38,1.14 [0.63-2.05],0.6700924326774592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP7,Matrilysin,27301,37,0.98 [0.54-1.78],0.9589556488775038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP8,Neutrophil collagenase,28067,39,1.13 [0.77-1.65],0.5280261780920965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP9,Matrix metalloproteinase-9,27797,38,0.74 [0.46-1.17],0.1922056359443171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23415,31,0.93 [0.46-1.89],0.8449733633406212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MN1,Transcriptional activator MN1,23520,31,0.99 [0.54-1.81],0.9735053732572022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNAT1,CDK-activating kinase assembly factor MAT1,23748,32,0.88 [0.39-1.98],0.7559121692363682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNDA,Myeloid cell nuclear differentiation antigen,27807,37,1.06 [0.81-1.39],0.6604637340140833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOCS2,Molybdopterin synthase catalytic subunit,23650,32,0.82 [0.49-1.36],0.4364677707793456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOG,Myelin-oligodendrocyte glycoprotein,28097,39,0.34 [0.15-0.81],0.0139916411517914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORC3,MORC family CW-type zinc finger protein 3,24123,32,0.44 [0.10-1.94],0.2792270954966578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L1,Mortality factor 4-like protein 1,23748,32,0.61 [0.22-1.70],0.3432473184809953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L2,Mortality factor 4-like protein 2,23333,31,0.62 [0.20-1.92],0.4112259469332295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORN4,MORN repeat-containing protein 4,23333,31,0.53 [0.28-1.02],0.0571802256322509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPHOSPH8,M-phase phosphoprotein 8,27343,37,0.98 [0.67-1.43],0.9105556132152868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPI,Mannose-6-phosphate isomerase,27720,38,0.89 [0.64-1.25],0.508059471082681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,27925,39,0.95 [0.66-1.35],0.760733056382835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPO,Myeloperoxidase,27836,38,1.02 [0.55-1.88],0.955782822775284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPRIP,Myosin phosphatase Rho-interacting protein,24037,32,0.96 [0.45-2.04],0.9103151204399998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRC1,Macrophage mannose receptor 1,24214,32,1.30 [0.40-4.22],0.6630892315421753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRI1,Methylthioribose-1-phosphate isomerase,23520,31,1.37 [0.81-2.33],0.2443910188621758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL24,"39S ribosomal protein L24, mitochondrial",23415,31,0.35 [0.11-1.09],0.0708432767317799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL28,"39S ribosomal protein L28, mitochondrial",24155,32,1.21 [0.58-2.53],0.6122807135902895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL46,"39S ribosomal protein L46, mitochondrial",27189,38,0.37 [0.11-1.20],0.098499484377081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL52,"39S ribosomal protein L52, mitochondrial",23294,31,0.86 [0.22-3.43],0.8287167918167744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24155,32,0.80 [0.46-1.41],0.4454283826402716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPS16,"28S ribosomal protein S16, mitochondrial",23505,32,0.85 [0.50-1.45],0.5577703455089783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLN,Mesothelin,27682,38,1.08 [0.65-1.79],0.7774197759693964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLNL,Mesothelin-like protein,23520,31,0.52 [0.18-1.51],0.2285393163405781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSMB,Beta-microseminoprotein,27768,37,1.08 [0.70-1.66],0.7375537905154832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSR1,Macrophage scavenger receptor types I and II,28109,39,1.85 [1.03-3.36],0.0411203545895652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSRA,Mitochondrial peptide methionine sulfoxide reductase,27911,38,0.93 [0.63-1.38],0.7277219623042783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MST1,Hepatocyte growth factor-like protein,23855,31,1.26 [0.64-2.51],0.504780614009948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSTN,Growth/differentiation factor 8,27343,37,1.49 [0.87-2.54],0.1440514202202016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTDH,Protein LYRIC,23505,32,0.99 [0.69-1.43],0.9671710183452852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24123,32,0.73 [0.17-3.15],0.6721351046795352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23748,32,0.83 [0.61-1.12],0.227527688611431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTIF3,"Translation initiation factor IF-3, mitochondrial",24098,32,0.84 [0.57-1.24],0.3912467099694381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTPN,Myotrophin,27343,37,0.82 [0.32-2.13],0.6852221863557808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTR,Methionine synthase,23415,31,0.44 [0.20-0.98],0.0457288974285266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS1,Protein MTSS 1,24098,32,0.80 [0.59-1.08],0.1398316807384945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS2,Protein MTSS 2,24076,32,1.00 [0.72-1.40],0.9979033321954784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTUS1,Microtubule-associated tumor suppressor 1,23748,32,1.12 [0.63-2.02],0.6958081932233153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC13,Mucin-13,27189,38,1.31 [0.75-2.27],0.3393970239734636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC16,Mucin-16,27720,38,1.18 [0.99-1.41],0.0689031474277065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC2,Mucin-2,24183,32,0.74 [0.51-1.08],0.1240075641745623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUCL3,Mucin-like protein 3,23333,31,0.45 [0.13-1.50],0.193748905462311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MVK,Mevalonate kinase,27328,39,1.09 [0.77-1.54],0.618729656621366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MXRA8,Matrix remodeling-associated protein 8,23650,32,1.02 [0.34-3.09],0.976430096694736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC1,"Myosin-binding protein C, slow-type",24190,32,0.82 [0.50-1.35],0.4370265471337133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC2,"Myosin-binding protein C, fast-type",23514,31,1.06 [0.72-1.55],0.7742149869418198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24155,32,1.03 [0.62-1.70],0.918291480506152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYDGF,Myeloid-derived growth factor,24190,32,0.97 [0.70-1.35],0.8647817857125095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH4,Myosin-4,23415,31,0.33 [0.11-0.95],0.0398953641660384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH7B,Myosin-7B,23333,31,1.34 [0.70-2.56],0.3818082411107234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH9,Myosin-9,24183,32,0.91 [0.67-1.22],0.5124856087699943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23415,31,0.92 [0.38-2.24],0.849232111003284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL3,Myosin light chain 3,23514,31,0.90 [0.57-1.43],0.6589163457952079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL4,Myosin light chain 4,23514,31,1.01 [0.53-1.92],0.9670334568927964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL6B,Myosin light chain 6B,23520,31,0.96 [0.65-1.42],0.8572690719140535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23520,31,0.82 [0.38-1.76],0.6098206131284536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO6,Unconventional myosin-VI,24155,32,0.79 [0.29-2.16],0.6506325183069149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO9B,Unconventional myosin-IXb,27328,39,0.68 [0.42-1.12],0.1317091346519638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOC,Myocilin,27836,38,1.00 [0.53-1.87],0.996360178505307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM1,Myomesin-1,23416,30,1.16 [0.60-2.24],0.6594579810707667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM2,Myomesin-2,23415,31,0.98 [0.51-1.87],0.9462857382480204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM3,Myomesin-3,23650,32,0.88 [0.61-1.26],0.4911357005818835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZB1,Marginal zone B- and B1-cell-specific protein,27916,39,1.19 [0.69-2.06],0.5368129125528542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZT1,Mitotic-spindle organizing protein 1,27162,39,0.70 [0.38-1.29],0.252238592969197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA10,N-alpha-acetyltransferase 10,23415,31,0.62 [0.32-1.19],0.1496656571092701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA80,N-alpha-acetyltransferase 80,23520,31,0.94 [0.71-1.24],0.6497819116905902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27520,38,0.79 [0.49-1.28],0.3418556867201011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NACC1,Nucleus accumbens-associated protein 1,24076,32,0.84 [0.44-1.59],0.5891546815349598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NADK,NAD kinase,27845,37,0.91 [0.54-1.55],0.7412915782441184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGA,Alpha-N-acetylgalactosaminidase,23471,32,0.36 [0.14-0.88],0.0261965316386132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGK,N-acetyl-D-glucosamine kinase,23470,31,0.81 [0.44-1.49],0.5017764976615786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23650,32,1.20 [0.25-5.74],0.8219783122203476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAMPT,Nicotinamide phosphoribosyltransferase,27162,39,0.76 [0.40-1.44],0.4001810138765029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAP1L4,Nucleosome assembly protein 1-like 4,24059,32,0.86 [0.40-1.84],0.6905709807179214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAPRT,Nicotinate phosphoribosyltransferase,24123,32,1.46 [0.59-3.64],0.4149726222958386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24155,32,0.77 [0.38-1.54],0.4580199157344201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBL1,Neuroblastoma suppressor of tumorigenicity 1,27911,38,1.34 [0.44-4.04],0.6042219703931354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBN,Nibrin,27328,39,0.57 [0.28-1.15],0.1149518387214543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM1,Neural cell adhesion molecule 1,27924,39,0.48 [0.19-1.20],0.1182415694536539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM2,Neural cell adhesion molecule 2,27836,38,0.70 [0.44-1.12],0.1372346432001403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAN,Neurocan core protein,28109,39,0.74 [0.54-1.01],0.0570199601048259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCF2,Neutrophil cytosol factor 2,27781,38,0.88 [0.62-1.26],0.494848770478316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCK2,Cytoplasmic protein NCK2,27968,39,1.01 [0.78-1.31],0.9498219583303776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCLN,Nicalin,27328,39,0.87 [0.47-1.64],0.6719707152088308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR1,Natural cytotoxicity triggering receptor 1,27795,38,1.12 [0.51-2.47],0.782293751524228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24098,32,1.38 [0.52-3.67],0.5144792753622986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCS1,Neuronal calcium sensor 1,28097,39,0.84 [0.31-2.29],0.7380056215765887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDRG1,Protein NDRG1,27189,38,0.84 [0.51-1.40],0.5105856699859148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24076,32,0.67 [0.32-1.43],0.3058899079669161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23456,32,1.43 [0.60-3.43],0.4196307402707553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24098,32,0.95 [0.65-1.39],0.7921521885857359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27162,39,1.01 [0.71-1.44],0.9669990144290144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEB,Nebulin,23415,31,2.22 [1.43-3.43],0.0003416361715129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECAP2,Adaptin ear-binding coat-associated protein 2,23415,31,0.92 [0.54-1.58],0.7660646218420964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN1,Nectin-1,23505,32,1.00 [0.36-2.73],0.994318630248547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN2,Nectin-2,27813,37,1.29 [0.48-3.45],0.6135575527766467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN4,Nectin-4,27911,38,1.06 [0.40-2.79],0.9052837768635068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23505,32,0.78 [0.40-1.52],0.4659523141301419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD9,Enhancer of filamentation 1,23505,32,0.43 [0.13-1.45],0.1740119044348935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEFL,Neurofilament light polypeptide,27102,38,2.12 [1.39-3.23],0.0005018793449433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEK7,Serine/threonine-protein kinase Nek7,23748,32,0.65 [0.36-1.18],0.1541601398017991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL1,Protein kinase C-binding protein NELL1,27911,38,0.76 [0.38-1.52],0.4347871540416005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL2,Protein kinase C-binding protein NELL2,27968,39,0.31 [0.11-0.86],0.0243193264678844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NENF,Neudesin,24076,32,0.74 [0.47-1.16],0.1876787066038753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEO1,Neogenin,24155,32,0.83 [0.42-1.63],0.5790199077348392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEXN,Nexilin,24214,32,0.67 [0.39-1.14],0.1362731069856685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFASC,Neurofascin,28182,39,0.77 [0.27-2.16],0.6168473938772692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFAT5,Nuclear factor of activated T-cells 5,23505,32,0.96 [0.64-1.44],0.8320780816049342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",27833,38,1.08 [0.81-1.44],0.5893853757982119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27328,39,1.00 [0.62-1.60],0.9931501879408668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFE2,Transcription factor NF-E2 45 kDa subunit,23514,31,0.89 [0.56-1.43],0.6338781616292808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFIC,Nuclear factor 1 C-type,24155,32,0.81 [0.56-1.18],0.2763008862430914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23415,31,0.80 [0.49-1.28],0.3457105926815762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23748,32,1.09 [0.64-1.85],0.7639338169438536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKBIE,NF-kappa-B inhibitor epsilon,27162,39,1.20 [0.69-2.07],0.519488387995072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24098,32,0.89 [0.64-1.23],0.4796492410000155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFX1,Transcriptional repressor NF-X1,23415,31,1.03 [0.62-1.71],0.8981968273528602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFYA,Nuclear transcription factor Y subunit alpha,23415,31,0.63 [0.21-1.89],0.4098979945718062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGF,Beta-nerve growth factor,27656,38,1.33 [0.13-13.57],0.8087934809628716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGFR,Tumor necrosis factor receptor superfamily member 16,24190,32,0.52 [0.14-1.90],0.3207031670642987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGRN,Neugrin,24123,32,0.65 [0.12-3.48],0.6119210515489506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NHLRC3,NHL repeat-containing protein 3,23103,31,0.78 [0.26-2.32],0.6502962584248945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID1,Nidogen-1,27845,39,0.73 [0.34-1.56],0.4099960339546362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID2,Nidogen-2,27836,38,0.86 [0.58-1.27],0.43955021888343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NINJ1,Ninjurin-1,27162,39,0.71 [0.36-1.40],0.3273205010864621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT1,Deaminated glutathione amidase,23514,31,1.36 [0.61-3.05],0.4558682167184912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT2,Omega-amidase NIT2,24096,31,1.07 [0.68-1.69],0.7801661970014608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN1,Neuroligin-1,23520,31,1.30 [0.91-1.85],0.1486627312035339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN2,Neuroligin-2,23416,30,0.98 [0.45-2.12],0.9541011503722184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME1,Nucleoside diphosphate kinase A,23505,32,0.36 [0.07-1.98],0.2400693179844873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME3,Nucleoside diphosphate kinase 3,27873,39,0.49 [0.13-1.79],0.2788569702530588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMI,N-myc-interactor,23974,32,1.06 [0.68-1.67],0.7935971304463304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27656,38,0.79 [0.51-1.23],0.2974639363628084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMRK2,Nicotinamide riboside kinase 2,23333,31,0.62 [0.20-1.95],0.4116409191195269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24155,32,1.06 [0.66-1.73],0.7986149259953125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOMO1,Nodal modulator 1,27836,38,0.81 [0.24-2.70],0.7274399838532273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOP56,Nucleolar protein 56,23415,31,0.93 [0.65-1.32],0.6667471812594166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS1,"Nitric oxide synthase, brain",27189,38,0.68 [0.39-1.16],0.1583152079864406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS2,"Nitric oxide synthase, inducible",23415,31,0.36 [0.14-0.97],0.0429053312075936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS3,"Nitric oxide synthase, endothelial",27189,38,1.02 [0.58-1.81],0.9376790645398017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH1,Neurogenic locus notch homolog protein 1,28187,37,0.57 [0.25-1.31],0.1837209511417356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH2,Neurogenic locus notch homolog protein 2,24183,32,0.64 [0.18-2.32],0.4983298328638414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH3,Neurogenic locus notch homolog protein 3,28187,37,0.87 [0.37-2.04],0.7426938088492359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPC2,NPC intracellular cholesterol transporter 2,23785,31,2.19 [1.07-4.49],0.0316523192461448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPDC1,Neural proliferation differentiation and control protein 1,27845,37,0.97 [0.37-2.59],0.9560232196301212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS1,Nephrin,23505,32,0.59 [0.21-1.68],0.3259722527135841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS2,Podocin,23505,32,1.06 [0.77-1.44],0.7279122506841577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPL,N-acetylneuraminate lyase,24190,32,1.07 [0.51-2.27],0.8587725087869279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPB,Natriuretic peptides B,27343,37,1.16 [0.91-1.48],0.238266702061739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPC,C-type natriuretic peptide,27833,38,0.90 [0.49-1.66],0.7439534329855674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPR1,Atrial natriuretic peptide receptor 1,23415,31,1.04 [0.45-2.42],0.925300742106358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTN,Neuroplastin,27162,39,0.59 [0.34-1.03],0.0620999308081284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX1,Neuronal pentraxin-1,27836,38,1.18 [0.59-2.33],0.6398174656371443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX2,Neuronal pentraxin-2,24183,32,1.73 [0.64-4.67],0.2771018979398045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTXR,Neuronal pentraxin receptor,27845,37,0.31 [0.12-0.80],0.0159243375176573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPY,Pro-neuropeptide Y,28097,39,0.85 [0.56-1.29],0.4376914514587976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRCAM,Neuronal cell adhesion molecule,27845,37,0.64 [0.22-1.84],0.4048215293243076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRGN,Neurogranin,24214,32,0.89 [0.62-1.28],0.5219066835253148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRN1,Neuritin,24155,32,0.71 [0.22-2.32],0.5739003872074551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP1,Neuropilin-1,27980,39,1.69 [0.62-4.64],0.3050708288086159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP2,Neuropilin-2,27836,38,1.05 [0.39-2.83],0.9209073083873373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRTN,Neurturin,27328,39,1.15 [0.69-1.91],0.603989206370783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRXN3,Neurexin-3,23520,31,0.42 [0.11-1.61],0.2036303803817031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NSFL1C,NSFL1 cofactor p47,28109,39,0.84 [0.54-1.30],0.4432353653660055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24190,32,0.75 [0.48-1.17],0.2011891759069398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C1A,Cytosolic 5'-nucleotidase 1A,24123,32,1.60 [0.68-3.78],0.2815801877158203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C3A,Cytosolic 5'-nucleotidase 3A,27784,36,0.93 [0.66-1.30],0.6624555704593103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5E,5'-nucleotidase,27911,38,1.95 [1.31-2.90],0.0009551000117405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF3,Neurotrophin-3,27833,38,1.11 [0.49-2.50],0.8039992261484291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF4,Neurotrophin-4,27162,39,0.66 [0.25-1.71],0.3932217303863961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK2,BDNF/NT-3 growth factors receptor,27845,37,0.40 [0.13-1.27],0.1209629160733197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK3,NT-3 growth factor receptor,28109,39,0.50 [0.14-1.82],0.2931780825880628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTproBNP,N-terminal prohormone of brain natriuretic peptide,27845,37,1.25 [0.94-1.65],0.1290845256436686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUB1,NEDD8 ultimate buster 1,27833,38,0.93 [0.66-1.31],0.6829347923630579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24076,32,0.84 [0.57-1.25],0.3978996760543548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUCB2,Nucleobindin-2,28059,39,0.80 [0.37-1.69],0.5525181676068565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDC,Nuclear migration protein nudC,28182,39,1.03 [0.67-1.59],0.9035702267426728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23514,31,1.83 [0.91-3.69],0.0922825615532515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23415,31,0.74 [0.32-1.69],0.4674179397501481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT16,U8 snoRNA-decapping enzyme,24061,32,0.98 [0.67-1.43],0.9143985166578106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27720,38,0.77 [0.46-1.31],0.336546755223546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT5,ADP-sugar pyrophosphatase,27836,38,0.94 [0.54-1.65],0.8329178133014601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUMB,Protein numb homolog,23505,32,0.82 [0.55-1.22],0.3283212238829639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUP50,Nuclear pore complex protein Nup50,23415,31,0.58 [0.15-2.20],0.4198476908608786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPE4,NXPE family member 4,23415,31,0.49 [0.13-1.79],0.2790020300067554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH1,Neurexophilin-1,27189,38,0.50 [0.23-1.10],0.0864999470439551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH3,Neurexophilin-3,23505,32,0.72 [0.44-1.19],0.1962596136321702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OBP2B,Odorant-binding protein 2b,27558,38,1.09 [0.68-1.74],0.7105076065213448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OCLN,Occludin,24155,32,1.61 [0.82-3.19],0.1679641182621008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ODAM,Odontogenic ameloblast-associated protein,27139,38,0.60 [0.32-1.15],0.1239021091590915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OFD1,Oral-facial-digital syndrome 1 protein,23748,32,0.99 [0.59-1.67],0.9799333231844412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGA,Protein O-GlcNAcase,24098,32,0.80 [0.49-1.30],0.3679746802556632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGFR,Opioid growth factor receptor,27720,38,0.66 [0.27-1.60],0.3539162375733783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGN,Mimecan,27836,38,1.26 [0.62-2.56],0.5226139852738843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23748,32,0.69 [0.35-1.37],0.2903157437503269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLFM4,Olfactomedin-4,22775,29,0.95 [0.71-1.27],0.7434806230756321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLR1,Oxidized low-density lipoprotein receptor 1,27578,37,0.79 [0.47-1.31],0.3542976732257094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMD,Osteomodulin,27968,39,2.09 [1.05-4.18],0.0364448078561122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMG,Oligodendrocyte-myelin glycoprotein,27720,38,0.45 [0.30-0.68],0.0001410456812077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMP,Olfactory marker protein,23416,30,1.04 [0.51-2.15],0.9105818656234542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPHN1,Oligophrenin-1,24123,32,1.00 [0.73-1.36],0.976337919225593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPLAH,5-oxoprolinase,23514,31,0.92 [0.56-1.53],0.7558223889666381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPTC,Opticin,27720,38,0.69 [0.34-1.41],0.3119016083922998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ORM1,Alpha-1-acid glycoprotein 1,24143,32,2.03 [0.40-10.27],0.3935188040711898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSBPL2,Oxysterol-binding protein-related protein 2,24123,32,0.63 [0.20-1.99],0.4284201247871224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSCAR,Osteoclast-associated immunoglobulin-like receptor,27873,39,0.91 [0.40-2.08],0.8239486239637287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSM,Oncostatin-M,27693,38,1.07 [0.72-1.59],0.7516581243466475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSMR,Oncostatin-M-specific receptor subunit beta,27980,39,0.40 [0.10-1.64],0.2033070675259433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSTN,Osteocrin,23520,31,0.93 [0.38-2.26],0.8679882451480494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTOA,Otoancorin,23416,30,1.11 [0.60-2.06],0.7390422921885276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD6B,Deubiquitinase OTUD6B,24098,32,0.78 [0.43-1.41],0.4139096411105911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD7B,OTU domain-containing protein 7B,24155,32,0.86 [0.50-1.46],0.5703299639421393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23514,31,0.92 [0.57-1.50],0.7474079441486188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXT,Oxytocin-neurophysin 1,28109,39,1.06 [0.87-1.29],0.5398570570876359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,P4HB,Protein disulfide-isomerase,27690,38,0.54 [0.27-1.06],0.0750791256637536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PACS2,Phosphofurin acidic cluster sorting protein 2,23415,31,0.92 [0.53-1.62],0.7795819292299376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI2,Protein-arginine deiminase type-2,27328,39,0.58 [0.29-1.14],0.1131975216712383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI4,Protein-arginine deiminase type-4,27139,38,0.95 [0.63-1.42],0.7857962333541224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAEP,Glycodelin,27656,38,1.05 [0.84-1.30],0.68951711390076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24155,32,0.78 [0.51-1.17],0.2295720890730931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23748,32,0.93 [0.46-1.88],0.8400123692934428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27343,37,1.05 [0.63-1.75],0.8425764425875084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAGR1,PAXIP1-associated glutamate-rich protein 1,23514,31,0.66 [0.27-1.59],0.3542423937292964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23287,31,0.45 [0.21-0.97],0.0407552888340004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAK4,Serine/threonine-protein kinase PAK 4,27189,38,0.75 [0.45-1.25],0.271887756434119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALLD,Palladin,23505,32,1.14 [0.52-2.51],0.7480195443834089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM,Paralemmin-1,23972,32,0.85 [0.29-2.48],0.7668097095655173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM2,Paralemmin-2,24123,32,2.00 [1.01-3.95],0.0475538316554424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM3,Paralemmin-3,23415,31,0.91 [0.54-1.53],0.7247082067796482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28049,37,0.91 [0.32-2.61],0.8652898372925548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAMR1,Inactive serine protease PAMR1,27836,38,0.65 [0.23-1.83],0.415041060508228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAPPA,Pappalysin-1,27328,39,0.76 [0.42-1.39],0.3767107049482888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARD3,Partitioning defective 3 homolog,23748,32,0.65 [0.38-1.11],0.1158145594624023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARK7,Parkinson disease protein 7,27836,38,0.80 [0.46-1.39],0.4328988377554881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARP1,Poly [ADP-ribose] polymerase 1,27833,38,0.99 [0.60-1.64],0.9615938133663008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAXX,Protein PAXX,23650,32,0.89 [0.43-1.87],0.7666032853570243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBK,Lymphokine-activated killer T-cell-originated protein kinase,23333,31,0.40 [0.13-1.16],0.0909498372353196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBLD,Phenazine biosynthesis-like domain-containing protein,27189,38,0.62 [0.34-1.13],0.1196272766872426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24098,32,0.72 [0.22-2.37],0.5921259951540099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCARE,Photoreceptor cilium actin regulator,23416,30,0.52 [0.26-1.07],0.0751455785403848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23598,32,1.11 [0.56-2.23],0.7591824985587484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBP2,Poly(rC)-binding protein 2,24155,32,0.83 [0.52-1.33],0.4488987393401437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH1,Protocadherin-1,28094,38,0.57 [0.13-2.53],0.4609968718360424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH12,Protocadherin-12,24155,32,0.42 [0.11-1.58],0.1984395859967319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH17,Protocadherin-17,27845,37,1.38 [0.62-3.05],0.4331652328686529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH7,Protocadherin-7,24098,32,0.95 [0.35-2.54],0.9121601789821708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH9,Protocadherin-9,24098,32,0.75 [0.30-1.87],0.5424446958140261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDHB15,Protocadherin beta-15,24076,32,1.19 [0.53-2.67],0.6762114858544406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCNA,Proliferating cell nuclear antigen,23333,31,0.77 [0.39-1.51],0.4462897571695843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK7,Proprotein convertase subtilisin/kexin type 7,24076,32,1.10 [0.54-2.28],0.7878228796490605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK9,Proprotein convertase subtilisin/kexin type 9,28187,37,0.64 [0.31-1.32],0.221925687129757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24098,32,0.91 [0.59-1.41],0.6698174435092916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24190,32,0.92 [0.65-1.29],0.6264902416014275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1,Programmed cell death protein 1,28055,39,1.64 [0.89-3.03],0.1122279357524678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1LG2,Programmed cell death 1 ligand 2,27720,38,0.70 [0.28-1.77],0.4508888728337769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD5,Programmed cell death protein 5,28109,39,0.86 [0.53-1.40],0.5479089767072407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD6,Programmed cell death protein 6,27845,37,1.25 [0.76-2.07],0.385732290017719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCL2,Phosducin-like protein 2,23333,31,0.42 [0.17-1.08],0.0711597547197322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23333,31,1.17 [0.69-1.97],0.568866322658304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23415,31,0.74 [0.36-1.55],0.4293907684514803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23650,32,0.91 [0.66-1.25],0.5447843173880733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFA,Platelet-derived growth factor subunit A,28187,37,0.82 [0.55-1.21],0.3106401538532775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFB,Platelet-derived growth factor subunit B,27968,39,0.79 [0.58-1.08],0.1356406315031366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFC,Platelet-derived growth factor C,27162,39,0.94 [0.35-2.53],0.90207971603371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRA,Platelet-derived growth factor receptor alpha,27845,37,1.28 [0.46-3.52],0.6360150098418194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRB,Platelet-derived growth factor receptor beta,28187,37,0.72 [0.32-1.60],0.4183508626302766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA2,Protein disulfide-isomerase A2,23333,31,0.70 [0.26-1.90],0.4873881357449076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA3,Protein disulfide-isomerase A3,23650,32,1.02 [0.27-3.89],0.9797337859388808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA4,Protein disulfide-isomerase A4,24183,32,0.86 [0.49-1.50],0.5932114310543715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA5,Protein disulfide-isomerase A5,23333,31,0.56 [0.29-1.08],0.0856481128332964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM5,PDZ and LIM domain protein 5,24155,32,0.93 [0.71-1.23],0.6282687755361074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM7,PDZ and LIM domain protein 7,27968,39,0.92 [0.74-1.15],0.4685788645086968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27162,39,0.61 [0.31-1.23],0.1668886328418803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDRG1,p53 and DNA damage-regulated protein 1,23520,31,0.45 [0.18-1.12],0.0846959324564273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23333,31,0.80 [0.37-1.75],0.5772848962196548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZD2,PDZ domain-containing protein 2,23415,31,1.38 [0.88-2.16],0.1629391557838354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23505,32,0.98 [0.45-2.12],0.9615886493800856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEAR1,Platelet endothelial aggregation receptor 1,28187,37,0.30 [0.09-0.99],0.0476988047351266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEBP1,Phosphatidylethanolamine-binding protein 1,27836,38,1.01 [0.62-1.65],0.9630773178189628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECAM1,Platelet endothelial cell adhesion molecule,27836,38,0.77 [0.30-1.99],0.5847650217342706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23514,31,1.10 [0.35-3.44],0.8762570278228252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PENK,Proenkephalin-A,23650,32,1.15 [0.39-3.40],0.8064717230872565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEPD,Xaa-Pro dipeptidase,24214,32,0.35 [0.10-1.20],0.0955699446202928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PER3,Period circadian protein homolog 3,23505,32,1.17 [0.89-1.53],0.2753519664782629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PF4,Platelet factor 4,24047,32,0.95 [0.67-1.33],0.7512778390147874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN2,Prefoldin subunit 2,27189,38,0.75 [0.45-1.28],0.2948689765004322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN4,Prefoldin subunit 4,23333,31,0.42 [0.18-0.95],0.03817989376155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN6,Prefoldin subunit 6,23520,31,0.67 [0.33-1.38],0.2815612719152804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",27681,38,0.89 [0.61-1.29],0.5296551350716854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGA4,Pepsin A-4,24214,32,0.94 [0.57-1.56],0.8127512718381528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24190,32,1.00 [0.54-1.86],0.999776143306359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGF,Placenta growth factor,28182,39,1.83 [0.70-4.79],0.2160612471040782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP1,Peptidoglycan recognition protein 1,28036,37,1.01 [0.51-2.02],0.9687383789897284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23907,31,0.97 [0.31-3.06],0.9644743375718636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP4,Peptidoglycan recognition protein 4,23415,31,0.87 [0.46-1.64],0.6584933679603937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGM2,Phosphoglucomutase-2,23520,31,0.52 [0.22-1.26],0.1502538910307078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGR,Progesterone receptor,23505,32,0.61 [0.33-1.15],0.1287051064835089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHACTR2,Phosphatase and actin regulator 2,24155,32,0.86 [0.64-1.15],0.3112570171996378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB1,Pleckstrin homology-like domain family B member 1,24098,32,0.90 [0.48-1.66],0.7268774406964764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB2,Pleckstrin homology-like domain family B member 2,23333,31,1.35 [1.06-1.73],0.0169721343933373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27656,38,0.66 [0.26-1.64],0.3691153393364053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23650,32,1.03 [0.46-2.30],0.9503488326550064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI16,Peptidase inhibitor 16,24214,32,1.15 [0.29-4.57],0.846228495682661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI3,Elafin,27456,36,0.99 [0.57-1.73],0.9737031143536024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24155,32,0.96 [0.62-1.48],0.8474370806105428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIGR,Polymeric immunoglobulin receptor,27478,38,1.44 [0.69-3.01],0.3281996532529854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,27833,38,0.90 [0.57-1.44],0.6743284885119718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27836,38,1.14 [0.38-3.43],0.8113224390294054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23505,32,0.99 [0.54-1.82],0.979962083329454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRA,Paired immunoglobulin-like type 2 receptor alpha,27836,38,1.56 [0.78-3.12],0.2129722483344235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRB,Paired immunoglobulin-like type 2 receptor beta,27845,37,1.48 [0.86-2.55],0.1609971029011199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23650,32,1.10 [0.66-1.81],0.7232582310996194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PITHD1,PITH domain-containing protein 1,23287,31,0.82 [0.47-1.41],0.4649998620595256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD1,Polycystin-1,24190,32,0.66 [0.18-2.35],0.52036052117762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD2,Polycystin-2,23415,31,0.86 [0.47-1.58],0.6199319284541905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKLR,Pyruvate kinase PKLR,27870,39,1.00 [0.65-1.54],0.9864089548986926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKN3,Serine/threonine-protein kinase N3,23748,32,0.73 [0.45-1.19],0.2091019297996498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G10,Group 10 secretory phospholipase A2,27656,38,1.93 [1.20-3.11],0.0065075850984075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G15,Phospholipase A2 group XV,27911,38,1.72 [0.62-4.77],0.2960688002424418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G1B,Phospholipase A2,28137,37,0.75 [0.38-1.48],0.4062547476173409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G2A,"Phospholipase A2, membrane associated",27787,37,0.85 [0.47-1.52],0.582813032092763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G4A,Cytosolic phospholipase A2,27968,39,0.97 [0.70-1.32],0.8270319361990688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G7,Platelet-activating factor acetylhydrolase,27836,38,0.55 [0.27-1.12],0.1013955610338485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAT,Tissue-type plasminogen activator,28088,37,1.04 [0.59-1.84],0.9002073154108351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAU,Urokinase-type plasminogen activator,27836,38,0.55 [0.20-1.54],0.2551999790685523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAUR,Urokinase plasminogen activator surface receptor,27635,39,1.48 [0.55-3.99],0.4363869407950435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLB1,"Phospholipase B1, membrane-associated",24123,32,1.10 [0.62-1.93],0.7489195637683725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23505,32,0.85 [0.60-1.19],0.3377897675562494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24123,32,0.82 [0.59-1.15],0.2553807145203846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24123,32,0.88 [0.54-1.44],0.6180859912119692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLG,Plasminogen,23595,31,0.73 [0.15-3.46],0.6893733096893424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN1,Perilipin-1,27189,38,0.84 [0.34-2.07],0.7107405226806487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN3,Perilipin-3,27845,37,0.83 [0.42-1.64],0.5874626847520183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLPBP,Pyridoxal phosphate homeostasis protein,27845,37,0.87 [0.57-1.34],0.5363285985931165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLSCR3,Phospholipid scramblase 3,24083,32,0.81 [0.46-1.45],0.4844711100969477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLTP,Phospholipid transfer protein,28087,37,0.62 [0.29-1.32],0.2174349132278847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC1,Plexin domain-containing protein 1,27162,39,1.08 [0.51-2.31],0.8352709327481173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC2,Plexin domain-containing protein 2,24123,32,0.62 [0.17-2.27],0.4724521198582572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNA4,Plexin-A4,27833,38,0.83 [0.58-1.18],0.2960513685610743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB2,Plexin-B2,28055,37,1.23 [0.37-4.10],0.737628063071764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB3,Plexin-B3,27744,37,0.65 [0.35-1.21],0.1763781502509329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,27733,37,1.16 [0.98-1.39],0.0882330878225682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMCH,Pro-MCH,23415,31,1.00 [0.64-1.54],0.9833427931505184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMM2,Phosphomannomutase 2,23415,31,0.84 [0.47-1.52],0.572039539595369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMS1,PMS1 protein homolog 1,23520,31,1.11 [0.58-2.12],0.7472328673982684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMVK,Phosphomevalonate kinase,27148,38,0.92 [0.72-1.17],0.4919545362714234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIP,Pancreatic triacylglycerol lipase,24214,32,1.24 [0.76-2.04],0.3938549329057802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24123,32,1.45 [0.97-2.17],0.0706855666961144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP2,Pancreatic lipase-related protein 2,27823,39,1.00 [0.91-1.10],0.9723469659766728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA1,Paraneoplastic antigen Ma1,23514,31,0.71 [0.38-1.35],0.3003196053469482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA2,Paraneoplastic antigen Ma2,23416,30,1.14 [0.52-2.50],0.753212699716858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27328,39,1.02 [0.81-1.29],0.8516447097524985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL,Podocalyxin,27720,38,2.05 [0.31-13.64],0.4590109852078969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL2,Podocalyxin-like protein 2,27911,38,0.58 [0.21-1.58],0.28469405680111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POF1B,Protein POF1B,23505,32,1.19 [0.60-2.38],0.6128331115292039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23505,32,1.14 [0.39-3.29],0.8151479675143434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27720,38,1.29 [0.65-2.55],0.4656714010326296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POMC,Pro-opiomelanocortin,23514,31,1.18 [0.74-1.87],0.4964407819579672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON1,Serum paraoxonase/arylesterase 1,24214,32,0.83 [0.25-2.77],0.7617007489257852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON2,Serum paraoxonase/arylesterase 2,27343,37,1.29 [0.57-2.94],0.5450522229412736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON3,Serum paraoxonase/lactonase 3,27968,39,0.62 [0.41-0.94],0.0228161418062394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POSTN,Periostin,24183,32,0.54 [0.22-1.32],0.1756893422387845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPBP,Platelet basic protein,24036,32,0.90 [0.61-1.33],0.5934838539728959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPCDC,Phosphopantothenoylcysteine decarboxylase,28109,39,1.10 [0.62-1.97],0.7455786185258595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIB,Peptidyl-prolyl cis-trans isomerase B,27845,37,0.92 [0.69-1.24],0.5843234984067103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIE,Peptidyl-prolyl cis-trans isomerase E,23748,32,1.13 [0.70-1.82],0.6138347102492361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24183,32,0.72 [0.39-1.31],0.2832260985596548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPL,Periplakin,23505,32,0.54 [0.17-1.70],0.2942540237783289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1A,Protein phosphatase 1A,27162,39,0.55 [0.20-1.55],0.2599583918080753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1B,Protein phosphatase 1B,23505,32,0.42 [0.17-1.07],0.0692125135497421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1F,Protein phosphatase 1F,24190,32,0.84 [0.45-1.59],0.5965739203911571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPME1,Protein phosphatase methylesterase 1,27720,38,1.01 [0.63-1.62],0.9764947862082816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24076,32,0.76 [0.50-1.15],0.1925971549515991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,27911,38,0.93 [0.69-1.25],0.6258717946371863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23748,32,0.95 [0.58-1.57],0.8448212060968441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24155,32,0.88 [0.57-1.38],0.5799035173395288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24155,32,0.63 [0.23-1.74],0.3751275493314099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R2,Protein phosphatase inhibitor 2,27845,37,0.89 [0.62-1.27],0.5165536028401674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R9B,Neurabin-2,28182,39,0.95 [0.71-1.28],0.7440223278491144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24098,32,0.83 [0.62-1.12],0.2225631980315571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP3R1,Calcineurin subunit B type 1,27656,38,0.70 [0.35-1.40],0.3087856515331433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPT1,Palmitoyl-protein thioesterase 1,23520,31,1.08 [0.72-1.63],0.7182662325735627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPY,Pancreatic prohormone,27774,38,1.41 [1.08-1.85],0.0118388685409503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PQBP1,Polyglutamine-binding protein 1,27162,39,0.84 [0.47-1.49],0.5466093330810342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAME,Melanoma antigen preferentially expressed in tumors,23333,31,0.86 [0.21-3.48],0.8297764236845532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAP1,Proline-rich acidic protein 1,24183,32,1.38 [0.59-3.25],0.4536111197004865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRC1,Protein regulator of cytokinesis 1,24076,32,0.38 [0.10-1.46],0.1603368796193062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRCP,Lysosomal Pro-X carboxypeptidase,27995,37,0.89 [0.35-2.25],0.7981117147741339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX1,Peroxiredoxin-1,27079,37,0.83 [0.59-1.18],0.2943062605985473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX2,Peroxiredoxin-2,23823,30,1.15 [0.67-1.99],0.6079170072730622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27328,39,0.86 [0.58-1.29],0.4750524273977221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX5,"Peroxiredoxin-5, mitochondrial",28182,39,0.88 [0.59-1.31],0.5319708290395484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX6,Peroxiredoxin-6,28097,39,0.83 [0.52-1.34],0.4528200780367442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PREB,Prolactin regulatory element-binding protein,27328,39,0.60 [0.20-1.78],0.3598618546939574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRELP,Prolargin,27823,39,0.85 [0.26-2.78],0.7853935559263201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG2,Bone marrow proteoglycan,24183,32,1.15 [0.61-2.17],0.6736764668171213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG3,Proteoglycan 3,24183,32,0.68 [0.36-1.26],0.2177812764275416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27328,39,0.98 [0.59-1.65],0.9531755757626336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23520,31,0.82 [0.25-2.69],0.7385437053581734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,27845,37,0.78 [0.56-1.10],0.162182151197634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24075,32,0.87 [0.57-1.31],0.4990456498238639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKCQ,Protein kinase C theta type,27328,39,0.47 [0.21-1.08],0.07531823432444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKD2,Serine/threonine-protein kinase D2,23415,31,0.68 [0.25-1.83],0.4492709832664423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKG1,cGMP-dependent protein kinase 1,23650,32,0.89 [0.68-1.17],0.4055613589189809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27162,39,0.78 [0.50-1.21],0.2679595458401703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRL,Prolactin,28109,39,1.21 [0.85-1.73],0.2860748393859191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRND,Prion-like protein doppel,24123,32,1.24 [0.65-2.36],0.519215472318245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROC,Vitamin K-dependent protein C,27890,39,0.35 [0.12-0.99],0.0486395428234197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROCR,Endothelial protein C receptor,23415,31,0.87 [0.29-2.60],0.8068266349997633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROK1,Prokineticin-1,27833,38,1.13 [0.70-1.82],0.6287604221262216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROS1,Vitamin K-dependent protein S,24225,32,0.62 [0.15-2.56],0.5083465582283256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR4,Proline-rich protein 4,23491,32,0.87 [0.53-1.41],0.5628744477739376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR5,Proline-rich protein 5,23505,32,1.02 [0.49-2.12],0.9625549224020864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRRT3,Proline-rich transmembrane protein 3,23514,31,0.45 [0.18-1.13],0.0905195682120608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS2,Trypsin-2,27924,39,1.35 [0.83-2.18],0.2253274530241043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS22,Brain-specific serine protease 4,23505,32,0.65 [0.21-2.01],0.4573099180119677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS27,Serine protease 27,27746,37,0.74 [0.36-1.53],0.4201194633463042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS53,Serine protease 53,24123,32,0.87 [0.39-1.93],0.7257201806918987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS8,Prostasin,27733,39,1.05 [0.53-2.08],0.8902682801922174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27189,38,0.94 [0.73-1.21],0.6533103835575231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTG,Protogenin,28097,39,0.84 [0.27-2.67],0.7688985021114634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTN3,Myeloblastin,27156,37,0.87 [0.47-1.65],0.6779504332107629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRUNE2,Protein prune homolog 2,23748,32,1.49 [0.56-4.01],0.4250172690839514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAP,Prosaposin,23963,31,1.79 [0.65-4.89],0.258896545785497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAPL1,Proactivator polypeptide-like 1,24098,32,0.71 [0.36-1.39],0.3129811138653701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSCA,Prostate stem cell antigen,24098,32,0.93 [0.82-1.05],0.2458011324515975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27656,38,1.01 [0.78-1.32],0.9219709562814208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSIP1,PC4 and SFRS1-interacting protein,27833,38,0.88 [0.55-1.43],0.6138384930030935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMA1,Proteasome subunit alpha type-1,27162,39,0.97 [0.52-1.83],0.9348747040489556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMC3,26S proteasome regulatory subunit 6A,23333,31,2.40 [1.00-5.77],0.0501087850968822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24155,32,0.71 [0.34-1.47],0.3551008015164767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23520,31,0.86 [0.41-1.80],0.6955722354331481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD9,26S proteasome non-ATPase regulatory subunit 9,27720,38,0.92 [0.55-1.56],0.7642855989965149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME1,Proteasome activator complex subunit 1,27623,38,0.86 [0.39-1.88],0.7103924435281896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME2,Proteasome activator complex subunit 2,27537,38,0.99 [0.45-2.18],0.975846912590292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG3,Proteasome assembly chaperone 3,27833,38,1.16 [0.67-2.02],0.5909089298936845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG4,Proteasome assembly chaperone 4,23505,32,1.11 [0.63-1.96],0.719401426637386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSPN,Persephin,27833,38,0.87 [0.63-1.19],0.3856806465448312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSRC1,Proline/serine-rich coiled-coil protein 1,27162,39,1.05 [0.65-1.68],0.8536853783225384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22783,31,1.01 [0.73-1.39],0.9505535879802784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27189,38,0.93 [0.36-2.40],0.8809644218990047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGDS,Prostaglandin-H2 D-isomerase,27626,39,0.73 [0.26-2.06],0.5551761691936137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGES2,Prostaglandin E synthase 2,23325,32,0.94 [0.51-1.76],0.8576472892310641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGR1,Prostaglandin reductase 1,24190,32,0.86 [0.57-1.31],0.4901684575306639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH,Parathyroid hormone,23520,31,1.09 [0.72-1.65],0.683126065453721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,27833,38,0.74 [0.29-1.90],0.5323009239096647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTK7,Inactive tyrosine-protein kinase 7,27189,38,0.69 [0.33-1.44],0.3210392646198906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTN,Pleiotrophin,27343,37,1.15 [0.64-2.06],0.6377132967951722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTP4A3,Protein tyrosine phosphatase type IVA 3,23505,32,1.29 [0.73-2.30],0.380064879175944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27656,38,0.91 [0.63-1.32],0.620714164634578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,27925,39,1.08 [0.79-1.49],0.6295035695850126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23456,32,0.82 [0.55-1.23],0.333941649691686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24190,32,2.42 [0.88-6.68],0.0871316412795242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRC,Receptor-type tyrosine-protein phosphatase C,24183,32,0.50 [0.11-2.27],0.3703750778068146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRF,Receptor-type tyrosine-protein phosphatase F,28187,37,0.69 [0.25-1.92],0.4825135221073694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRH,Receptor-type tyrosine-protein phosphatase H,24098,32,1.16 [0.60-2.26],0.6633469246683776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24098,32,0.64 [0.11-3.60],0.6120225485754183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRM,Receptor-type tyrosine-protein phosphatase mu,27782,38,0.67 [0.21-2.12],0.4931126796988971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27557,38,0.65 [0.26-1.65],0.3682770698641955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRR,Receptor-type tyrosine-protein phosphatase R,24123,32,0.44 [0.18-1.08],0.0731443361287958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRS,Receptor-type tyrosine-protein phosphatase S,28187,37,0.44 [0.14-1.42],0.1706939687717921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24190,32,0.57 [0.19-1.67],0.303063622049366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23650,32,0.82 [0.46-1.45],0.4942691168985569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27065,37,1.26 [0.76-2.08],0.3767685434462046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTTG1,Securin,23748,32,0.91 [0.39-2.09],0.8151199626558294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTX3,Pentraxin-related protein PTX3,27833,38,0.82 [0.49-1.37],0.4479214538177438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVALB,Parvalbumin alpha,27987,39,0.92 [0.72-1.16],0.4627056672633451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVR,Poliovirus receptor,28109,39,1.41 [0.71-2.82],0.3272990461513987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXDNL,Peroxidasin-like protein,24076,32,0.91 [0.48-1.71],0.7701166565072943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXN,Paxillin,27189,38,0.61 [0.32-1.14],0.1187097377401314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYDC1,Pyrin domain-containing protein 1,23514,31,1.19 [0.54-2.61],0.6625191625673386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYY,Peptide YY,23415,31,1.02 [0.71-1.47],0.912303649615765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PZP,Pregnancy zone protein,24225,32,1.35 [0.68-2.69],0.3926233682607248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QDPR,Dihydropteridine reductase,27710,37,0.81 [0.41-1.59],0.5360787630013777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QPCT,Glutaminyl-peptide cyclotransferase,27849,37,0.50 [0.28-0.87],0.0147269128784751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QSOX1,Sulfhydryl oxidase 1,23723,32,1.45 [0.94-2.22],0.0902042096214761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB10,Ras-related protein Rab-10,24190,32,0.76 [0.39-1.45],0.4024677702148395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB11FIP3,Rab11 family-interacting protein 3,24190,32,0.87 [0.64-1.19],0.3909755512748263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB27B,Ras-related protein Rab-27B,24190,32,0.74 [0.51-1.08],0.1213518425308269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB2B,Ras-related protein Rab-2B,24076,32,0.71 [0.41-1.25],0.2369541793106223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB33A,Ras-related protein Rab-33A,23415,31,0.75 [0.44-1.30],0.3073384913075599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB37,Ras-related protein Rab-37,27328,39,0.83 [0.56-1.23],0.3579864967819698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB39B,Ras-related protein Rab-39B,23415,31,0.72 [0.41-1.27],0.2540309472182083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23416,30,1.31 [0.86-1.99],0.2146872598602027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB44,Ras-related protein Rab-44,24076,32,0.59 [0.22-1.60],0.2971173869094543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6A,Ras-related protein Rab-6A,27833,38,0.56 [0.30-1.08],0.0827473140408048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6B,Ras-related protein Rab-6B,27189,38,1.06 [0.57-1.96],0.8597576006316057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEP1,Rab GTPase-binding effector protein 1,23650,32,0.82 [0.52-1.30],0.4029875391262287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEPK,Rab9 effector protein with kelch motifs,27162,39,1.11 [0.71-1.72],0.6597811131027076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABGAP1L,Rab GTPase-activating protein 1-like,27328,39,0.84 [0.51-1.37],0.4786381858378066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAC3,Ras-related C3 botulinum toxin substrate 3,23520,31,1.01 [0.61-1.67],0.970001723067219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD23B,UV excision repair protein RAD23 homolog B,27162,39,0.77 [0.41-1.44],0.4146207581992368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD51,DNA repair protein RAD51 homolog 1,23748,32,1.28 [0.83-1.97],0.2679062770084603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALB,Ras-related protein Ral-B,23505,32,0.73 [0.43-1.24],0.2483680287058975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALY,RNA-binding protein Raly,24076,32,0.90 [0.43-1.85],0.7689387674343804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP1,Ran-specific GTPase-activating protein,23514,31,0.77 [0.39-1.50],0.4398739705960636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP2,E3 SUMO-protein ligase RanBP2,23416,30,0.32 [0.10-1.00],0.050545554061449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANGAP1,Ran GTPase-activating protein 1,27162,39,0.70 [0.35-1.39],0.3080431882658823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAP1A,Ras-related protein Rap-1A,23505,32,0.54 [0.26-1.13],0.1032529508005863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAPGEF2,Rap guanine nucleotide exchange factor 2,23748,32,0.77 [0.39-1.54],0.4613957680092342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES1,Retinoic acid receptor responder protein 1,27162,39,0.57 [0.20-1.60],0.2827953390792949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES2,Retinoic acid receptor responder protein 2,27980,39,0.90 [0.50-1.62],0.7346254172487503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASA1,Ras GTPase-activating protein 1,27189,38,0.97 [0.41-2.30],0.9463485288381877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23333,31,0.66 [0.28-1.55],0.3398886721079472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASSF2,Ras association domain-containing protein 2,27162,39,0.67 [0.36-1.23],0.1935154672721919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBFOX3,RNA binding protein fox-1 homolog 3,24155,32,0.79 [0.31-2.02],0.6201830194691715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBKS,Ribokinase,27208,38,0.86 [0.50-1.49],0.5960803371738495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM17,Splicing factor 45,24155,32,1.29 [0.86-1.94],0.2164717652523545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM19,Probable RNA-binding protein 19,23415,31,0.74 [0.30-1.82],0.5149751271625425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM25,RNA-binding protein 25,23333,31,1.55 [0.81-2.97],0.1821934135753969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP1,Retinol-binding protein 1,23520,31,0.83 [0.45-1.52],0.5474958711879405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP2,Retinol-binding protein 2,27720,38,0.82 [0.56-1.20],0.3089272830839516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP5,Retinol-binding protein 5,27720,38,1.04 [0.63-1.72],0.8729990354668382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP7,Retinoid-binding protein 7,24098,32,1.03 [0.62-1.74],0.8967804364470104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS,RNA-binding protein with multiple splicing,23505,32,0.52 [0.23-1.21],0.1291695625735743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS2,RNA-binding protein with multiple splicing 2,23514,31,0.87 [0.62-1.22],0.4156411366173733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCC1,Regulator of chromosome condensation,24076,32,1.36 [0.84-2.21],0.215369732955676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCOR1,REST corepressor 1,27343,37,0.69 [0.29-1.68],0.4154162201024549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23514,31,1.28 [0.25-6.68],0.7696327299643312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REEP4,Receptor expression-enhancing protein 4,24155,32,0.67 [0.36-1.24],0.2013179448239368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1A,Lithostathine-1-alpha,27680,39,1.01 [0.55-1.83],0.9822232898069584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1B,Lithostathine-1-beta,28187,37,1.10 [0.66-1.82],0.7179359755343201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3A,Regenerating islet-derived protein 3-alpha,28187,37,1.38 [0.90-2.11],0.1374765017912408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3G,Regenerating islet-derived protein 3-gamma,24076,32,0.80 [0.33-1.96],0.6269323047145282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG4,Regenerating islet-derived protein 4,27873,39,0.52 [0.28-0.97],0.0386313758185649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELB,Transcription factor RelB,23505,32,0.90 [0.42-1.91],0.7825087010791509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELT,Tumor necrosis factor receptor superfamily member 19L,27836,38,1.10 [0.38-3.23],0.856248155743432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REN,Renin,27845,37,0.90 [0.58-1.40],0.6312120224748515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REPS1,RalBP1-associated Eps domain-containing protein 1,23505,32,0.37 [0.13-1.07],0.0667755971552044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REST,RE1-silencing transcription factor,23333,31,0.81 [0.28-2.34],0.6952522312909988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27720,38,0.75 [0.35-1.60],0.4515095002436105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RETN,Resistin,27772,37,1.10 [0.56-2.14],0.7834920627865869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REXO2,"Oligoribonuclease, mitochondrial",23415,31,0.75 [0.31-1.81],0.5192930727330021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RFC4,Replication factor C subunit 4,24076,32,1.19 [0.27-5.15],0.8184666295252447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGCC,Regulator of cell cycle RGCC,24155,32,0.83 [0.54-1.30],0.4191334517811055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23748,32,0.59 [0.28-1.23],0.157074920511324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMA,Repulsive guidance molecule A,28109,39,0.76 [0.31-1.86],0.549601524672215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMB,RGM domain family member B,28109,39,0.55 [0.18-1.66],0.288816232659232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS10,Regulator of G-protein signaling 10,24155,32,0.73 [0.41-1.32],0.3010124969310587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS8,Regulator of G-protein signaling 8,27328,39,0.59 [0.31-1.12],0.1091824483062066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RHOC,Rho-related GTP-binding protein RhoC,27491,38,0.97 [0.76-1.23],0.8102753799183817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RICTOR,Rapamycin-insensitive companion of mTOR,23505,32,1.16 [0.62-2.15],0.645790597751639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23650,32,1.28 [0.67-2.44],0.4482447300386387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILP,Rab-interacting lysosomal protein,28024,39,0.85 [0.53-1.36],0.5043389741292176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILPL2,RILP-like protein 2,24190,32,0.85 [0.61-1.19],0.3480426176157608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23415,31,0.63 [0.30-1.29],0.2072343793031578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN1,Prorelaxin H1,24155,32,1.30 [0.90-1.88],0.163385124852154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN2,Prorelaxin H2,23610,32,1.13 [0.86-1.50],0.3749377633055852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE1,Ribonuclease pancreatic,24214,32,1.91 [0.60-6.09],0.2757050713014768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE10,Inactive ribonuclease-like protein 10,23514,31,1.28 [0.66-2.47],0.4692202256596148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE3,Eosinophil cationic protein,27708,37,0.89 [0.68-1.17],0.3955397123590202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE4,Ribonuclease 4,23438,31,0.70 [0.18-2.74],0.6054474820231851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE6,Ribonuclease K6,24042,32,1.74 [0.81-3.76],0.1584162452371605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASEH2A,Ribonuclease H2 subunit A,24155,32,0.47 [0.19-1.18],0.107457145292958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASET2,Ribonuclease T2,28043,37,0.87 [0.29-2.67],0.8126390975291127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF149,E3 ubiquitin-protein ligase RNF149,23514,31,2.34 [0.87-6.26],0.0916765246251607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF168,E3 ubiquitin-protein ligase RNF168,23505,32,0.54 [0.20-1.49],0.2362432168023434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF31,E3 ubiquitin-protein ligase RNF31,23505,32,0.45 [0.14-1.47],0.1858192375223793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF4,E3 ubiquitin-protein ligase RNF4,23748,32,0.86 [0.48-1.55],0.6250942512563172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF41,E3 ubiquitin-protein ligase NRDP1,27162,39,0.89 [0.58-1.36],0.5763031484041301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF43,E3 ubiquitin-protein ligase RNF43,23748,32,1.23 [0.77-1.97],0.3753082314765004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF5,E3 ubiquitin-protein ligase RNF5,23514,31,1.00 [0.62-1.61],0.9952837791993228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO1,Roundabout homolog 1,27873,39,0.66 [0.19-2.32],0.5220510324402727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO2,Roundabout homolog 2,28109,39,0.45 [0.13-1.56],0.208002183983838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO4,Roundabout homolog 4,23514,31,1.51 [0.22-10.35],0.6765839549918642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,27845,37,0.98 [0.39-2.47],0.9574471713805756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RP2,Protein XRP2,27720,38,0.65 [0.32-1.33],0.2394171747759242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPA2,Replication protein A 32 kDa subunit,23505,32,0.49 [0.14-1.75],0.2748357675706939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPE,Ribulose-phosphate 3-epimerase,23748,32,0.93 [0.57-1.53],0.776457538837574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPGR,X-linked retinitis pigmentosa GTPase regulator,23520,31,1.03 [0.45-2.37],0.939101565925134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPL14,60S ribosomal protein L14,23514,31,0.54 [0.19-1.48],0.2290089729970129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPS10,40S ribosomal protein S10,23415,31,0.46 [0.16-1.33],0.1504783594392159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRAS,Ras-related protein R-Ras,23520,31,0.94 [0.72-1.23],0.6653907261464291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27162,39,1.49 [1.04-2.15],0.0318989558496811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27162,39,1.01 [0.67-1.52],0.9769009139444756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRP15,RRP15-like protein,23416,30,1.03 [0.70-1.51],0.8877417808021297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO1,R-spondin-1,27656,38,0.93 [0.41-2.11],0.8554583472485806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO3,R-spondin-3,28097,39,1.17 [0.41-3.32],0.7750512691083569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTBDN,Retbindin,27720,38,0.34 [0.12-0.91],0.0323688544201361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTKN2,Rhotekin-2,23415,31,0.81 [0.37-1.76],0.5922987135510056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24155,32,0.90 [0.63-1.30],0.5900725067977162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4R,Reticulon-4 receptor,28097,39,1.44 [0.69-3.01],0.3311066222844194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RUVBL1,RuvB-like 1,27162,39,0.96 [0.71-1.29],0.7777032538084675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RWDD1,RWD domain-containing protein 1,28109,39,0.96 [0.61-1.49],0.842835574351246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RYR1,Ryanodine receptor 1,23415,31,0.41 [0.11-1.49],0.1737625280265035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A11,Protein S100-A11,27619,37,0.95 [0.51-1.77],0.8755479420766427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A12,Protein S100-A12,27456,38,1.06 [0.72-1.54],0.7723091184991665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A13,Protein S100-A13,23505,32,0.79 [0.29-2.15],0.6429054066108797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A14,Protein S100-A14,24155,32,0.87 [0.44-1.71],0.6794547240589932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A16,Protein S100-A16,27139,38,0.84 [0.52-1.38],0.4992433701078175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A3,Protein S100-A3,24076,32,0.45 [0.13-1.59],0.2147852298446863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A4,Protein S100-A4,27911,38,1.10 [0.66-1.84],0.7054699384512163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100G,Protein S100-G,24155,32,0.62 [0.28-1.39],0.24552011892361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100P,Protein S100-P,27343,37,1.05 [0.63-1.75],0.861673104775246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAA4,Serum amyloid A-4 protein,24225,32,1.43 [0.80-2.56],0.226468628822626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAFB2,Scaffold attachment factor B2,24155,32,0.67 [0.17-2.56],0.5556098500660083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAG,S-arrestin,23416,30,1.29 [0.75-2.23],0.3610018965242808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAMD9L,Sterile alpha motif domain-containing protein 9-like,27833,38,0.94 [0.64-1.39],0.7577924154995617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAP18,Histone deacetylase complex subunit SAP18,23748,32,0.73 [0.41-1.30],0.2804928819134008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SARG,Specifically androgen-regulated gene protein,24110,32,0.99 [0.73-1.34],0.9370396593142084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23415,31,0.73 [0.24-2.20],0.5793843765447684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT1,Diamine acetyltransferase 1,23415,31,0.46 [0.18-1.22],0.1201440393457728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT2,Thialysine N-epsilon-acetyltransferase,23748,32,0.76 [0.43-1.35],0.3463544330811103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SATB1,DNA-binding protein SATB1,24155,32,0.58 [0.14-2.37],0.4508503368942396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SBSN,Suprabasin,24139,32,0.89 [0.33-2.38],0.8199208556659373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCAMP3,Secretory carrier-associated membrane protein 3,27720,38,0.99 [0.70-1.38],0.935642009792144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARA5,Scavenger receptor class A member 5,28109,39,0.80 [0.31-2.09],0.6507118979382136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB1,Scavenger receptor class B member 1,27189,38,1.03 [0.62-1.71],0.9196331538705071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB2,Lysosome membrane protein 2,27123,36,2.86 [1.29-6.36],0.0098363574590912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF1,Scavenger receptor class F member 1,28187,37,0.93 [0.47-1.82],0.824053790399966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF2,Scavenger receptor class F member 2,28109,39,0.64 [0.25-1.60],0.3384919979362826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG2,Secretogranin-2,27986,39,1.29 [0.53-3.14],0.5791370589672202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG3,Secretogranin-3,27873,39,0.34 [0.15-0.79],0.0117571790860741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB1A1,Uteroglobin,27890,39,0.91 [0.55-1.51],0.7275471732406935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB2A2,Mammaglobin-A,23415,31,0.54 [0.14-2.01],0.3549091969388001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A1,Secretoglobin family 3A member 1,23650,32,1.88 [0.50-7.07],0.3483595781366457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A2,Secretoglobin family 3A member 2,27925,39,0.97 [0.68-1.40],0.8908275574725336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGN,Secretagogin,27328,39,0.79 [0.41-1.54],0.4855995272640058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCIN,Adseverin,23416,30,1.25 [0.84-1.85],0.2712440220200771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCLY,Selenocysteine lyase,28024,39,1.38 [0.80-2.37],0.2514175278055245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2A,Sodium channel protein type 2 subunit alpha,23416,30,0.48 [0.18-1.26],0.1351803114430365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2B,Sodium channel subunit beta-2,23520,31,1.11 [0.33-3.71],0.8667239517703659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3A,Sodium channel protein type 3 subunit alpha,23520,31,0.92 [0.35-2.42],0.8663125113292799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3B,Sodium channel subunit beta-3,23416,30,0.51 [0.19-1.37],0.1824599357006924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN4B,Sodium channel subunit beta-4,23514,31,0.63 [0.28-1.43],0.2703768297872481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCP2,Non-specific lipid-transfer protein,27162,39,1.06 [0.75-1.51],0.736671967355688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCPEP1,Retinoid-inducible serine carboxypeptidase,23432,31,1.07 [0.54-2.09],0.849997229842279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRG1,Scrapie-responsive protein 1,24190,32,1.14 [0.37-3.50],0.813133922208774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRIB,Protein scribble homolog,23514,31,1.18 [0.84-1.65],0.3364712958483209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRN1,Secernin-1,27833,38,0.90 [0.53-1.51],0.6826211344804369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCT,Secretin,23520,31,0.87 [0.40-1.92],0.7338103719933893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC1,Syndecan-1,27845,37,1.88 [1.02-3.46],0.0437399663061711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC4,Syndecan-4,27845,37,0.63 [0.34-1.14],0.1251005393210515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDCCAG8,Serologically defined colon cancer antigen 8,24076,32,0.98 [0.73-1.32],0.8880843667704956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDHB,Succinate dehydrogenase,24098,32,1.09 [0.68-1.75],0.7281115439486954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDK2,Protein sidekick-2,23650,32,0.80 [0.31-2.08],0.6449523749514919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEC31A,Protein transport protein Sec31A,23514,31,0.95 [0.61-1.48],0.8245541346067813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEL1L,Protein sel-1 homolog 1,23514,31,1.53 [0.87-2.70],0.1383851048451516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELE,E-selectin,28187,37,1.54 [0.85-2.77],0.1513648577765003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELENOP,Selenoprotein P,24225,32,0.31 [0.07-1.42],0.1322695780889978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELL,L-selectin,24225,32,0.71 [0.16-3.12],0.6491694289930623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELP,P-selectin,27924,39,0.69 [0.42-1.14],0.1485140951256861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELPLG,P-selectin glycoprotein ligand 1,27833,38,1.16 [0.45-2.97],0.7563039781128722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3F,Semaphorin-3F,27845,37,0.64 [0.21-1.99],0.4441513033764239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3G,Semaphorin-3G,23650,32,1.27 [0.62-2.59],0.5112183969257499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4C,Semaphorin-4C,27720,38,1.54 [0.76-3.12],0.2313993089773585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4D,Semaphorin-4D,28109,39,0.67 [0.28-1.63],0.3782095452503203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA6C,Semaphorin-6C,23505,32,0.79 [0.44-1.42],0.4271988114530318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA7A,Semaphorin-7A,28088,37,1.12 [0.39-3.25],0.8283287112835301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN3,Neuronal-specific septin-3,24155,32,0.92 [0.59-1.45],0.7283046834164728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN7,Septin-7,23748,32,0.47 [0.18-1.23],0.1252028016778328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN8,Septin-8,24069,32,1.43 [0.58-3.52],0.442617889546155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN9,Septin-9,27720,38,0.34 [0.10-1.08],0.0681956850272216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA1,Alpha-1-antitrypsin,23789,31,2.39 [0.04-131.88],0.6700699671917533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA11,Serpin A11,28187,37,0.67 [0.34-1.33],0.2550315896890601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA12,Serpin A12,27072,37,0.98 [0.78-1.23],0.8584633557808544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA3,Alpha-1-antichymotrypsin,24147,32,2.83 [0.48-16.56],0.2490579593285708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA4,Kallistatin,23785,32,1.02 [0.24-4.25],0.979604887529814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA5,Plasma serine protease inhibitor,23874,32,0.66 [0.20-2.16],0.4935060932501902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA6,Corticosteroid-binding globulin,24225,32,1.97 [0.28-14.07],0.4992877434699813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA7,Thyroxine-binding globulin,24225,32,1.26 [0.21-7.51],0.8015137664273108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA9,Serpin A9,27589,38,0.85 [0.58-1.25],0.4130789716741936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB1,Leukocyte elastase inhibitor,27748,38,0.91 [0.66-1.25],0.5546102067177379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB5,Serpin B5,27343,37,1.23 [0.66-2.28],0.5132022153811271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB6,Serpin B6,28013,39,0.89 [0.55-1.42],0.6184007899256254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB8,Serpin B8,28182,39,0.91 [0.55-1.52],0.7222816373336377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB9,Serpin B9,27656,38,0.88 [0.37-2.10],0.776787427132846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINC1,Antithrombin-III,24175,32,0.95 [0.09-9.78],0.9643619410443892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPIND1,Heparin cofactor 2,24175,32,0.86 [0.27-2.76],0.7996897619506649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE1,Plasminogen activator inhibitor 1,28187,37,0.75 [0.50-1.13],0.166028930999126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE2,Glia-derived nexin,24190,32,0.77 [0.45-1.30],0.3293469408896246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF1,Pigment epithelium-derived factor,23866,30,1.08 [0.28-4.11],0.9132399631073442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF2,Alpha-2-antiplasmin,23777,30,0.35 [0.03-4.63],0.4282259952442879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPING1,Plasma protease C1 inhibitor,24175,32,1.01 [0.16-6.18],0.994568219720108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINH1,Serpin H1,23748,32,1.05 [0.81-1.36],0.7095220905472044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI1,Neuroserpin,23598,32,0.78 [0.47-1.29],0.3283499849257048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI2,Serpin I2,24098,32,0.79 [0.43-1.44],0.4384307017028729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27189,38,0.70 [0.43-1.12],0.1386826791030324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SETMAR,Histone-lysine N-methyltransferase SETMAR,27568,38,0.80 [0.30-2.12],0.6533986072501126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6,Seizure protein 6 homolog,23520,31,0.61 [0.19-1.98],0.412877169479702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L,Seizure 6-like protein,27911,38,0.44 [0.18-1.10],0.0791742662354021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L2,Seizure 6-like protein 2,27720,38,0.70 [0.20-2.40],0.5678564656680457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SF3B4,Splicing factor 3B subunit 4,27720,38,0.71 [0.47-1.06],0.096991201159208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP1,Secreted frizzled-related protein 1,27557,38,1.17 [0.61-2.25],0.629097182014505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP4,Secreted frizzled-related protein 4,23650,32,0.83 [0.36-1.92],0.658493854207197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA1,Pulmonary surfactant-associated protein A1,27162,39,1.08 [0.68-1.73],0.7343094510190694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA2,Pulmonary surfactant-associated protein A2,27162,39,1.34 [0.80-2.26],0.2678078413478658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPD,Pulmonary surfactant-associated protein D,27845,37,0.70 [0.46-1.07],0.1031470272890603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SGSH,N-sulphoglucosamine sulphohydrolase,23809,32,1.44 [0.89-2.33],0.1333731570653102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2B3,SH2B adapter protein 3,27162,39,0.98 [0.74-1.31],0.9006686414893815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2D1A,SH2 domain-containing protein 1A,27833,38,0.94 [0.56-1.57],0.8028189830364975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23416,30,0.65 [0.30-1.42],0.2807554421569735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BP1,SH3 domain-binding protein 1,24098,32,0.67 [0.30-1.51],0.3368467704517909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GL3,Endophilin-A3,23597,32,0.82 [0.56-1.18],0.2823158673757575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GLB2,Endophilin-B2,24123,32,0.75 [0.45-1.26],0.2780909866426396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHBG,Sex hormone-binding globulin,24214,32,0.70 [0.36-1.36],0.2923233280119073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHC1,SHC-transforming protein 1,23333,31,0.94 [0.68-1.30],0.7021735359834411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHD,SH2 domain-containing adapter protein D,23380,31,0.90 [0.55-1.46],0.657457051026445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHH,Sonic hedgehog protein,23505,32,0.54 [0.23-1.26],0.1521010521877551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHISA5,Protein shisa-5,24183,32,1.96 [0.78-4.88],0.1502866156233111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHMT1,"Serine hydroxymethyltransferase, cytosolic",27925,39,0.80 [0.57-1.11],0.1768415518007034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHPK,Sedoheptulokinase,23748,32,1.60 [0.88-2.89],0.121378243721612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIAE,Sialate O-acetylesterase,27862,38,0.77 [0.42-1.40],0.3879814638405303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC1,Sialoadhesin,27968,39,1.02 [0.52-2.01],0.9487692357403146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC10,Sialic acid-binding Ig-like lectin 10,27833,38,1.56 [0.69-3.49],0.28416558413283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27189,38,1.08 [0.76-1.53],0.6591263983560325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC5,Sialic acid-binding Ig-like lectin 5,27836,38,1.02 [0.80-1.30],0.8878171553417745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28097,39,1.24 [0.52-2.92],0.6283620387579412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC7,Sialic acid-binding Ig-like lectin 7,27845,37,1.04 [0.38-2.91],0.9332664040710872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23514,31,0.87 [0.41-1.81],0.7010098189034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28061,39,1.58 [0.64-3.90],0.3221008890012412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIL1,Nucleotide exchange factor SIL1,23514,31,1.24 [0.51-2.98],0.6323607579746637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,27909,37,0.70 [0.44-1.11],0.1307685192137222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPB1,Signal-regulatory protein beta-1,27768,39,1.17 [0.63-2.20],0.6173020395006725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23505,32,0.58 [0.29-1.16],0.1245419218673405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT2,NAD-dependent protein deacetylase sirtuin-2,27720,38,0.94 [0.68-1.30],0.7116690304431058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27189,38,0.83 [0.46-1.49],0.5337878100450482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIT1,Signaling threshold-regulating transmembrane adapter 1,27328,39,1.00 [0.60-1.68],0.9996075997120742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP1,Src kinase-associated phosphoprotein 1,27608,38,0.91 [0.61-1.36],0.6462601103005117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP2,Src kinase-associated phosphoprotein 2,27968,39,0.83 [0.63-1.08],0.1709480462528664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKIV2L,Helicase SKI2W,23415,31,0.66 [0.23-1.86],0.4314720617956178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLA2,Src-like-adapter 2,24155,32,0.94 [0.69-1.29],0.702224775397742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF1,Signaling lymphocytic activation molecule,27328,39,1.11 [0.68-1.81],0.689082064265734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF6,SLAM family member 6,27162,39,1.40 [0.73-2.67],0.3125640764810412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF7,SLAM family member 7,27833,38,1.51 [0.95-2.39],0.0810099280933523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF8,SLAM family member 8,27162,39,1.30 [0.74-2.31],0.3622765115279756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC12A2,Solute carrier family 12 member 2,23415,31,0.43 [0.11-1.70],0.2259577244967269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC13A1,Solute carrier family 13 member 1,24076,32,0.87 [0.45-1.68],0.6794580664337542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC16A1,Monocarboxylate transporter 1,27189,38,1.07 [0.66-1.73],0.77398309975918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC1A4,Neutral amino acid transporter A,23520,31,0.97 [0.49-1.91],0.9212886738182816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC27A4,Long-chain fatty acid transport protein 4,27189,38,0.74 [0.45-1.22],0.2392938603210992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC28A1,Sodium/nucleoside cotransporter 1,23333,31,1.08 [0.63-1.85],0.7868816088318094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC34A3,Sodium-dependent phosphate transport protein 2C,23333,31,1.15 [0.60-2.23],0.6728157636153357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A14,Zinc transporter ZIP14,27189,38,0.63 [0.25-1.63],0.3414767587976665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A5,Zinc transporter ZIP5,27833,38,0.82 [0.47-1.42],0.4777442129513404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC44A4,Choline transporter-like protein 4,23520,31,0.61 [0.29-1.28],0.1928911500743612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC4A1,Band 3 anion transport protein,24183,32,0.77 [0.37-1.58],0.4717134290358548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC51B,Organic solute transporter subunit beta,23415,31,1.13 [0.74-1.73],0.5587943597682432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23650,32,0.88 [0.60-1.31],0.5397003588928985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24098,32,0.78 [0.35-1.73],0.5420097539077227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23333,31,0.83 [0.42-1.65],0.6016266652109911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIT2,Slit homolog 2 protein,27189,38,0.88 [0.49-1.59],0.680790795785654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK1,SLIT and NTRK-like protein 1,23505,32,0.70 [0.45-1.09],0.1184367484081675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK2,SLIT and NTRK-like protein 2,28097,39,1.14 [0.57-2.31],0.7084085669704396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK6,SLIT and NTRK-like protein 6,27343,37,0.38 [0.16-0.91],0.0303694115335622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLK,STE20-like serine/threonine-protein kinase,23748,32,0.93 [0.57-1.51],0.7651820120186164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLMAP,Sarcolemmal membrane-associated protein,24098,32,0.91 [0.60-1.36],0.6374118182045854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLURP1,Secreted Ly-6/uPAR-related protein 1,24006,32,0.95 [0.38-2.40],0.9155695050267402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD1,Mothers against decapentaplegic homolog 1,27162,39,0.93 [0.66-1.31],0.6844930931065987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD2,Mothers against decapentaplegic homolog 2,24076,32,0.76 [0.45-1.26],0.2791779840032614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD3,Mothers against decapentaplegic homolog 3,24076,32,0.65 [0.33-1.30],0.2260420109053469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD5,Mothers against decapentaplegic homolog 5,27720,38,0.97 [0.24-3.92],0.9617513546178812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMARCA2,Probable global transcription activator SNF2L2,27189,38,1.05 [0.71-1.56],0.8004241525920079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMC3,Structural maintenance of chromosomes protein 3,23333,31,1.31 [0.81-2.12],0.2667013842332074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMNDC1,Survival of motor neuron-related-splicing factor 30,24098,32,0.92 [0.52-1.61],0.769824527119232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC1,SPARC-related modular calcium-binding protein 1,28097,39,1.20 [0.51-2.81],0.6766689192219806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC2,SPARC-related modular calcium-binding protein 2,27968,39,0.85 [0.40-1.82],0.6758684140146676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD1,Sphingomyelin phosphodiesterase,27971,39,0.77 [0.43-1.36],0.3637547920792431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD3,Sphingomyelin phosphodiesterase 3,23505,32,0.47 [0.17-1.30],0.1466285403532214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,27913,39,0.70 [0.47-1.05],0.0878539170964636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24076,32,0.91 [0.56-1.50],0.7228115835990447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMS,Spermine synthase,23416,30,0.87 [0.48-1.59],0.6568588015721956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMTN,Smoothelin,24067,32,0.83 [0.57-1.21],0.3332774576978929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP23,Synaptosomal-associated protein 23,27845,37,0.92 [0.67-1.27],0.6180769700319881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP25,Synaptosomal-associated protein 25,23416,30,1.03 [0.49-2.16],0.9308792963934154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP29,Synaptosomal-associated protein 29,27911,38,0.94 [0.69-1.28],0.7056478492515275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAPIN,SNARE-associated protein Snapin,24155,32,0.54 [0.29-1.00],0.050118345971921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCA,Alpha-synuclein,23650,32,0.97 [0.72-1.29],0.8214305806973637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCG,Gamma-synuclein,27656,38,0.90 [0.58-1.40],0.6526167166880752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23514,31,0.58 [0.18-1.86],0.359734704030519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNRPB2,U2 small nuclear ribonucleoprotein B'',24123,32,0.87 [0.37-2.02],0.7457830697023975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNU13,NHP2-like protein 1,23415,31,0.55 [0.24-1.23],0.1426580963451543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX15,Sorting nexin-15,23650,32,1.17 [0.63-2.14],0.6224597799866742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX18,Sorting nexin-18,24098,32,0.60 [0.24-1.51],0.2775161721512468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX2,Sorting nexin-2,24076,32,0.76 [0.48-1.21],0.2436193650381804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX5,Sorting nexin-5,23514,31,0.47 [0.13-1.70],0.251525782332379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX9,Sorting nexin-9,27845,37,0.92 [0.60-1.42],0.718578599325024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD1,Superoxide dismutase [Cu-Zn],27243,37,0.89 [0.49-1.63],0.7031386491000824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD2,"Superoxide dismutase [Mn], mitochondrial",27836,38,1.04 [0.49-2.22],0.9135230217245532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD3,Extracellular superoxide dismutase,24214,32,0.72 [0.34-1.56],0.412305380067816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORBS1,Sorbin and SH3 domain-containing protein 1,24155,32,1.24 [0.58-2.63],0.5773861354420093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORCS2,VPS10 domain-containing receptor SorCS2,27162,39,0.89 [0.38-2.07],0.7832662372117756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORD,Sorbitol dehydrogenase,27973,39,0.79 [0.54-1.15],0.2198174590968171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORT1,Sortilin,27813,37,0.68 [0.31-1.48],0.327416448733871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOST,Sclerostin,27813,37,0.59 [0.28-1.23],0.160611494574219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23520,31,0.74 [0.31-1.80],0.5088878556315815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX2,Transcription factor SOX-2,24116,32,0.77 [0.40-1.48],0.430388844834786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX9,Transcription factor SOX-9,23520,31,0.98 [0.27-3.55],0.9797471382442784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24155,32,0.93 [0.29-3.04],0.9067335164050104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPAG1,Sperm-associated antigen 1,24155,32,1.23 [0.77-1.96],0.3960074047607359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARC,SPARC,27911,38,0.80 [0.55-1.15],0.2315643520846022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARCL1,SPARC-like protein 1,27832,39,0.68 [0.23-1.96],0.473750103067822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPART,Spartin,23650,32,0.85 [0.55-1.32],0.4720359438970413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPESP1,Sperm equatorial segment protein 1,24190,32,1.97 [0.75-5.18],0.1709388750111102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK1,Serine protease inhibitor Kazal-type 1,27836,38,1.51 [0.77-2.96],0.2328498902638536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK2,Serine protease inhibitor Kazal-type 2,23650,32,1.61 [0.76-3.42],0.2157020435314184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK4,Serine protease inhibitor Kazal-type 4,27833,38,1.54 [1.03-2.31],0.0345116187715538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK5,Serine protease inhibitor Kazal-type 5,27836,38,0.88 [0.38-2.06],0.772743971839899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK6,Serine protease inhibitor Kazal-type 6,28097,39,1.47 [0.88-2.48],0.1427248454833379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK8,Serine protease inhibitor Kazal-type 8,23415,31,0.37 [0.11-1.27],0.1143828429550064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT1,Kunitz-type protease inhibitor 1,27737,38,1.15 [0.37-3.58],0.8060373972789535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT2,Kunitz-type protease inhibitor 2,27968,39,1.08 [0.53-2.17],0.8388528028762401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT3,Kunitz-type protease inhibitor 3,24098,32,0.86 [0.71-1.05],0.136629277620903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPOCK1,Testican-1,27656,38,0.77 [0.47-1.28],0.3162989831435264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON1,Spondin-1,27873,39,1.20 [0.51-2.86],0.6741069731535099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON2,Spondin-2,27711,37,1.10 [0.46-2.65],0.825838561465996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPP1,Osteopontin,28135,37,2.08 [1.14-3.81],0.0171180820693515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23505,32,0.30 [0.12-0.79],0.0142320201474854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRING1,SREBP regulating gene protein,23333,31,0.82 [0.41-1.63],0.5701396782075516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR1B,Cornifin-B,23748,32,0.94 [0.61-1.45],0.7709863299726547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR3,Small proline-rich protein 3,24123,32,1.06 [0.63-1.78],0.8229568107258024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRY2,Protein sprouty homolog 2,27328,39,0.86 [0.63-1.18],0.3644013961607787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23416,30,0.82 [0.25-2.62],0.7345341740227689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTLC1,Serine palmitoyltransferase 1,24123,32,0.84 [0.31-2.31],0.7398832888735238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRC,Proto-oncogene tyrosine-protein kinase Src,27867,38,0.96 [0.76-1.21],0.7351629598008693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRP14,Signal recognition particle 14 kDa protein,27720,38,1.07 [0.68-1.69],0.7747578664546151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPK2,SRSF protein kinase 2,27833,38,0.99 [0.70-1.39],0.9469389044582952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPX,Sushi repeat-containing protein SRPX,24190,32,1.48 [0.55-3.94],0.4380554580613266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSB,Lupus La protein,27189,38,0.61 [0.32-1.17],0.1366346251738119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23505,32,1.13 [0.47-2.70],0.782948508704732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,27813,37,0.87 [0.67-1.12],0.272121279425443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,27924,39,1.05 [0.54-2.03],0.8838897163740879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSH3,Protein phosphatase Slingshot homolog 3,23333,31,0.65 [0.18-2.33],0.5092489408124163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24098,32,0.97 [0.50-1.88],0.9298988022697924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST13,Hsc70-interacting protein,23650,32,0.89 [0.48-1.65],0.7033589792143322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27720,38,0.59 [0.27-1.28],0.1812075105486513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28187,37,0.79 [0.29-2.17],0.652942809962541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23505,32,0.69 [0.26-1.78],0.4374967001441237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAB2,Stabilin-2,24183,32,1.28 [0.39-4.20],0.689273186379945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAM,Signal transducing adapter molecule 1,24076,32,0.73 [0.27-1.99],0.5379456236785253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAMBP,STAM-binding protein,27608,38,0.89 [0.57-1.40],0.6112548723815927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT2,Signal transducer and activator of transcription 2,23505,32,0.90 [0.58-1.40],0.6541802510795139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT5B,Signal transducer and activator of transcription 5B,27720,38,0.98 [0.79-1.20],0.8337306095776638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23333,31,1.25 [0.81-1.94],0.3105305203093337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC1,Stanniocalcin-1,28109,39,1.53 [0.86-2.73],0.1482574526198206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC2,Stanniocalcin-2,27798,38,1.00 [0.32-3.13],0.9976778386938352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STEAP4,Metalloreductase STEAP4,23416,30,0.83 [0.48-1.45],0.5173992221210528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STIP1,Stress-induced-phosphoprotein 1,27787,38,0.78 [0.49-1.23],0.2852937355608467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK11,Serine/threonine-protein kinase STK11,27343,37,0.92 [0.61-1.37],0.673223657470416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK24,Serine/threonine-protein kinase 24,27189,38,0.89 [0.56-1.42],0.6193274859213744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK4,Serine/threonine-protein kinase 4,27845,37,0.83 [0.60-1.16],0.2759012228214906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STOML2,"Stomatin-like protein 2, mitochondrial",23333,31,0.77 [0.50-1.19],0.2382997966200895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX16,Syntaxin-16,27162,39,0.97 [0.59-1.60],0.9048073894335602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX1B,Syntaxin-1B,23520,31,0.69 [0.24-1.95],0.4824782516556863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX3,Syntaxin-3,24123,32,1.42 [0.72-2.81],0.3105985763585793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX4,Syntaxin-4,27720,38,0.81 [0.47-1.38],0.431701309798962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX5,Syntaxin-5,23505,32,0.73 [0.27-1.95],0.5278227346371138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX6,Syntaxin-6,27162,39,0.75 [0.45-1.23],0.2487611564069503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX7,Syntaxin-7,23505,32,0.90 [0.45-1.80],0.7662358737235806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX8,Syntaxin-8,27833,38,0.84 [0.46-1.53],0.5623018525579095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP1,Syntaxin-binding protein 1,24155,32,1.00 [0.65-1.54],0.9952094294065328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP3,Syntaxin-binding protein 3,27162,39,0.49 [0.23-1.06],0.0699223629315805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGP1,SURP and G-patch domain-containing protein 1,24098,32,0.70 [0.29-1.71],0.438555428068179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGT1,Protein SGT1 homolog,27162,39,0.87 [0.61-1.24],0.4459682061268841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT1A1,Sulfotransferase 1A1,28109,39,1.02 [0.82-1.27],0.8343626524991778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT2A1,Bile salt sulfotransferase,27833,38,1.01 [0.61-1.67],0.9584230997873104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF1,Formylglycine-generating enzyme,23505,32,0.81 [0.43-1.53],0.5246046792752561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28109,39,0.97 [0.58-1.62],0.8958804922417863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUOX,"Sulfite oxidase, mitochondrial",24155,32,0.97 [0.56-1.67],0.9049792595010916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD1,Sushi domain-containing protein 1,27343,37,1.05 [0.57-1.92],0.8816817536560155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD2,Sushi domain-containing protein 2,27836,38,0.93 [0.34-2.49],0.8775181314808568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD4,Sushi domain-containing protein 4,24076,32,0.50 [0.19-1.26],0.1416769178633275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD5,Sushi domain-containing protein 5,23523,32,2.65 [1.01-6.98],0.0484164659240324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SV2A,Synaptic vesicle glycoprotein 2A,23520,31,1.13 [0.66-1.91],0.6619764847156941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SWAP70,Switch-associated protein 70,24098,32,1.36 [0.62-2.95],0.4412973480381272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYAP1,Synapse-associated protein 1,23650,32,0.68 [0.36-1.29],0.2380210267990461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23416,30,1.00 [0.53-1.89],0.9993303314098884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYT1,Synaptotagmin-1,24123,32,0.37 [0.11-1.21],0.1004656269768075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYTL4,Synaptotagmin-like protein 4,24190,32,0.60 [0.36-1.01],0.0565756846360177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23748,32,0.85 [0.62-1.17],0.3084076297236711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACC3,Transforming acidic coiled-coil-containing protein 3,27720,38,0.96 [0.75-1.22],0.7363857977363737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACSTD2,Tumor-associated calcium signal transducer 2,24725,35,0.55 [0.19-1.56],0.2594176032389662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TADA3,Transcriptional adapter 3,24076,32,0.70 [0.29-1.67],0.4153549864270837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAFA5,Chemokine-like protein TAFA-5,27720,38,1.19 [0.52-2.74],0.6778044121251521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAGLN3,Transgelin-3,23333,31,0.55 [0.36-0.85],0.0075004530195292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TALDO1,Transaldolase,24103,32,0.76 [0.35-1.63],0.4808073477157015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TANK,TRAF family member-associated NF-kappa-B activator,27328,39,0.95 [0.63-1.42],0.7882886177299967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAP1,Antigen peptide transporter 1,23748,32,1.43 [1.03-1.99],0.0339474081505249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARBP2,RISC-loading complex subunit TARBP2,27189,38,0.85 [0.59-1.23],0.3978836214929815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23520,31,0.74 [0.41-1.34],0.3258280206071098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24076,32,0.40 [0.15-1.04],0.0611217044433574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAX1BP1,Tax1-binding protein 1,24123,32,0.74 [0.41-1.32],0.3080746661584559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D17,TBC1 domain family member 17,27189,38,0.77 [0.38-1.55],0.4644323780478575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D23,TBC1 domain family member 23,27720,38,0.89 [0.65-1.23],0.4824898467935536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D5,TBC1 domain family member 5,27833,38,0.88 [0.60-1.28],0.4944858132280921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCA,Tubulin-specific chaperone A,23650,32,0.93 [0.63-1.39],0.7348675813428756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCB,Tubulin-folding cofactor B,27656,38,0.93 [0.70-1.23],0.6100180858062745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCC,Tubulin-specific chaperone C,27656,38,0.91 [0.64-1.30],0.6097135630488317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27162,39,0.98 [0.70-1.36],0.8899742452916567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBR1,T-box brain protein 1,23520,31,1.44 [0.90-2.30],0.1282017116751887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1A,T-cell leukemia/lymphoma protein 1A,27603,37,0.80 [0.60-1.08],0.1419084309556317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1B,T-cell leukemia/lymphoma protein 1B,27343,37,0.81 [0.51-1.29],0.3771005730310383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN1,Transcobalamin-1,23733,30,0.82 [0.29-2.35],0.7086366606745185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN2,Transcobalamin-2,28135,37,0.88 [0.32-2.41],0.8022105110046556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCOF1,Treacle protein,24190,32,1.33 [0.52-3.39],0.5498518243786974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCP11,T-complex protein 11 homolog,23748,32,1.24 [0.80-1.91],0.3444327102196755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCTN3,Tectonic-3,24190,32,0.82 [0.26-2.51],0.7223261734424484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDGF1,Teratocarcinoma-derived growth factor 1,27189,38,0.98 [0.80-1.20],0.8593768562023262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDO2,"Tryptophan 2,3-dioxygenase",23520,31,1.76 [1.05-2.96],0.0327338598207379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDP1,Tyrosyl-DNA phosphodiesterase 1,24076,32,0.59 [0.30-1.14],0.1173539541318857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDRKH,Tudor and KH domain-containing protein,27189,38,0.81 [0.57-1.17],0.2652367816578179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEF,Thyrotroph embryonic factor,23415,31,1.21 [0.56-2.62],0.6271525248552952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEK,Angiopoietin-1 receptor,27911,38,0.46 [0.15-1.38],0.1676113009401647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TERF1,Telomeric repeat-binding factor 1,23505,32,0.82 [0.25-2.74],0.752414512858449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TET2,Methylcytosine dioxygenase TET2,23714,31,1.01 [0.72-1.42],0.952162871064791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX101,Testis-expressed protein 101,23520,31,1.27 [0.68-2.38],0.4525697481506032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX33,Testis-expressed protein 33,23748,32,0.94 [0.37-2.37],0.8891575636443757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TF,Serotransferrin,24225,32,0.79 [0.17-3.73],0.766980498341185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFAP2A,Transcription factor AP-2-alpha,23416,30,1.15 [0.67-1.98],0.6016750276204971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF1,Trefoil factor 1,27704,38,1.33 [0.97-1.83],0.0778452557885014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF2,Trefoil factor 2,27925,39,1.48 [0.95-2.31],0.0811608787090088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF3,Trefoil factor 3,27801,39,0.89 [0.41-1.89],0.7531276044536541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI,Tissue factor pathway inhibitor,27746,39,0.41 [0.16-1.05],0.0624467222728478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI2,Tissue factor pathway inhibitor 2,27816,38,0.95 [0.45-2.01],0.8987782191075951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFRC,Transferrin receptor protein 1,27939,39,0.95 [0.46-2.00],0.9019722737540288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TG,Thyroglobulin,24076,32,1.05 [0.77-1.43],0.7663762083880872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFA,Protransforming growth factor alpha,27833,38,1.18 [0.65-2.17],0.5851332425739827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB1,Transforming growth factor beta-1 proprotein,28133,38,1.15 [0.56-2.36],0.697294511658646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB2,Transforming growth factor beta-2 proprotein,24076,32,1.07 [0.57-1.99],0.8315957512067982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBI,Transforming growth factor-beta-induced protein ig-h3,27658,39,0.67 [0.23-1.96],0.4598862419868732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR1,TGF-beta receptor type-1,23505,32,1.05 [0.25-4.36],0.9466727951069543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR2,TGF-beta receptor type-2,27911,38,1.49 [0.61-3.63],0.3759298765027362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR3,Transforming growth factor beta receptor type 3,28187,37,0.71 [0.30-1.72],0.4520820575136012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGM2,Protein-glutamine gamma-glutamyltransferase 2,27792,37,1.16 [0.78-1.71],0.4644446001924811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGOLN2,Trans-Golgi network integral membrane protein 2,24214,32,1.37 [0.36-5.17],0.6387207052160704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23287,31,0.99 [0.66-1.48],0.9442279235914102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBD,Thrombomodulin,27845,37,0.58 [0.19-1.75],0.3349294373080218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS2,Thrombospondin-2,27836,38,0.90 [0.39-2.04],0.794631261324423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS4,Thrombospondin-4,27845,39,1.04 [0.56-1.95],0.8955674386760428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THOP1,Thimet oligopeptidase,27727,37,0.97 [0.39-2.43],0.9472863120619128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THPO,Thrombopoietin,27343,37,0.35 [0.16-0.76],0.0077853738395055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THRAP3,Thyroid hormone receptor-associated protein 3,23415,31,1.20 [0.94-1.52],0.141530480316417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THSD1,Thrombospondin type-1 domain-containing protein 1,23331,32,1.76 [0.87-3.58],0.1156729027660742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THTPA,Thiamine-triphosphatase,24024,32,0.92 [0.63-1.36],0.6880915322391609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THY1,Thy-1 membrane glycoprotein,28109,39,1.10 [0.39-3.12],0.8580729903793268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIA1,Nucleolysin TIA-1 isoform p40,27040,37,0.95 [0.75-1.20],0.6595194961416602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIE1,Tyrosine-protein kinase receptor Tie-1,28187,37,0.67 [0.38-1.16],0.1528811447681561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27141,38,0.82 [0.44-1.52],0.5226367314594584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23748,32,1.10 [0.46-2.64],0.826642161922445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,27924,39,0.69 [0.36-1.34],0.272828229197214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24190,32,0.58 [0.23-1.43],0.2364723147142877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24123,32,0.85 [0.57-1.26],0.4111144768158756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP1,Metalloproteinase inhibitor 1,27516,39,1.12 [0.40-3.10],0.8294929524435575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP2,Metalloproteinase inhibitor 2,24190,32,1.03 [0.27-3.94],0.969545398827967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP3,Metalloproteinase inhibitor 3,27968,39,1.01 [0.81-1.25],0.9627998927252084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP4,Metalloproteinase inhibitor 4,27836,38,0.70 [0.33-1.49],0.3489011740080306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TINAGL1,Tubulointerstitial nephritis antigen-like,27763,37,2.28 [0.64-8.14],0.2040013862678847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJAP1,Tight junction-associated protein 1,27911,38,0.97 [0.69-1.37],0.8676347482114883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJP3,Tight junction protein ZO-3,23416,30,0.71 [0.27-1.89],0.4965461867675512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TK1,"Thymidine kinase, cytosolic",23748,32,1.73 [1.20-2.51],0.0035892192945749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR1,Toll-like receptor 1,23505,32,1.13 [0.31-4.15],0.8579710322194082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR2,Toll-like receptor 2,23748,32,1.13 [0.26-4.91],0.8740874950067159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR3,Toll-like receptor 3,28182,39,1.01 [0.63-1.61],0.9753120649287532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR4,Toll-like receptor 4,23505,32,0.69 [0.20-2.39],0.5582617641201492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23520,31,1.30 [0.73-2.32],0.3758428833422976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED1,Transmembrane emp24 domain-containing protein 1,23748,32,1.38 [0.89-2.12],0.1487816661269762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED10,Transmembrane emp24 domain-containing protein 10,23415,31,0.54 [0.16-1.76],0.3037353380770793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED4,Transmembrane emp24 domain-containing protein 4,23415,31,0.56 [0.24-1.33],0.1875180839623469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED8,Protein TMED8,24098,32,0.93 [0.67-1.28],0.6352822702493868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM106A,Transmembrane protein 106A,24076,32,0.86 [0.53-1.39],0.535059360849835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM132A,Transmembrane protein 132A,23514,31,0.75 [0.43-1.31],0.3174303211527235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM25,Transmembrane protein 25,24155,32,0.85 [0.38-1.90],0.6955227268907551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMOD4,Tropomodulin-4,23333,31,0.80 [0.33-1.93],0.6230679244821877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11B,Transmembrane protease serine 11B,23416,30,0.54 [0.27-1.07],0.0753941368919422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11D,Transmembrane protease serine 11D,24069,32,0.89 [0.35-2.24],0.8074532792017597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS15,Enteropeptidase,27720,38,1.12 [0.81-1.55],0.4798531891392308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS5,Transmembrane protease serine 5,27511,37,0.99 [0.46-2.10],0.9697228076326974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMSB10,Thymosin beta-10,27836,38,0.96 [0.66-1.38],0.8123697661605125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNC,Tenascin,27924,39,1.42 [0.80-2.52],0.2334232364948157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNF,Tumor necrosis factor,27294,37,0.75 [0.30-1.89],0.5459267173434087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24098,32,0.98 [0.50-1.91],0.9481307871195964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27328,39,1.16 [0.54-2.50],0.6953498104584754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23650,32,0.80 [0.46-1.39],0.4244708408861494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27656,38,2.04 [0.97-4.26],0.0596415865386407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27656,38,1.36 [0.96-1.92],0.0797579832278891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27896,37,1.09 [0.60-1.99],0.7736992451581893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28182,39,1.24 [0.57-2.66],0.588124552684347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27823,39,0.71 [0.26-1.92],0.5033297062621028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,27911,38,1.48 [0.68-3.22],0.3189824534294109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27873,39,1.55 [0.78-3.09],0.2089047819852739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27328,39,1.06 [0.55-2.04],0.8546575091828165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27873,39,1.11 [0.43-2.85],0.8324728269453997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23650,32,1.68 [0.75-3.79],0.2108083733614418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28097,39,1.83 [0.79-4.26],0.1608410346953637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27836,38,1.36 [0.50-3.74],0.5491422635580783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27836,38,1.50 [0.85-2.66],0.1638974938274542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28109,39,0.54 [0.18-1.58],0.2600524338421847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28133,38,2.05 [1.07-3.92],0.0312631807746132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27656,38,1.11 [0.67-1.83],0.6914745075462105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28109,39,1.97 [1.19-3.25],0.008087641350832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27656,38,1.53 [0.85-2.78],0.1571632267599555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28182,39,0.32 [0.11-0.93],0.0355028375853808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF11,Tumor necrosis factor ligand superfamily member 11,27833,38,0.79 [0.50-1.26],0.3236654788993764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28182,39,1.00 [0.38-2.69],0.992656041795864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13,Tumor necrosis factor ligand superfamily member 13,27968,39,0.97 [0.33-2.82],0.9545388123663012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28134,37,1.26 [0.44-3.62],0.6679311099424938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27656,38,0.98 [0.60-1.59],0.9307558978180184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24183,32,0.84 [0.32-2.19],0.7192255066332727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNIP1,TNFAIP3-interacting protein 1,24123,32,0.86 [0.59-1.28],0.4625300199472304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNN,Tenascin-N,24183,32,1.18 [0.55-2.54],0.6723249733912073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNNI3,"Troponin I, cardiac muscle",27343,37,1.06 [0.74-1.51],0.7641419761534165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNPO1,Transportin-1,23748,32,0.86 [0.33-2.27],0.7632650665316115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNR,Tenascin-R,27656,38,0.68 [0.34-1.34],0.268322539841555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNXB,Tenascin-X,27836,38,0.95 [0.32-2.84],0.9220105250511432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24190,32,0.67 [0.41-1.08],0.1004480380698423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1,DNA topoisomerase 1,24098,32,1.50 [1.12-2.01],0.0071667149951066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1MT,"DNA topoisomerase I, mitochondrial",23333,31,1.09 [0.55-2.16],0.803799002703919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP2B,DNA topoisomerase 2-beta,23505,32,0.85 [0.55-1.33],0.4843371154158593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOR1AIP1,Torsin-1A-interacting protein 1,23514,31,1.07 [0.59-1.96],0.8221134751708126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53,Cellular tumor antigen p53,27162,39,0.75 [0.39-1.45],0.3918051397638962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53BP1,TP53-binding protein 1,23505,32,1.12 [0.77-1.63],0.5553033725635003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53I3,Quinone oxidoreductase PIG3,23134,31,1.03 [0.54-1.97],0.9341830831084944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27343,37,0.40 [0.10-1.58],0.1920216151169184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP73,Tumor protein p73,23520,31,0.78 [0.28-2.15],0.6237977297866589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPBGL,Trophoblast glycoprotein-like,23520,31,1.08 [0.47-2.50],0.8548443065956681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPD52L2,Tumor protein D54,23650,32,0.94 [0.69-1.28],0.7133490812404557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPK1,Thiamin pyrophosphokinase 1,24190,32,0.75 [0.23-2.42],0.6268448802665443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPM3,Tropomyosin alpha-3 chain,23415,31,0.83 [0.58-1.19],0.3045813407458936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPMT,Thiopurine S-methyltransferase,27162,39,0.74 [0.49-1.13],0.1624756433340425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPP1,Tripeptidyl-peptidase 1,27643,39,0.88 [0.47-1.65],0.6968559268955894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP2,Tubulin polymerization-promoting protein family member 2,23748,32,1.15 [0.79-1.67],0.4540676498201045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP3,Tubulin polymerization-promoting protein family member 3,27189,38,0.94 [0.45-1.98],0.8745560030196065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPR,Nucleoprotein TPR,23415,31,0.82 [0.37-1.82],0.632152693673572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPRKB,EKC/KEOPS complex subunit TPRKB,23333,31,1.21 [0.79-1.83],0.3836880008777691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSAB1,Tryptase alpha/beta-1,28131,39,1.30 [0.75-2.25],0.345361067979364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSD1,Tryptase delta,24155,32,0.87 [0.32-2.37],0.7825149124563595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSG1,Tryptase gamma,23505,32,0.70 [0.18-2.72],0.6049708271140951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPT1,Translationally-controlled tumor protein,27328,39,0.64 [0.35-1.16],0.1420131339319493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF2,TNF receptor-associated factor 2,27833,38,1.02 [0.68-1.53],0.9276344705597936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23505,32,1.02 [0.42-2.48],0.9594151420642298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23415,31,0.55 [0.20-1.50],0.2453689405888712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23748,32,0.79 [0.51-1.24],0.3083048017155453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREH,Trehalase,24183,32,1.10 [0.70-1.71],0.6898484246666079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREM2,Triggering receptor expressed on myeloid cells 2,27823,39,0.92 [0.54-1.57],0.7694624091354011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML1,Trem-like transcript 1 protein,24214,32,0.78 [0.41-1.49],0.4561620125524696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML2,Trem-like transcript 2 protein,27836,38,1.00 [0.43-2.35],0.9925839114194114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28097,39,0.92 [0.59-1.43],0.7224164256649036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM21,E3 ubiquitin-protein ligase TRIM21,27833,38,0.76 [0.54-1.07],0.1194440772311093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM24,Transcription intermediary factor 1-alpha,23698,32,0.96 [0.57-1.62],0.8767298481951536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24098,32,0.98 [0.72-1.34],0.8919840530962947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM26,Tripartite motif-containing protein 26,23333,31,1.09 [0.63-1.91],0.7487008474693306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM40,E3 ubiquitin ligase TRIM40,23520,31,0.84 [0.52-1.37],0.4821119584785263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM5,Tripartite motif-containing protein 5,27833,38,1.06 [0.76-1.48],0.7215515138601677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM58,E3 ubiquitin-protein ligase TRIM58,24076,32,0.69 [0.47-1.03],0.0701868102793909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRPV3,Transient receptor potential cation channel subfamily V member 3,23415,31,0.75 [0.33-1.71],0.4967535975345317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC1,Hamartin,23505,32,0.51 [0.24-1.10],0.0879915357575427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC22D1,TSC22 domain family protein 1,24155,32,0.81 [0.47-1.37],0.4244376733113965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSHB,Thyrotropin subunit beta,27845,37,0.79 [0.53-1.18],0.2495435395007368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSLP,Thymic stromal lymphopoietin,27343,37,0.58 [0.31-1.11],0.1026758717852662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSNAX,Translin-associated protein X,23415,31,0.55 [0.22-1.39],0.2061273412751126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN1,Tetraspanin-1,27343,37,1.10 [0.63-1.92],0.7376193080496447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN15,Tetraspanin-15,23415,31,0.30 [0.11-0.87],0.0266782343459842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN7,Tetraspanin-7,23416,30,1.13 [0.81-1.56],0.4808969604021287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN8,Tetraspanin-8,24098,32,1.15 [0.82-1.62],0.4061473829118319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPYL1,Testis-specific Y-encoded-like protein 1,23505,32,0.46 [0.18-1.19],0.1075011524556566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TST,Thiosulfate sulfurtransferase,27150,38,0.80 [0.54-1.17],0.252063598008634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTF2,Transcription termination factor 2,23520,31,0.88 [0.43-1.77],0.7115408328703994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTN,Titin,23415,31,0.52 [0.24-1.09],0.0834970900027589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTR,Transthyretin,23957,31,0.59 [0.16-2.25],0.444268925337534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TUBB3,Tubulin beta-3 chain,23416,30,0.54 [0.15-1.93],0.3420554346514257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TWF2,Twinfilin-2,24183,32,0.82 [0.55-1.22],0.3246432761375378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXK,Tyrosine-protein kinase TXK,23748,32,0.60 [0.30-1.20],0.1495882897158196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXLNA,Alpha-taxilin,27656,38,1.07 [0.78-1.48],0.6678561961973775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXN,Thioredoxin,23823,32,0.74 [0.32-1.71],0.4776646537967178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC15,Thioredoxin domain-containing protein 15,27911,38,1.34 [0.49-3.67],0.5741946581147559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC5,Thioredoxin domain-containing protein 5,28109,39,0.83 [0.55-1.26],0.3843317847313033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC9,Thioredoxin domain-containing protein 9,24123,32,0.71 [0.36-1.42],0.3370678267413409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNL1,Thioredoxin-like protein 1,23373,30,0.91 [0.61-1.35],0.6268035203588257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",27836,38,0.94 [0.51-1.74],0.8380951794764813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYMP,Thymidine phosphorylase,27670,37,1.05 [0.69-1.60],0.8168583727404533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRO3,Tyrosine-protein kinase receptor TYRO3,27845,37,0.63 [0.22-1.76],0.3785026240051092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23505,32,1.27 [0.72-2.21],0.4088984064284588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBAC1,Ubiquitin-associated domain-containing protein 1,27720,38,1.13 [0.49-2.58],0.7805350802707987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2B,Ubiquitin-conjugating enzyme E2 B,24076,32,0.40 [0.11-1.44],0.1608250157598845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24190,32,1.10 [0.65-1.88],0.7178890839887025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23505,32,0.52 [0.25-1.11],0.0908358610030496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBQLN3,Ubiquilin-3,23415,31,1.02 [0.49-2.13],0.9647668972407376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBXN1,UBX domain-containing protein 1,23650,32,0.91 [0.56-1.50],0.717637498785674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24098,32,0.92 [0.73-1.16],0.4908427062593344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UGDH,UDP-glucose 6-dehydrogenase,23415,31,0.89 [0.60-1.34],0.5850448911986483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UHRF2,E3 ubiquitin-protein ligase UHRF2,23415,31,1.08 [0.41-2.83],0.8702068479584109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ULBP2,UL16-binding protein 2,27656,38,0.96 [0.45-2.02],0.9132570879021926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UMOD,Uromodulin,28091,37,0.59 [0.37-0.95],0.0295977257957832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC5D,Netrin receptor UNC5D,23505,32,0.71 [0.40-1.27],0.2483426559978895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC79,Protein unc-79 homolog,23333,31,0.51 [0.25-1.05],0.066089403748579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNG,Uracil-DNA glycosylase,24076,32,1.70 [1.01-2.86],0.0462613296992089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPB1,Beta-ureidopropionase,24190,32,1.06 [0.74-1.52],0.7457434536190872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3A,Uroplakin-3a,23416,30,1.13 [0.56-2.30],0.7352747143580811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3BL1,Uroplakin-3b-like protein 1,23709,32,0.95 [0.48-1.87],0.8707988831065967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROD,Uroporphyrinogen decarboxylase,23650,32,0.92 [0.56-1.51],0.7457554495609873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROS,Uroporphyrinogen-III synthase,23520,31,0.82 [0.47-1.44],0.4859885419713025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USO1,General vesicular transport factor p115,27720,38,0.89 [0.64-1.22],0.4526310417099572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24076,32,0.93 [0.58-1.48],0.7581355903314627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24123,32,0.75 [0.25-2.26],0.6143975699197923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23415,31,1.03 [0.70-1.52],0.8631145225210897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27343,37,1.00 [0.74-1.35],0.992890493238682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UXS1,UDP-glucuronic acid decarboxylase 1,27162,39,0.82 [0.46-1.47],0.5030583770372767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP5,Vesicle-associated membrane protein 5,27343,37,1.52 [1.06-2.18],0.0220890225628991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP8,Vesicle-associated membrane protein 8,23505,32,0.91 [0.62-1.34],0.6276439146948352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASH1,Tubulinyl-Tyr carboxypeptidase 1,27833,38,0.98 [0.69-1.38],0.9093718428708084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASN,Vasorin,27397,39,0.49 [0.18-1.35],0.1651287150661526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASP,Vasodilator-stimulated phosphoprotein,24214,32,0.79 [0.49-1.26],0.3163227817695803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27720,38,0.30 [0.07-1.34],0.1143493772113217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAV3,Guanine nucleotide exchange factor VAV3,23416,30,0.80 [0.56-1.14],0.2165362612466503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAM1,Vascular cell adhesion protein 1,27890,39,1.01 [0.35-2.93],0.9780965849851784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAN,Versican core protein,28109,39,1.37 [0.54-3.46],0.5025887789616825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCPKMT,Protein-lysine methyltransferase METTL21D,23333,31,0.73 [0.42-1.26],0.2577332652989135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFA,Vascular endothelial growth factor A,28088,39,0.97 [0.60-1.59],0.9180393675018792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFB,Vascular endothelial growth factor B,23505,32,0.94 [0.29-3.00],0.9104962290636136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFC,Vascular endothelial growth factor C,27911,38,0.82 [0.50-1.36],0.4416879433066968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFD,Vascular endothelial growth factor D,28133,39,0.66 [0.39-1.12],0.1216935018855424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VGF,Neurosecretory protein VGF,24155,32,0.32 [0.10-0.96],0.0428406544744425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIM,Vimentin,27343,37,1.00 [0.78-1.28],0.9787219598224972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIPR1,Vasoactive intestinal polypeptide receptor 1,23514,31,1.22 [0.36-4.17],0.7526935209917667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIT,Vitrin,24190,32,2.17 [0.93-5.04],0.0721592273549663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VMO1,Vitelline membrane outer layer protein 1 homolog,27720,38,0.96 [0.63-1.47],0.8671098763983278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN1,Pantetheinase,24214,32,0.70 [0.46-1.06],0.0950334411241064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN2,Vascular non-inflammatory molecule 2,27720,38,1.70 [0.89-3.25],0.1110131254626146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23748,32,0.69 [0.40-1.21],0.1956255671630526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS37A,Vacuolar protein sorting-associated protein 37A,27720,38,0.92 [0.64-1.33],0.6616267754054554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS4B,Vacuolar protein sorting-associated protein 4B,24076,32,0.92 [0.64-1.31],0.6353378264088748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS53,Vacuolar protein sorting-associated protein 53 homolog,27720,38,0.93 [0.64-1.36],0.717378287060743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10,V-set and immunoglobulin domain-containing protein 10,24076,32,0.70 [0.24-1.99],0.4988372858655043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23415,31,0.31 [0.09-1.01],0.051403237180706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG2,V-set and immunoglobulin domain-containing protein 2,24076,32,1.46 [0.86-2.47],0.1604215275016917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG4,V-set and immunoglobulin domain-containing protein 4,27798,38,1.60 [0.79-3.25],0.1928419222580788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27807,37,0.67 [0.40-1.12],0.1259015886908368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSNL1,Visinin-like protein 1,24123,32,1.35 [0.64-2.84],0.432111598866593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM1,V-set and transmembrane domain-containing protein 1,27189,38,0.75 [0.41-1.37],0.3500588104506401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2B,V-set and transmembrane domain-containing protein 2B,23748,32,0.92 [0.38-2.22],0.8594594444222244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27343,37,0.73 [0.42-1.29],0.2811802587784746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28109,39,0.96 [0.65-1.42],0.8371776695449935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27162,39,0.63 [0.25-1.57],0.31937831103696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23650,32,0.68 [0.36-1.29],0.2365202176140683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA1,von Willebrand factor A domain-containing protein 1,28060,39,0.82 [0.42-1.60],0.5533048518989739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA5A,von Willebrand factor A domain-containing protein 5A,23333,31,0.66 [0.34-1.29],0.2271056588179613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2,Brorin,27560,38,1.22 [0.58-2.55],0.5957816799151474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2L,von Willebrand factor C domain-containing protein 2-like,24155,32,0.86 [0.62-1.19],0.3657770567379801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWF,von Willebrand factor,28187,37,1.17 [0.80-1.73],0.4152155087379778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WARS,"Tryptophan--tRNA ligase, cytoplasmic",27836,38,1.95 [0.93-4.10],0.0777038451637881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WAS,Wiskott-Aldrich syndrome protein,27328,39,0.75 [0.48-1.18],0.2102627430589955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF1,Wiskott-Aldrich syndrome protein family member 1,27343,37,0.90 [0.66-1.24],0.5152473559061939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF3,Wiskott-Aldrich syndrome protein family member 3,27189,38,0.87 [0.64-1.20],0.40462180497029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASHC3,WASH complex subunit 3,24123,32,0.85 [0.53-1.34],0.4806854465387596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASL,Neural Wiskott-Aldrich syndrome protein,23505,32,0.85 [0.45-1.60],0.6099159456710814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WDR46,WD repeat-containing protein 46,24076,32,0.78 [0.29-2.11],0.6277168069114688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC1,WAP four-disulfide core domain protein 1,23599,31,1.15 [0.64-2.06],0.6411115531565619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC12,WAP four-disulfide core domain protein 12,28045,39,0.74 [0.47-1.17],0.1988550488297813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC2,WAP four-disulfide core domain protein 2,26406,38,2.12 [1.11-4.06],0.022791725327413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27568,38,0.59 [0.29-1.19],0.1392162433555366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",27873,39,0.40 [0.24-0.67],0.0005393526634274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WIF1,Wnt inhibitory factor 1,28097,39,1.20 [0.53-2.73],0.665411894449899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WNT9A,Protein Wnt-9a,27328,39,0.98 [0.35-2.78],0.9769890204165976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27656,38,0.94 [0.55-1.62],0.8312789044797932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XCL1,Lymphotactin,28097,39,1.24 [0.79-1.95],0.3516161375698636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XG,Glycoprotein Xg,28042,36,0.74 [0.31-1.77],0.5010401501901469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XIAP,E3 ubiquitin-protein ligase XIAP,23505,32,0.75 [0.41-1.38],0.3547569139142059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XPNPEP2,Xaa-Pro aminopeptidase 2,27911,38,0.88 [0.68-1.15],0.3522734612961975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XRCC4,DNA repair protein XRCC4,27189,38,0.50 [0.22-1.17],0.1097253524628265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YAP1,Transcriptional coactivator YAP1,24123,32,1.32 [0.40-4.39],0.6489741030257588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24098,32,0.99 [0.79-1.24],0.9287110837477216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YES1,Tyrosine-protein kinase Yes,27720,38,0.97 [0.76-1.25],0.8301426805960511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YJU2,Splicing factor YJU2,24076,32,0.51 [0.17-1.54],0.2336833615698467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YOD1,Ubiquitin thioesterase OTU1,23415,31,0.93 [0.53-1.62],0.7921373455029312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YTHDF3,YTH domain-containing family protein 3,27328,39,0.94 [0.67-1.31],0.6958121814164667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YWHAQ,14-3-3 protein theta,23650,32,0.87 [0.55-1.39],0.5698797932521278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YY1,Transcriptional repressor protein YY1,23505,32,0.61 [0.17-2.20],0.4538355692092902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBP1,Z-DNA-binding protein 1,23505,32,0.43 [0.14-1.36],0.1507550117759299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB16,Zinc finger and BTB domain-containing protein 16,27162,39,0.75 [0.49-1.15],0.1890408977947223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB17,Zinc finger and BTB domain-containing protein 17,27343,37,1.43 [0.85-2.41],0.176296696235446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23415,31,0.74 [0.37-1.48],0.3984380664926009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZFYVE19,Abscission/NoCut checkpoint regulator,24098,32,0.85 [0.59-1.24],0.406239985783088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZHX2,Zinc fingers and homeoboxes protein 2,24123,32,0.90 [0.32-2.55],0.8386863147795494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF174,Zinc finger protein 174,23505,32,0.73 [0.24-2.23],0.5785459346561421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF75D,Zinc finger protein 75D,23748,32,0.50 [0.24-1.01],0.0545862879347889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF830,Zinc finger protein 830,24076,32,0.92 [0.58-1.45],0.7233098412558643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRD2,Protein ZNRD2,24098,32,1.05 [0.65-1.69],0.8577948130685407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24076,32,0.84 [0.43-1.64],0.6096348789490487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP3,Zona pellucida sperm-binding protein 3,23514,31,1.13 [0.97-1.31],0.1242754913523085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP4,Zona pellucida sperm-binding protein 4,23333,31,0.48 [0.11-2.03],0.3161705792751745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZPR1,Zinc finger protein ZPR1,23416,30,1.15 [0.84-1.57],0.384828786222545
